AGE_ADJUSTED_CI_LOWER|AGE_ADJUSTED_CI_UPPER|AGE_ADJUSTED_RATE|COUNT|ICCC_GROUP|POPULATION|AGE|RACE|SEX|YEAR|CRUDE_CI_LOWER|CRUDE_CI_UPPER|CRUDE_RATE
142.3|148.5|145.4|8498|All ICCC Groups Combined|58588724|0-14|All Races|Male and Female|1999|||
43.6|47.1|45.3|2651|I Leukemias, myeloproliferative & myelodysplastic diseases|58588724|0-14|All Races|Male and Female|1999|||
34.0|37.1|35.5|2081|I(a) Lymphoid leukemias|58588724|0-14|All Races|Male and Female|1999|||
6.9|8.3|7.6|441|I(b) Acute myeloid leukemias|58588724|0-14|All Races|Male and Female|1999|||
0.4|0.9|0.6|36|I(c) Chronic myeloproliferative diseases|58588724|0-14|All Races|Male and Female|1999|||
~|~|~|~|I(d) Myelodysplastic syndrome and other myeloproliferative diseases|58588724|0-14|All Races|Male and Female|1999|||
1.1|1.7|1.4|82|I(e) Unspecified and other specified leukemias|58588724|0-14|All Races|Male and Female|1999|||
14.3|16.4|15.3|897|II Lymphomas and reticuloendothelial neoplasms|58588724|0-14|All Races|Male and Female|1999|||
4.9|6.1|5.5|319|II(a) Hodgkin lymphomas|58588724|0-14|All Races|Male and Female|1999|||
5.4|6.6|6.0|350|II(b) Non-Hodgkin lymphomas (except Burkitt lymphoma)|58588724|0-14|All Races|Male and Female|1999|||
2.1|3.0|2.5|148|II(c) Burkitt lymphoma|58588724|0-14|All Races|Male and Female|1999|||
0.7|1.2|0.9|52|II(d) Miscellaneous lymphoreticular neoplasms|58588724|0-14|All Races|Male and Female|1999|||
0.3|0.7|0.5|28|II(e) Unspecified lymphomas|58588724|0-14|All Races|Male and Female|1999|||
30.1|33.0|31.6|1850|III CNS and misc intracranial and intraspinal neoplasms|58588724|0-14|All Races|Male and Female|1999|||
2.6|3.5|3.0|174|III(a) Ependymomas and choroid plexus tumor|58588724|0-14|All Races|Male and Female|1999|||
13.4|15.4|14.4|843|III(b) Astrocytomas|58588724|0-14|All Races|Male and Female|1999|||
7.1|8.6|7.8|460|III(c) Intracranial and intraspinal embryonal tumors|58588724|0-14|All Races|Male and Female|1999|||
4.6|5.7|5.1|301|III(d) Other gliomas|58588724|0-14|All Races|Male and Female|1999|||
0.3|0.7|0.5|30|III(e) Other specified intracranial & intraspinal neoplasms|58588724|0-14|All Races|Male and Female|1999|||
0.5|1.0|0.7|42|III(f) Unspecified intracranial and intraspinal neoplasms|58588724|0-14|All Races|Male and Female|1999|||
9.8|11.5|10.6|617|IV Neuroblastoma and other peripheral nervous cell tumors|58588724|0-14|All Races|Male and Female|1999|||
9.6|11.3|10.4|607|IV(a) Neuroblastoma and ganglioneuroblastoma|58588724|0-14|All Races|Male and Female|1999|||
~|~|~|~|IV(b) Other peripheral nervous cell tumors|58588724|0-14|All Races|Male and Female|1999|||
8.7|10.3|9.5|554|IX Soft tissue and other extraosseous sarcomas|58588724|0-14|All Races|Male and Female|1999|||
4.4|5.5|4.9|289|IX(a) Rhabdomyosarcomas|58588724|0-14|All Races|Male and Female|1999|||
0.7|1.2|0.9|55|IX(b) Fibrosarcomas, peripheral nerve sheath tumors & other fibrous neoplams|58588724|0-14|All Races|Male and Female|1999|||
~|~|~|~|IX(c) Kaposi sarcoma|58588724|0-14|All Races|Male and Female|1999|||
2.3|3.1|2.7|156|IX(d) Other specified soft tissue sarcomas|58588724|0-14|All Races|Male and Female|1999|||
0.7|1.2|0.9|53|IX(e) Unspecified soft tissue sarcomas|58588724|0-14|All Races|Male and Female|1999|||
0.2|0.4|0.3|16|Not classified by ICCC|58588724|0-14|All Races|Male and Female|1999|||
3.7|4.7|4.2|243|V Retinoblastoma|58588724|0-14|All Races|Male and Female|1999|||
7.3|8.8|8.0|468|VI Renal tumors|58588724|0-14|All Races|Male and Female|1999|||
6.9|8.3|7.6|442|VI(a) Nephroblastoma and other nonepithelial renal tumors|58588724|0-14|All Races|Male and Female|1999|||
0.2|0.6|0.4|23|VI(b) Renal carcinomas|58588724|0-14|All Races|Male and Female|1999|||
~|~|~|~|VI(c) Unspecified malignant renal tumors|58588724|0-14|All Races|Male and Female|1999|||
1.8|2.5|2.1|123|VII Hepatic tumors|58588724|0-14|All Races|Male and Female|1999|||
1.4|2.1|1.7|101|VII(a) Hepatoblastoma|58588724|0-14|All Races|Male and Female|1999|||
0.2|0.6|0.4|22|VII(b) Hepatic carcinomas|58588724|0-14|All Races|Male and Female|1999|||
~|~|~|~|VII(c) Unspecified malignant hepatic tumors|58588724|0-14|All Races|Male and Female|1999|||
6.5|7.9|7.2|420|VIII Malignant bone tumors|58588724|0-14|All Races|Male and Female|1999|||
3.7|4.8|4.2|246|VIII(a) Osteosarcomas|58588724|0-14|All Races|Male and Female|1999|||
~|~|~|~|VIII(b) Chondrosarcomas|58588724|0-14|All Races|Male and Female|1999|||
2.0|2.8|2.3|137|VIII(c) Ewing tumor and related sarcomas of bone|58588724|0-14|All Races|Male and Female|1999|||
0.2|0.5|0.3|19|VIII(d) Other specified malignant bone tumors|58588724|0-14|All Races|Male and Female|1999|||
~|~|~|~|VIII(e) Unspecified malignant bone tumors|58588724|0-14|All Races|Male and Female|1999|||
4.4|5.6|5.0|289|X Germ cell, trophoblastic tumors & neoplasms of gonads|58588724|0-14|All Races|Male and Female|1999|||
1.0|1.6|1.3|75|X(a) Intracranial & intraspinal germ cell tumors|58588724|0-14|All Races|Male and Female|1999|||
1.1|1.7|1.3|78|X(b) Malignant extracranial & extragonadal germ cell tumors|58588724|0-14|All Races|Male and Female|1999|||
1.8|2.5|2.1|124|X(c) Malignant gonadal germ cell tumors|58588724|0-14|All Races|Male and Female|1999|||
~|~|~|~|X(d) Gonadal carcinomas|58588724|0-14|All Races|Male and Female|1999|||
~|~|~|~|X(e) Other and unspecified malignant gonadal tumors|58588724|0-14|All Races|Male and Female|1999|||
5.2|6.5|5.8|340|XI Other malignant epithelial neoplasms and malignant melanomas|58588724|0-14|All Races|Male and Female|1999|||
~|~|~|~|XI(a) Adrenocortical carcinomas|58588724|0-14|All Races|Male and Female|1999|||
1.5|2.2|1.8|108|XI(b) Thyroid carcinomas|58588724|0-14|All Races|Male and Female|1999|||
0.2|0.6|0.4|22|XI(c) Nasopharyngeal carcinomas|58588724|0-14|All Races|Male and Female|1999|||
1.4|2.1|1.8|102|XI(d) Malignant melanomas|58588724|0-14|All Races|Male and Female|1999|||
~|~|~|~|XI(e) Skin carcinomas|58588724|0-14|All Races|Male and Female|1999|||
1.3|1.9|1.6|91|XI(f) Other and unspecified carcinomas|58588724|0-14|All Races|Male and Female|1999|||
0.3|0.7|0.5|30|XII Other and unspecified malignant neoplasms|58588724|0-14|All Races|Male and Female|1999|||
~|~|~|~|XII(a) Other specified malignant tumors|58588724|0-14|All Races|Male and Female|1999|||
0.2|0.5|0.3|19|XII(b) Other unspecified malignant tumors|58588724|0-14|All Races|Male and Female|1999|||
146.7|152.9|149.8|8803|All ICCC Groups Combined|58914904|0-14|All Races|Male and Female|2000|||
44.2|47.7|45.9|2695|I Leukemias, myeloproliferative & myelodysplastic diseases|58914904|0-14|All Races|Male and Female|2000|||
35.5|38.6|37.1|2173|I(a) Lymphoid leukemias|58914904|0-14|All Races|Male and Female|2000|||
5.9|7.3|6.6|386|I(b) Acute myeloid leukemias|58914904|0-14|All Races|Male and Female|2000|||
0.6|1.0|0.8|45|I(c) Chronic myeloproliferative diseases|58914904|0-14|All Races|Male and Female|2000|||
~|~|~|~|I(d) Myelodysplastic syndrome and other myeloproliferative diseases|58914904|0-14|All Races|Male and Female|2000|||
1.1|1.7|1.4|82|I(e) Unspecified and other specified leukemias|58914904|0-14|All Races|Male and Female|2000|||
15.5|17.6|16.5|977|II Lymphomas and reticuloendothelial neoplasms|58914904|0-14|All Races|Male and Female|2000|||
5.2|6.5|5.8|346|II(a) Hodgkin lymphomas|58914904|0-14|All Races|Male and Female|2000|||
5.4|6.6|6.0|353|II(b) Non-Hodgkin lymphomas (except Burkitt lymphoma)|58914904|0-14|All Races|Male and Female|2000|||
2.4|3.3|2.8|166|II(c) Burkitt lymphoma|58914904|0-14|All Races|Male and Female|2000|||
1.0|1.6|1.3|75|II(d) Miscellaneous lymphoreticular neoplasms|58914904|0-14|All Races|Male and Female|2000|||
0.4|0.9|0.6|37|II(e) Unspecified lymphomas|58914904|0-14|All Races|Male and Female|2000|||
31.7|34.7|33.2|1952|III CNS and misc intracranial and intraspinal neoplasms|58914904|0-14|All Races|Male and Female|2000|||
2.3|3.1|2.7|158|III(a) Ependymomas and choroid plexus tumor|58914904|0-14|All Races|Male and Female|2000|||
16.1|18.2|17.1|1008|III(b) Astrocytomas|58914904|0-14|All Races|Male and Female|2000|||
6.9|8.3|7.6|445|III(c) Intracranial and intraspinal embryonal tumors|58914904|0-14|All Races|Male and Female|2000|||
4.1|5.2|4.7|274|III(d) Other gliomas|58914904|0-14|All Races|Male and Female|2000|||
0.3|0.6|0.4|26|III(e) Other specified intracranial & intraspinal neoplasms|58914904|0-14|All Races|Male and Female|2000|||
0.5|0.9|0.7|41|III(f) Unspecified intracranial and intraspinal neoplasms|58914904|0-14|All Races|Male and Female|2000|||
9.3|10.9|10.1|588|IV Neuroblastoma and other peripheral nervous cell tumors|58914904|0-14|All Races|Male and Female|2000|||
9.2|10.8|9.9|581|IV(a) Neuroblastoma and ganglioneuroblastoma|58914904|0-14|All Races|Male and Female|2000|||
~|~|~|~|IV(b) Other peripheral nervous cell tumors|58914904|0-14|All Races|Male and Female|2000|||
9.6|11.3|10.4|615|IX Soft tissue and other extraosseous sarcomas|58914904|0-14|All Races|Male and Female|2000|||
4.7|5.9|5.3|309|IX(a) Rhabdomyosarcomas|58914904|0-14|All Races|Male and Female|2000|||
0.7|1.2|1.0|56|IX(b) Fibrosarcomas, peripheral nerve sheath tumors & other fibrous neoplams|58914904|0-14|All Races|Male and Female|2000|||
~|~|~|~|IX(c) Kaposi sarcoma|58914904|0-14|All Races|Male and Female|2000|||
2.7|3.7|3.2|188|IX(d) Other specified soft tissue sarcomas|58914904|0-14|All Races|Male and Female|2000|||
0.8|1.3|1.0|61|IX(e) Unspecified soft tissue sarcomas|58914904|0-14|All Races|Male and Female|2000|||
~|~|~|~|Not classified by ICCC|58914904|0-14|All Races|Male and Female|2000|||
3.9|5.0|4.4|256|V Retinoblastoma|58914904|0-14|All Races|Male and Female|2000|||
8.1|9.6|8.8|515|VI Renal tumors|58914904|0-14|All Races|Male and Female|2000|||
7.7|9.2|8.4|492|VI(a) Nephroblastoma and other nonepithelial renal tumors|58914904|0-14|All Races|Male and Female|2000|||
0.2|0.6|0.4|22|VI(b) Renal carcinomas|58914904|0-14|All Races|Male and Female|2000|||
~|~|~|~|VI(c) Unspecified malignant renal tumors|58914904|0-14|All Races|Male and Female|2000|||
1.8|2.6|2.2|129|VII Hepatic tumors|58914904|0-14|All Races|Male and Female|2000|||
1.6|2.3|1.9|113|VII(a) Hepatoblastoma|58914904|0-14|All Races|Male and Female|2000|||
~|~|~|~|VII(b) Hepatic carcinomas|58914904|0-14|All Races|Male and Female|2000|||
~|~|~|~|VII(c) Unspecified malignant hepatic tumors|58914904|0-14|All Races|Male and Female|2000|||
5.9|7.2|6.5|386|VIII Malignant bone tumors|58914904|0-14|All Races|Male and Female|2000|||
3.1|4.1|3.6|211|VIII(a) Osteosarcomas|58914904|0-14|All Races|Male and Female|2000|||
~|~|~|~|VIII(b) Chondrosarcomas|58914904|0-14|All Races|Male and Female|2000|||
2.2|3.1|2.6|155|VIII(c) Ewing tumor and related sarcomas of bone|58914904|0-14|All Races|Male and Female|2000|||
~|~|~|~|VIII(d) Other specified malignant bone tumors|58914904|0-14|All Races|Male and Female|2000|||
~|~|~|~|VIII(e) Unspecified malignant bone tumors|58914904|0-14|All Races|Male and Female|2000|||
4.4|5.5|4.9|291|X Germ cell, trophoblastic tumors & neoplasms of gonads|58914904|0-14|All Races|Male and Female|2000|||
1.2|1.8|1.5|86|X(a) Intracranial & intraspinal germ cell tumors|58914904|0-14|All Races|Male and Female|2000|||
0.9|1.4|1.1|66|X(b) Malignant extracranial & extragonadal germ cell tumors|58914904|0-14|All Races|Male and Female|2000|||
1.8|2.6|2.2|128|X(c) Malignant gonadal germ cell tumors|58914904|0-14|All Races|Male and Female|2000|||
~|~|~|~|X(d) Gonadal carcinomas|58914904|0-14|All Races|Male and Female|2000|||
~|~|~|~|X(e) Other and unspecified malignant gonadal tumors|58914904|0-14|All Races|Male and Female|2000|||
5.2|6.4|5.8|341|XI Other malignant epithelial neoplasms and malignant melanomas|58914904|0-14|All Races|Male and Female|2000|||
0.2|0.5|0.3|18|XI(a) Adrenocortical carcinomas|58914904|0-14|All Races|Male and Female|2000|||
1.6|2.3|1.9|112|XI(b) Thyroid carcinomas|58914904|0-14|All Races|Male and Female|2000|||
0.2|0.5|0.3|19|XI(c) Nasopharyngeal carcinomas|58914904|0-14|All Races|Male and Female|2000|||
1.4|2.1|1.8|104|XI(d) Malignant melanomas|58914904|0-14|All Races|Male and Female|2000|||
~|~|~|~|XI(e) Skin carcinomas|58914904|0-14|All Races|Male and Female|2000|||
1.1|1.8|1.4|85|XI(f) Other and unspecified carcinomas|58914904|0-14|All Races|Male and Female|2000|||
0.5|1.0|0.7|44|XII Other and unspecified malignant neoplasms|58914904|0-14|All Races|Male and Female|2000|||
~|~|~|~|XII(a) Other specified malignant tumors|58914904|0-14|All Races|Male and Female|2000|||
0.4|0.7|0.5|31|XII(b) Other unspecified malignant tumors|58914904|0-14|All Races|Male and Female|2000|||
152.9|159.3|156.1|9328|All ICCC Groups Combined|59815030|0-14|All Races|Male and Female|2001|||
48.7|52.3|50.5|3003|I Leukemias, myeloproliferative & myelodysplastic diseases|59815030|0-14|All Races|Male and Female|2001|||
37.1|40.3|38.7|2294|I(a) Lymphoid leukemias|59815030|0-14|All Races|Male and Female|2001|||
6.6|8.0|7.3|438|I(b) Acute myeloid leukemias|59815030|0-14|All Races|Male and Female|2001|||
1.3|2.0|1.7|100|I(c) Chronic myeloproliferative diseases|59815030|0-14|All Races|Male and Female|2001|||
1.3|2.0|1.6|96|I(d) Myelodysplastic syndrome and other myeloproliferative diseases|59815030|0-14|All Races|Male and Female|2001|||
1.0|1.6|1.3|75|I(e) Unspecified and other specified leukemias|59815030|0-14|All Races|Male and Female|2001|||
15.1|17.1|16.1|967|II Lymphomas and reticuloendothelial neoplasms|59815030|0-14|All Races|Male and Female|2001|||
5.3|6.5|5.9|356|II(a) Hodgkin lymphomas|59815030|0-14|All Races|Male and Female|2001|||
5.9|7.2|6.5|390|II(b) Non-Hodgkin lymphomas (except Burkitt lymphoma)|59815030|0-14|All Races|Male and Female|2001|||
1.9|2.7|2.3|135|II(c) Burkitt lymphoma|59815030|0-14|All Races|Male and Female|2001|||
0.8|1.3|1.0|61|II(d) Miscellaneous lymphoreticular neoplasms|59815030|0-14|All Races|Male and Female|2001|||
0.3|0.6|0.4|25|II(e) Unspecified lymphomas|59815030|0-14|All Races|Male and Female|2001|||
31.4|34.3|32.8|1957|III CNS and misc intracranial and intraspinal neoplasms|59815030|0-14|All Races|Male and Female|2001|||
2.3|3.2|2.7|164|III(a) Ependymomas and choroid plexus tumor|59815030|0-14|All Races|Male and Female|2001|||
15.3|17.4|16.3|973|III(b) Astrocytomas|59815030|0-14|All Races|Male and Female|2001|||
6.7|8.1|7.3|437|III(c) Intracranial and intraspinal embryonal tumors|59815030|0-14|All Races|Male and Female|2001|||
4.8|6.0|5.4|320|III(d) Other gliomas|59815030|0-14|All Races|Male and Female|2001|||
0.5|0.9|0.7|42|III(e) Other specified intracranial & intraspinal neoplasms|59815030|0-14|All Races|Male and Female|2001|||
0.2|0.5|0.3|21|III(f) Unspecified intracranial and intraspinal neoplasms|59815030|0-14|All Races|Male and Female|2001|||
10.7|12.5|11.6|693|IV Neuroblastoma and other peripheral nervous cell tumors|59815030|0-14|All Races|Male and Female|2001|||
10.6|12.3|11.4|685|IV(a) Neuroblastoma and ganglioneuroblastoma|59815030|0-14|All Races|Male and Female|2001|||
~|~|~|~|IV(b) Other peripheral nervous cell tumors|59815030|0-14|All Races|Male and Female|2001|||
9.7|11.3|10.5|627|IX Soft tissue and other extraosseous sarcomas|59815030|0-14|All Races|Male and Female|2001|||
4.6|5.8|5.2|308|IX(a) Rhabdomyosarcomas|59815030|0-14|All Races|Male and Female|2001|||
1.0|1.6|1.2|75|IX(b) Fibrosarcomas, peripheral nerve sheath tumors & other fibrous neoplams|59815030|0-14|All Races|Male and Female|2001|||
~|~|~|~|IX(c) Kaposi sarcoma|59815030|0-14|All Races|Male and Female|2001|||
2.6|3.5|3.0|184|IX(d) Other specified soft tissue sarcomas|59815030|0-14|All Races|Male and Female|2001|||
0.8|1.3|1.0|60|IX(e) Unspecified soft tissue sarcomas|59815030|0-14|All Races|Male and Female|2001|||
~|~|~|~|Not classified by ICCC|59815030|0-14|All Races|Male and Female|2001|||
3.9|5.0|4.4|266|V Retinoblastoma|59815030|0-14|All Races|Male and Female|2001|||
7.9|9.4|8.6|512|VI Renal tumors|59815030|0-14|All Races|Male and Female|2001|||
7.5|9.0|8.2|489|VI(a) Nephroblastoma and other nonepithelial renal tumors|59815030|0-14|All Races|Male and Female|2001|||
0.2|0.5|0.3|21|VI(b) Renal carcinomas|59815030|0-14|All Races|Male and Female|2001|||
~|~|~|~|VI(c) Unspecified malignant renal tumors|59815030|0-14|All Races|Male and Female|2001|||
1.8|2.5|2.1|126|VII Hepatic tumors|59815030|0-14|All Races|Male and Female|2001|||
1.4|2.0|1.7|100|VII(a) Hepatoblastoma|59815030|0-14|All Races|Male and Female|2001|||
0.3|0.6|0.4|25|VII(b) Hepatic carcinomas|59815030|0-14|All Races|Male and Female|2001|||
~|~|~|~|VII(c) Unspecified malignant hepatic tumors|59815030|0-14|All Races|Male and Female|2001|||
6.2|7.6|6.9|416|VIII Malignant bone tumors|59815030|0-14|All Races|Male and Female|2001|||
3.3|4.3|3.8|230|VIII(a) Osteosarcomas|59815030|0-14|All Races|Male and Female|2001|||
~|~|~|~|VIII(b) Chondrosarcomas|59815030|0-14|All Races|Male and Female|2001|||
2.2|3.0|2.6|156|VIII(c) Ewing tumor and related sarcomas of bone|59815030|0-14|All Races|Male and Female|2001|||
~|~|~|~|VIII(d) Other specified malignant bone tumors|59815030|0-14|All Races|Male and Female|2001|||
~|~|~|~|VIII(e) Unspecified malignant bone tumors|59815030|0-14|All Races|Male and Female|2001|||
4.5|5.6|5.0|303|X Germ cell, trophoblastic tumors & neoplasms of gonads|59815030|0-14|All Races|Male and Female|2001|||
1.0|1.6|1.3|79|X(a) Intracranial & intraspinal germ cell tumors|59815030|0-14|All Races|Male and Female|2001|||
1.1|1.7|1.4|84|X(b) Malignant extracranial & extragonadal germ cell tumors|59815030|0-14|All Races|Male and Female|2001|||
1.7|2.4|2.0|121|X(c) Malignant gonadal germ cell tumors|59815030|0-14|All Races|Male and Female|2001|||
~|~|~|~|X(d) Gonadal carcinomas|59815030|0-14|All Races|Male and Female|2001|||
~|~|~|~|X(e) Other and unspecified malignant gonadal tumors|59815030|0-14|All Races|Male and Female|2001|||
6.0|7.3|6.6|400|XI Other malignant epithelial neoplasms and malignant melanomas|59815030|0-14|All Races|Male and Female|2001|||
0.2|0.5|0.3|17|XI(a) Adrenocortical carcinomas|59815030|0-14|All Races|Male and Female|2001|||
1.9|2.7|2.3|140|XI(b) Thyroid carcinomas|59815030|0-14|All Races|Male and Female|2001|||
0.2|0.5|0.3|19|XI(c) Nasopharyngeal carcinomas|59815030|0-14|All Races|Male and Female|2001|||
1.7|2.4|2.0|121|XI(d) Malignant melanomas|59815030|0-14|All Races|Male and Female|2001|||
~|~|~|~|XI(e) Skin carcinomas|59815030|0-14|All Races|Male and Female|2001|||
1.3|2.0|1.7|100|XI(f) Other and unspecified carcinomas|59815030|0-14|All Races|Male and Female|2001|||
0.5|1.0|0.7|43|XII Other and unspecified malignant neoplasms|59815030|0-14|All Races|Male and Female|2001|||
0.2|0.6|0.4|22|XII(a) Other specified malignant tumors|59815030|0-14|All Races|Male and Female|2001|||
0.2|0.5|0.4|21|XII(b) Other unspecified malignant tumors|59815030|0-14|All Races|Male and Female|2001|||
151.8|158.1|154.9|9269|All ICCC Groups Combined|59834318|0-14|All Races|Male and Female|2002|||
47.6|51.2|49.4|2942|I Leukemias, myeloproliferative & myelodysplastic diseases|59834318|0-14|All Races|Male and Female|2002|||
35.5|38.6|37.0|2201|I(a) Lymphoid leukemias|59834318|0-14|All Races|Male and Female|2002|||
7.2|8.6|7.9|474|I(b) Acute myeloid leukemias|59834318|0-14|All Races|Male and Female|2002|||
1.3|1.9|1.6|94|I(c) Chronic myeloproliferative diseases|59834318|0-14|All Races|Male and Female|2002|||
1.3|1.9|1.6|95|I(d) Myelodysplastic syndrome and other myeloproliferative diseases|59834318|0-14|All Races|Male and Female|2002|||
1.0|1.6|1.3|78|I(e) Unspecified and other specified leukemias|59834318|0-14|All Races|Male and Female|2002|||
14.7|16.7|15.6|943|II Lymphomas and reticuloendothelial neoplasms|59834318|0-14|All Races|Male and Female|2002|||
4.9|6.1|5.5|335|II(a) Hodgkin lymphomas|59834318|0-14|All Races|Male and Female|2002|||
5.5|6.7|6.1|365|II(b) Non-Hodgkin lymphomas (except Burkitt lymphoma)|59834318|0-14|All Races|Male and Female|2002|||
2.3|3.2|2.7|163|II(c) Burkitt lymphoma|59834318|0-14|All Races|Male and Female|2002|||
0.9|1.4|1.1|68|II(d) Miscellaneous lymphoreticular neoplasms|59834318|0-14|All Races|Male and Female|2002|||
~|~|~|~|II(e) Unspecified lymphomas|59834318|0-14|All Races|Male and Female|2002|||
33.0|36.0|34.5|2054|III CNS and misc intracranial and intraspinal neoplasms|59834318|0-14|All Races|Male and Female|2002|||
3.1|4.1|3.6|214|III(a) Ependymomas and choroid plexus tumor|59834318|0-14|All Races|Male and Female|2002|||
15.4|17.4|16.4|977|III(b) Astrocytomas|59834318|0-14|All Races|Male and Female|2002|||
6.7|8.1|7.4|441|III(c) Intracranial and intraspinal embryonal tumors|59834318|0-14|All Races|Male and Female|2002|||
5.3|6.6|6.0|354|III(d) Other gliomas|59834318|0-14|All Races|Male and Female|2002|||
0.5|1.0|0.7|43|III(e) Other specified intracranial & intraspinal neoplasms|59834318|0-14|All Races|Male and Female|2002|||
0.3|0.6|0.4|25|III(f) Unspecified intracranial and intraspinal neoplasms|59834318|0-14|All Races|Male and Female|2002|||
10.2|11.9|11.0|659|IV Neuroblastoma and other peripheral nervous cell tumors|59834318|0-14|All Races|Male and Female|2002|||
10.1|11.8|10.9|651|IV(a) Neuroblastoma and ganglioneuroblastoma|59834318|0-14|All Races|Male and Female|2002|||
~|~|~|~|IV(b) Other peripheral nervous cell tumors|59834318|0-14|All Races|Male and Female|2002|||
10.0|11.7|10.9|651|IX Soft tissue and other extraosseous sarcomas|59834318|0-14|All Races|Male and Female|2002|||
4.8|6.0|5.4|319|IX(a) Rhabdomyosarcomas|59834318|0-14|All Races|Male and Female|2002|||
0.9|1.4|1.1|69|IX(b) Fibrosarcomas, peripheral nerve sheath tumors & other fibrous neoplams|59834318|0-14|All Races|Male and Female|2002|||
~|~|~|~|IX(c) Kaposi sarcoma|59834318|0-14|All Races|Male and Female|2002|||
3.0|3.9|3.4|208|IX(d) Other specified soft tissue sarcomas|59834318|0-14|All Races|Male and Female|2002|||
0.7|1.2|0.9|55|IX(e) Unspecified soft tissue sarcomas|59834318|0-14|All Races|Male and Female|2002|||
0.2|0.5|0.3|20|Not classified by ICCC|59834318|0-14|All Races|Male and Female|2002|||
3.3|4.3|3.7|224|V Retinoblastoma|59834318|0-14|All Races|Male and Female|2002|||
7.6|9.0|8.3|491|VI Renal tumors|59834318|0-14|All Races|Male and Female|2002|||
7.3|8.8|8.1|478|VI(a) Nephroblastoma and other nonepithelial renal tumors|59834318|0-14|All Races|Male and Female|2002|||
~|~|~|~|VI(b) Renal carcinomas|59834318|0-14|All Races|Male and Female|2002|||
~|~|~|~|VI(c) Unspecified malignant renal tumors|59834318|0-14|All Races|Male and Female|2002|||
1.6|2.3|1.9|114|VII Hepatic tumors|59834318|0-14|All Races|Male and Female|2002|||
1.2|1.9|1.5|92|VII(a) Hepatoblastoma|59834318|0-14|All Races|Male and Female|2002|||
0.2|0.5|0.3|21|VII(b) Hepatic carcinomas|59834318|0-14|All Races|Male and Female|2002|||
~|~|~|~|VII(c) Unspecified malignant hepatic tumors|59834318|0-14|All Races|Male and Female|2002|||
6.2|7.6|6.9|417|VIII Malignant bone tumors|59834318|0-14|All Races|Male and Female|2002|||
3.2|4.2|3.7|223|VIII(a) Osteosarcomas|59834318|0-14|All Races|Male and Female|2002|||
~|~|~|~|VIII(b) Chondrosarcomas|59834318|0-14|All Races|Male and Female|2002|||
2.2|3.1|2.6|157|VIII(c) Ewing tumor and related sarcomas of bone|59834318|0-14|All Races|Male and Female|2002|||
0.2|0.5|0.3|20|VIII(d) Other specified malignant bone tumors|59834318|0-14|All Races|Male and Female|2002|||
~|~|~|~|VIII(e) Unspecified malignant bone tumors|59834318|0-14|All Races|Male and Female|2002|||
4.7|5.9|5.3|318|X Germ cell, trophoblastic tumors & neoplasms of gonads|59834318|0-14|All Races|Male and Female|2002|||
1.1|1.7|1.4|85|X(a) Intracranial & intraspinal germ cell tumors|59834318|0-14|All Races|Male and Female|2002|||
1.2|1.8|1.5|88|X(b) Malignant extracranial & extragonadal germ cell tumors|59834318|0-14|All Races|Male and Female|2002|||
1.9|2.6|2.2|134|X(c) Malignant gonadal germ cell tumors|59834318|0-14|All Races|Male and Female|2002|||
~|~|~|~|X(d) Gonadal carcinomas|59834318|0-14|All Races|Male and Female|2002|||
~|~|~|~|X(e) Other and unspecified malignant gonadal tumors|59834318|0-14|All Races|Male and Female|2002|||
6.0|7.3|6.6|400|XI Other malignant epithelial neoplasms and malignant melanomas|59834318|0-14|All Races|Male and Female|2002|||
~|~|~|~|XI(a) Adrenocortical carcinomas|59834318|0-14|All Races|Male and Female|2002|||
1.7|2.4|2.0|122|XI(b) Thyroid carcinomas|59834318|0-14|All Races|Male and Female|2002|||
~|~|~|~|XI(c) Nasopharyngeal carcinomas|59834318|0-14|All Races|Male and Female|2002|||
1.9|2.7|2.3|140|XI(d) Malignant melanomas|59834318|0-14|All Races|Male and Female|2002|||
~|~|~|~|XI(e) Skin carcinomas|59834318|0-14|All Races|Male and Female|2002|||
1.4|2.1|1.7|104|XI(f) Other and unspecified carcinomas|59834318|0-14|All Races|Male and Female|2002|||
0.4|0.8|0.6|36|XII Other and unspecified malignant neoplasms|59834318|0-14|All Races|Male and Female|2002|||
0.2|0.5|0.3|21|XII(a) Other specified malignant tumors|59834318|0-14|All Races|Male and Female|2002|||
~|~|~|~|XII(b) Other unspecified malignant tumors|59834318|0-14|All Races|Male and Female|2002|||
149.0|155.2|152.1|9239|All ICCC Groups Combined|60628650|0-14|All Races|Male and Female|2003|||
45.9|49.4|47.6|2877|I Leukemias, myeloproliferative & myelodysplastic diseases|60628650|0-14|All Races|Male and Female|2003|||
34.4|37.5|35.9|2166|I(a) Lymphoid leukemias|60628650|0-14|All Races|Male and Female|2003|||
6.8|8.2|7.5|456|I(b) Acute myeloid leukemias|60628650|0-14|All Races|Male and Female|2003|||
1.2|1.8|1.5|89|I(c) Chronic myeloproliferative diseases|60628650|0-14|All Races|Male and Female|2003|||
1.5|2.2|1.8|109|I(d) Myelodysplastic syndrome and other myeloproliferative diseases|60628650|0-14|All Races|Male and Female|2003|||
0.7|1.2|0.9|57|I(e) Unspecified and other specified leukemias|60628650|0-14|All Races|Male and Female|2003|||
15.2|17.2|16.2|985|II Lymphomas and reticuloendothelial neoplasms|60628650|0-14|All Races|Male and Female|2003|||
5.3|6.5|5.9|363|II(a) Hodgkin lymphomas|60628650|0-14|All Races|Male and Female|2003|||
5.7|7.0|6.3|384|II(b) Non-Hodgkin lymphomas (except Burkitt lymphoma)|60628650|0-14|All Races|Male and Female|2003|||
2.3|3.1|2.7|162|II(c) Burkitt lymphoma|60628650|0-14|All Races|Male and Female|2003|||
0.9|1.4|1.1|69|II(d) Miscellaneous lymphoreticular neoplasms|60628650|0-14|All Races|Male and Female|2003|||
~|~|~|~|II(e) Unspecified lymphomas|60628650|0-14|All Races|Male and Female|2003|||
31.4|34.3|32.8|1985|III CNS and misc intracranial and intraspinal neoplasms|60628650|0-14|All Races|Male and Female|2003|||
2.1|2.9|2.5|152|III(a) Ependymomas and choroid plexus tumor|60628650|0-14|All Races|Male and Female|2003|||
15.3|17.4|16.3|989|III(b) Astrocytomas|60628650|0-14|All Races|Male and Female|2003|||
6.5|7.9|7.2|434|III(c) Intracranial and intraspinal embryonal tumors|60628650|0-14|All Races|Male and Female|2003|||
5.0|6.2|5.6|338|III(d) Other gliomas|60628650|0-14|All Races|Male and Female|2003|||
0.6|1.1|0.9|52|III(e) Other specified intracranial & intraspinal neoplasms|60628650|0-14|All Races|Male and Female|2003|||
0.2|0.5|0.3|20|III(f) Unspecified intracranial and intraspinal neoplasms|60628650|0-14|All Races|Male and Female|2003|||
9.9|11.6|10.7|653|IV Neuroblastoma and other peripheral nervous cell tumors|60628650|0-14|All Races|Male and Female|2003|||
9.8|11.4|10.6|643|IV(a) Neuroblastoma and ganglioneuroblastoma|60628650|0-14|All Races|Male and Female|2003|||
~|~|~|~|IV(b) Other peripheral nervous cell tumors|60628650|0-14|All Races|Male and Female|2003|||
9.8|11.4|10.6|646|IX Soft tissue and other extraosseous sarcomas|60628650|0-14|All Races|Male and Female|2003|||
4.5|5.7|5.1|307|IX(a) Rhabdomyosarcomas|60628650|0-14|All Races|Male and Female|2003|||
0.8|1.3|1.0|62|IX(b) Fibrosarcomas, peripheral nerve sheath tumors & other fibrous neoplams|60628650|0-14|All Races|Male and Female|2003|||
~|~|~|~|IX(c) Kaposi sarcoma|60628650|0-14|All Races|Male and Female|2003|||
3.1|4.0|3.5|217|IX(d) Other specified soft tissue sarcomas|60628650|0-14|All Races|Male and Female|2003|||
0.7|1.2|0.9|58|IX(e) Unspecified soft tissue sarcomas|60628650|0-14|All Races|Male and Female|2003|||
0.2|0.4|0.3|16|Not classified by ICCC|60628650|0-14|All Races|Male and Female|2003|||
3.6|4.6|4.1|250|V Retinoblastoma|60628650|0-14|All Races|Male and Female|2003|||
7.8|9.3|8.5|516|VI Renal tumors|60628650|0-14|All Races|Male and Female|2003|||
7.4|8.9|8.1|491|VI(a) Nephroblastoma and other nonepithelial renal tumors|60628650|0-14|All Races|Male and Female|2003|||
0.2|0.5|0.3|21|VI(b) Renal carcinomas|60628650|0-14|All Races|Male and Female|2003|||
~|~|~|~|VI(c) Unspecified malignant renal tumors|60628650|0-14|All Races|Male and Female|2003|||
2.1|2.9|2.5|152|VII Hepatic tumors|60628650|0-14|All Races|Male and Female|2003|||
1.7|2.4|2.0|124|VII(a) Hepatoblastoma|60628650|0-14|All Races|Male and Female|2003|||
0.3|0.7|0.5|28|VII(b) Hepatic carcinomas|60628650|0-14|All Races|Male and Female|2003|||
~|~|~|~|VII(c) Unspecified malignant hepatic tumors|60628650|0-14|All Races|Male and Female|2003|||
6.0|7.3|6.6|408|VIII Malignant bone tumors|60628650|0-14|All Races|Male and Female|2003|||
3.2|4.2|3.7|227|VIII(a) Osteosarcomas|60628650|0-14|All Races|Male and Female|2003|||
~|~|~|~|VIII(b) Chondrosarcomas|60628650|0-14|All Races|Male and Female|2003|||
1.9|2.6|2.2|137|VIII(c) Ewing tumor and related sarcomas of bone|60628650|0-14|All Races|Male and Female|2003|||
0.2|0.4|0.3|17|VIII(d) Other specified malignant bone tumors|60628650|0-14|All Races|Male and Female|2003|||
~|~|~|~|VIII(e) Unspecified malignant bone tumors|60628650|0-14|All Races|Male and Female|2003|||
4.5|5.7|5.1|312|X Germ cell, trophoblastic tumors & neoplasms of gonads|60628650|0-14|All Races|Male and Female|2003|||
0.9|1.5|1.2|73|X(a) Intracranial & intraspinal germ cell tumors|60628650|0-14|All Races|Male and Female|2003|||
1.1|1.8|1.4|87|X(b) Malignant extracranial & extragonadal germ cell tumors|60628650|0-14|All Races|Male and Female|2003|||
1.8|2.6|2.2|136|X(c) Malignant gonadal germ cell tumors|60628650|0-14|All Races|Male and Female|2003|||
~|~|~|~|X(d) Gonadal carcinomas|60628650|0-14|All Races|Male and Female|2003|||
~|~|~|~|X(e) Other and unspecified malignant gonadal tumors|60628650|0-14|All Races|Male and Female|2003|||
5.7|7.0|6.3|391|XI Other malignant epithelial neoplasms and malignant melanomas|60628650|0-14|All Races|Male and Female|2003|||
~|~|~|~|XI(a) Adrenocortical carcinomas|60628650|0-14|All Races|Male and Female|2003|||
1.8|2.6|2.2|134|XI(b) Thyroid carcinomas|60628650|0-14|All Races|Male and Female|2003|||
~|~|~|~|XI(c) Nasopharyngeal carcinomas|60628650|0-14|All Races|Male and Female|2003|||
1.6|2.3|1.9|118|XI(d) Malignant melanomas|60628650|0-14|All Races|Male and Female|2003|||
~|~|~|~|XI(e) Skin carcinomas|60628650|0-14|All Races|Male and Female|2003|||
1.5|2.2|1.8|112|XI(f) Other and unspecified carcinomas|60628650|0-14|All Races|Male and Female|2003|||
0.6|1.0|0.8|48|XII Other and unspecified malignant neoplasms|60628650|0-14|All Races|Male and Female|2003|||
0.2|0.5|0.3|20|XII(a) Other specified malignant tumors|60628650|0-14|All Races|Male and Female|2003|||
0.3|0.7|0.5|28|XII(b) Other unspecified malignant tumors|60628650|0-14|All Races|Male and Female|2003|||
156.7|163.1|159.9|9740|All ICCC Groups Combined|60651802|0-14|All Races|Male and Female|2004|||
49.3|52.9|51.1|3098|I Leukemias, myeloproliferative & myelodysplastic diseases|60651802|0-14|All Races|Male and Female|2004|||
37.2|40.3|38.7|2344|I(a) Lymphoid leukemias|60651802|0-14|All Races|Male and Female|2004|||
7.2|8.7|7.9|484|I(b) Acute myeloid leukemias|60651802|0-14|All Races|Male and Female|2004|||
1.2|1.9|1.5|93|I(c) Chronic myeloproliferative diseases|60651802|0-14|All Races|Male and Female|2004|||
1.2|1.9|1.5|93|I(d) Myelodysplastic syndrome and other myeloproliferative diseases|60651802|0-14|All Races|Male and Female|2004|||
1.1|1.7|1.4|84|I(e) Unspecified and other specified leukemias|60651802|0-14|All Races|Male and Female|2004|||
15.1|17.1|16.1|982|II Lymphomas and reticuloendothelial neoplasms|60651802|0-14|All Races|Male and Female|2004|||
4.7|5.9|5.3|324|II(a) Hodgkin lymphomas|60651802|0-14|All Races|Male and Female|2004|||
6.2|7.6|6.9|419|II(b) Non-Hodgkin lymphomas (except Burkitt lymphoma)|60651802|0-14|All Races|Male and Female|2004|||
2.1|2.9|2.4|147|II(c) Burkitt lymphoma|60651802|0-14|All Races|Male and Female|2004|||
1.0|1.6|1.3|80|II(d) Miscellaneous lymphoreticular neoplasms|60651802|0-14|All Races|Male and Female|2004|||
~|~|~|~|II(e) Unspecified lymphomas|60651802|0-14|All Races|Male and Female|2004|||
33.6|36.6|35.1|2122|III CNS and misc intracranial and intraspinal neoplasms|60651802|0-14|All Races|Male and Female|2004|||
2.6|3.4|3.0|181|III(a) Ependymomas and choroid plexus tumor|60651802|0-14|All Races|Male and Female|2004|||
16.5|18.6|17.5|1060|III(b) Astrocytomas|60651802|0-14|All Races|Male and Female|2004|||
7.1|8.5|7.8|472|III(c) Intracranial and intraspinal embryonal tumors|60651802|0-14|All Races|Male and Female|2004|||
4.8|6.0|5.4|325|III(d) Other gliomas|60651802|0-14|All Races|Male and Female|2004|||
0.6|1.1|0.8|49|III(e) Other specified intracranial & intraspinal neoplasms|60651802|0-14|All Races|Male and Female|2004|||
0.4|0.8|0.6|35|III(f) Unspecified intracranial and intraspinal neoplasms|60651802|0-14|All Races|Male and Female|2004|||
10.2|11.9|11.0|677|IV Neuroblastoma and other peripheral nervous cell tumors|60651802|0-14|All Races|Male and Female|2004|||
10.0|11.7|10.8|662|IV(a) Neuroblastoma and ganglioneuroblastoma|60651802|0-14|All Races|Male and Female|2004|||
~|~|~|~|IV(b) Other peripheral nervous cell tumors|60651802|0-14|All Races|Male and Female|2004|||
9.8|11.5|10.6|649|IX Soft tissue and other extraosseous sarcomas|60651802|0-14|All Races|Male and Female|2004|||
4.1|5.2|4.7|283|IX(a) Rhabdomyosarcomas|60651802|0-14|All Races|Male and Female|2004|||
1.0|1.5|1.2|76|IX(b) Fibrosarcomas, peripheral nerve sheath tumors & other fibrous neoplams|60651802|0-14|All Races|Male and Female|2004|||
~|~|~|~|IX(c) Kaposi sarcoma|60651802|0-14|All Races|Male and Female|2004|||
3.2|4.2|3.7|225|IX(d) Other specified soft tissue sarcomas|60651802|0-14|All Races|Male and Female|2004|||
0.8|1.3|1.0|63|IX(e) Unspecified soft tissue sarcomas|60651802|0-14|All Races|Male and Female|2004|||
~|~|~|~|Not classified by ICCC|60651802|0-14|All Races|Male and Female|2004|||
3.8|4.9|4.3|266|V Retinoblastoma|60651802|0-14|All Races|Male and Female|2004|||
7.4|8.9|8.1|494|VI Renal tumors|60651802|0-14|All Races|Male and Female|2004|||
7.1|8.5|7.8|471|VI(a) Nephroblastoma and other nonepithelial renal tumors|60651802|0-14|All Races|Male and Female|2004|||
0.2|0.6|0.4|23|VI(b) Renal carcinomas|60651802|0-14|All Races|Male and Female|2004|||
~|~|~|~|VI(c) Unspecified malignant renal tumors|60651802|0-14|All Races|Male and Female|2004|||
2.3|3.1|2.7|164|VII Hepatic tumors|60651802|0-14|All Races|Male and Female|2004|||
2.0|2.8|2.3|144|VII(a) Hepatoblastoma|60651802|0-14|All Races|Male and Female|2004|||
~|~|~|~|VII(b) Hepatic carcinomas|60651802|0-14|All Races|Male and Female|2004|||
~|~|~|~|VII(c) Unspecified malignant hepatic tumors|60651802|0-14|All Races|Male and Female|2004|||
6.5|7.8|7.1|437|VIII Malignant bone tumors|60651802|0-14|All Races|Male and Female|2004|||
3.6|4.7|4.1|253|VIII(a) Osteosarcomas|60651802|0-14|All Races|Male and Female|2004|||
0.2|0.4|0.3|17|VIII(b) Chondrosarcomas|60651802|0-14|All Races|Male and Female|2004|||
2.0|2.8|2.3|144|VIII(c) Ewing tumor and related sarcomas of bone|60651802|0-14|All Races|Male and Female|2004|||
0.2|0.5|0.3|18|VIII(d) Other specified malignant bone tumors|60651802|0-14|All Races|Male and Female|2004|||
~|~|~|~|VIII(e) Unspecified malignant bone tumors|60651802|0-14|All Races|Male and Female|2004|||
5.0|6.2|5.6|347|X Germ cell, trophoblastic tumors & neoplasms of gonads|60651802|0-14|All Races|Male and Female|2004|||
1.3|1.9|1.6|96|X(a) Intracranial & intraspinal germ cell tumors|60651802|0-14|All Races|Male and Female|2004|||
1.1|1.7|1.3|83|X(b) Malignant extracranial & extragonadal germ cell tumors|60651802|0-14|All Races|Male and Female|2004|||
2.0|2.8|2.4|148|X(c) Malignant gonadal germ cell tumors|60651802|0-14|All Races|Male and Female|2004|||
~|~|~|~|X(d) Gonadal carcinomas|60651802|0-14|All Races|Male and Female|2004|||
~|~|~|~|X(e) Other and unspecified malignant gonadal tumors|60651802|0-14|All Races|Male and Female|2004|||
6.6|8.0|7.3|447|XI Other malignant epithelial neoplasms and malignant melanomas|60651802|0-14|All Races|Male and Female|2004|||
0.2|0.4|0.3|16|XI(a) Adrenocortical carcinomas|60651802|0-14|All Races|Male and Female|2004|||
2.2|3.0|2.6|160|XI(b) Thyroid carcinomas|60651802|0-14|All Races|Male and Female|2004|||
0.2|0.6|0.4|24|XI(c) Nasopharyngeal carcinomas|60651802|0-14|All Races|Male and Female|2004|||
2.1|2.9|2.5|154|XI(d) Malignant melanomas|60651802|0-14|All Races|Male and Female|2004|||
~|~|~|~|XI(e) Skin carcinomas|60651802|0-14|All Races|Male and Female|2004|||
1.1|1.7|1.4|87|XI(f) Other and unspecified carcinomas|60651802|0-14|All Races|Male and Female|2004|||
0.5|0.9|0.7|43|XII Other and unspecified malignant neoplasms|60651802|0-14|All Races|Male and Female|2004|||
0.2|0.5|0.3|18|XII(a) Other specified malignant tumors|60651802|0-14|All Races|Male and Female|2004|||
0.3|0.6|0.4|25|XII(b) Other unspecified malignant tumors|60651802|0-14|All Races|Male and Female|2004|||
152.5|158.8|155.7|9472|All ICCC Groups Combined|60519046|0-14|All Races|Male and Female|2005|||
47.4|51.0|49.2|2986|I Leukemias, myeloproliferative & myelodysplastic diseases|60519046|0-14|All Races|Male and Female|2005|||
35.9|39.0|37.4|2269|I(a) Lymphoid leukemias|60519046|0-14|All Races|Male and Female|2005|||
6.6|8.0|7.3|445|I(b) Acute myeloid leukemias|60519046|0-14|All Races|Male and Female|2005|||
1.1|1.7|1.4|86|I(c) Chronic myeloproliferative diseases|60519046|0-14|All Races|Male and Female|2005|||
1.3|2.0|1.6|100|I(d) Myelodysplastic syndrome and other myeloproliferative diseases|60519046|0-14|All Races|Male and Female|2005|||
1.1|1.7|1.4|86|I(e) Unspecified and other specified leukemias|60519046|0-14|All Races|Male and Female|2005|||
15.6|17.7|16.6|1012|II Lymphomas and reticuloendothelial neoplasms|60519046|0-14|All Races|Male and Female|2005|||
5.3|6.5|5.9|359|II(a) Hodgkin lymphomas|60519046|0-14|All Races|Male and Female|2005|||
5.8|7.1|6.4|391|II(b) Non-Hodgkin lymphomas (except Burkitt lymphoma)|60519046|0-14|All Races|Male and Female|2005|||
2.2|3.0|2.6|155|II(c) Burkitt lymphoma|60519046|0-14|All Races|Male and Female|2005|||
1.2|1.9|1.5|93|II(d) Miscellaneous lymphoreticular neoplasms|60519046|0-14|All Races|Male and Female|2005|||
~|~|~|~|II(e) Unspecified lymphomas|60519046|0-14|All Races|Male and Female|2005|||
31.4|34.3|32.8|1983|III CNS and misc intracranial and intraspinal neoplasms|60519046|0-14|All Races|Male and Female|2005|||
2.9|3.8|3.3|200|III(a) Ependymomas and choroid plexus tumor|60519046|0-14|All Races|Male and Female|2005|||
15.4|17.5|16.5|996|III(b) Astrocytomas|60519046|0-14|All Races|Male and Female|2005|||
6.3|7.6|6.9|418|III(c) Intracranial and intraspinal embryonal tumors|60519046|0-14|All Races|Male and Female|2005|||
4.5|5.7|5.1|305|III(d) Other gliomas|60519046|0-14|All Races|Male and Female|2005|||
0.4|0.8|0.6|35|III(e) Other specified intracranial & intraspinal neoplasms|60519046|0-14|All Races|Male and Female|2005|||
0.3|0.7|0.5|29|III(f) Unspecified intracranial and intraspinal neoplasms|60519046|0-14|All Races|Male and Female|2005|||
11.0|12.7|11.8|727|IV Neuroblastoma and other peripheral nervous cell tumors|60519046|0-14|All Races|Male and Female|2005|||
10.8|12.6|11.7|718|IV(a) Neuroblastoma and ganglioneuroblastoma|60519046|0-14|All Races|Male and Female|2005|||
~|~|~|~|IV(b) Other peripheral nervous cell tumors|60519046|0-14|All Races|Male and Female|2005|||
9.8|11.5|10.6|646|IX Soft tissue and other extraosseous sarcomas|60519046|0-14|All Races|Male and Female|2005|||
4.7|5.9|5.3|321|IX(a) Rhabdomyosarcomas|60519046|0-14|All Races|Male and Female|2005|||
0.9|1.4|1.1|69|IX(b) Fibrosarcomas, peripheral nerve sheath tumors & other fibrous neoplams|60519046|0-14|All Races|Male and Female|2005|||
~|~|~|~|IX(c) Kaposi sarcoma|60519046|0-14|All Races|Male and Female|2005|||
2.9|3.8|3.3|205|IX(d) Other specified soft tissue sarcomas|60519046|0-14|All Races|Male and Female|2005|||
0.6|1.1|0.8|49|IX(e) Unspecified soft tissue sarcomas|60519046|0-14|All Races|Male and Female|2005|||
0.2|0.5|0.3|19|Not classified by ICCC|60519046|0-14|All Races|Male and Female|2005|||
3.4|4.4|3.9|240|V Retinoblastoma|60519046|0-14|All Races|Male and Female|2005|||
7.5|9.0|8.2|501|VI Renal tumors|60519046|0-14|All Races|Male and Female|2005|||
7.2|8.6|7.8|478|VI(a) Nephroblastoma and other nonepithelial renal tumors|60519046|0-14|All Races|Male and Female|2005|||
0.2|0.5|0.3|19|VI(b) Renal carcinomas|60519046|0-14|All Races|Male and Female|2005|||
~|~|~|~|VI(c) Unspecified malignant renal tumors|60519046|0-14|All Races|Male and Female|2005|||
2.0|2.8|2.4|145|VII Hepatic tumors|60519046|0-14|All Races|Male and Female|2005|||
1.6|2.3|1.9|116|VII(a) Hepatoblastoma|60519046|0-14|All Races|Male and Female|2005|||
0.3|0.6|0.4|27|VII(b) Hepatic carcinomas|60519046|0-14|All Races|Male and Female|2005|||
~|~|~|~|VII(c) Unspecified malignant hepatic tumors|60519046|0-14|All Races|Male and Female|2005|||
6.2|7.5|6.8|415|VIII Malignant bone tumors|60519046|0-14|All Races|Male and Female|2005|||
3.3|4.2|3.7|227|VIII(a) Osteosarcomas|60519046|0-14|All Races|Male and Female|2005|||
~|~|~|~|VIII(b) Chondrosarcomas|60519046|0-14|All Races|Male and Female|2005|||
2.0|2.8|2.4|147|VIII(c) Ewing tumor and related sarcomas of bone|60519046|0-14|All Races|Male and Female|2005|||
0.2|0.5|0.3|20|VIII(d) Other specified malignant bone tumors|60519046|0-14|All Races|Male and Female|2005|||
~|~|~|~|VIII(e) Unspecified malignant bone tumors|60519046|0-14|All Races|Male and Female|2005|||
4.9|6.1|5.5|338|X Germ cell, trophoblastic tumors & neoplasms of gonads|60519046|0-14|All Races|Male and Female|2005|||
1.1|1.7|1.4|83|X(a) Intracranial & intraspinal germ cell tumors|60519046|0-14|All Races|Male and Female|2005|||
1.3|2.0|1.6|100|X(b) Malignant extracranial & extragonadal germ cell tumors|60519046|0-14|All Races|Male and Female|2005|||
1.9|2.6|2.2|138|X(c) Malignant gonadal germ cell tumors|60519046|0-14|All Races|Male and Female|2005|||
~|~|~|~|X(d) Gonadal carcinomas|60519046|0-14|All Races|Male and Female|2005|||
~|~|~|~|X(e) Other and unspecified malignant gonadal tumors|60519046|0-14|All Races|Male and Female|2005|||
6.3|7.6|6.9|424|XI Other malignant epithelial neoplasms and malignant melanomas|60519046|0-14|All Races|Male and Female|2005|||
~|~|~|~|XI(a) Adrenocortical carcinomas|60519046|0-14|All Races|Male and Female|2005|||
1.8|2.6|2.2|135|XI(b) Thyroid carcinomas|60519046|0-14|All Races|Male and Female|2005|||
~|~|~|~|XI(c) Nasopharyngeal carcinomas|60519046|0-14|All Races|Male and Female|2005|||
2.1|2.9|2.4|149|XI(d) Malignant melanomas|60519046|0-14|All Races|Male and Female|2005|||
~|~|~|~|XI(e) Skin carcinomas|60519046|0-14|All Races|Male and Female|2005|||
1.6|2.3|1.9|117|XI(f) Other and unspecified carcinomas|60519046|0-14|All Races|Male and Female|2005|||
0.4|0.8|0.6|36|XII Other and unspecified malignant neoplasms|60519046|0-14|All Races|Male and Female|2005|||
0.2|0.5|0.3|19|XII(a) Other specified malignant tumors|60519046|0-14|All Races|Male and Female|2005|||
0.2|0.5|0.3|17|XII(b) Other unspecified malignant tumors|60519046|0-14|All Races|Male and Female|2005|||
155.2|161.5|158.3|9637|All ICCC Groups Combined|60516709|0-14|All Races|Male and Female|2006|||
49.7|53.3|51.5|3131|I Leukemias, myeloproliferative & myelodysplastic diseases|60516709|0-14|All Races|Male and Female|2006|||
37.3|40.4|38.8|2356|I(a) Lymphoid leukemias|60516709|0-14|All Races|Male and Female|2006|||
7.2|8.6|7.9|481|I(b) Acute myeloid leukemias|60516709|0-14|All Races|Male and Female|2006|||
1.4|2.1|1.7|105|I(c) Chronic myeloproliferative diseases|60516709|0-14|All Races|Male and Female|2006|||
1.4|2.1|1.7|106|I(d) Myelodysplastic syndrome and other myeloproliferative diseases|60516709|0-14|All Races|Male and Female|2006|||
1.1|1.7|1.4|83|I(e) Unspecified and other specified leukemias|60516709|0-14|All Races|Male and Female|2006|||
15.7|17.8|16.7|1016|II Lymphomas and reticuloendothelial neoplasms|60516709|0-14|All Races|Male and Female|2006|||
5.5|6.8|6.1|373|II(a) Hodgkin lymphomas|60516709|0-14|All Races|Male and Female|2006|||
5.8|7.1|6.5|391|II(b) Non-Hodgkin lymphomas (except Burkitt lymphoma)|60516709|0-14|All Races|Male and Female|2006|||
2.1|2.9|2.5|151|II(c) Burkitt lymphoma|60516709|0-14|All Races|Male and Female|2006|||
1.2|1.8|1.5|89|II(d) Miscellaneous lymphoreticular neoplasms|60516709|0-14|All Races|Male and Female|2006|||
~|~|~|~|II(e) Unspecified lymphomas|60516709|0-14|All Races|Male and Female|2006|||
32.4|35.4|33.9|2050|III CNS and misc intracranial and intraspinal neoplasms|60516709|0-14|All Races|Male and Female|2006|||
2.6|3.5|3.0|184|III(a) Ependymomas and choroid plexus tumor|60516709|0-14|All Races|Male and Female|2006|||
15.3|17.4|16.3|990|III(b) Astrocytomas|60516709|0-14|All Races|Male and Female|2006|||
7.0|8.4|7.7|464|III(c) Intracranial and intraspinal embryonal tumors|60516709|0-14|All Races|Male and Female|2006|||
5.1|6.3|5.7|340|III(d) Other gliomas|60516709|0-14|All Races|Male and Female|2006|||
0.3|0.7|0.5|31|III(e) Other specified intracranial & intraspinal neoplasms|60516709|0-14|All Races|Male and Female|2006|||
0.5|0.9|0.7|41|III(f) Unspecified intracranial and intraspinal neoplasms|60516709|0-14|All Races|Male and Female|2006|||
9.5|11.1|10.3|632|IV Neuroblastoma and other peripheral nervous cell tumors|60516709|0-14|All Races|Male and Female|2006|||
9.4|11.0|10.2|627|IV(a) Neuroblastoma and ganglioneuroblastoma|60516709|0-14|All Races|Male and Female|2006|||
~|~|~|~|IV(b) Other peripheral nervous cell tumors|60516709|0-14|All Races|Male and Female|2006|||
9.7|11.4|10.5|640|IX Soft tissue and other extraosseous sarcomas|60516709|0-14|All Races|Male and Female|2006|||
4.3|5.5|4.9|296|IX(a) Rhabdomyosarcomas|60516709|0-14|All Races|Male and Female|2006|||
0.8|1.4|1.1|67|IX(b) Fibrosarcomas, peripheral nerve sheath tumors & other fibrous neoplams|60516709|0-14|All Races|Male and Female|2006|||
~|~|~|~|IX(c) Kaposi sarcoma|60516709|0-14|All Races|Male and Female|2006|||
3.0|3.9|3.4|210|IX(d) Other specified soft tissue sarcomas|60516709|0-14|All Races|Male and Female|2006|||
0.8|1.4|1.1|65|IX(e) Unspecified soft tissue sarcomas|60516709|0-14|All Races|Male and Female|2006|||
~|~|~|~|Not classified by ICCC|60516709|0-14|All Races|Male and Female|2006|||
3.6|4.6|4.1|255|V Retinoblastoma|60516709|0-14|All Races|Male and Female|2006|||
7.5|9.0|8.2|503|VI Renal tumors|60516709|0-14|All Races|Male and Female|2006|||
7.2|8.6|7.9|480|VI(a) Nephroblastoma and other nonepithelial renal tumors|60516709|0-14|All Races|Male and Female|2006|||
0.2|0.5|0.3|19|VI(b) Renal carcinomas|60516709|0-14|All Races|Male and Female|2006|||
~|~|~|~|VI(c) Unspecified malignant renal tumors|60516709|0-14|All Races|Male and Female|2006|||
2.2|3.0|2.6|160|VII Hepatic tumors|60516709|0-14|All Races|Male and Female|2006|||
1.8|2.5|2.1|133|VII(a) Hepatoblastoma|60516709|0-14|All Races|Male and Female|2006|||
0.2|0.6|0.4|23|VII(b) Hepatic carcinomas|60516709|0-14|All Races|Male and Female|2006|||
~|~|~|~|VII(c) Unspecified malignant hepatic tumors|60516709|0-14|All Races|Male and Female|2006|||
6.4|7.7|7.0|425|VIII Malignant bone tumors|60516709|0-14|All Races|Male and Female|2006|||
3.5|4.5|4.0|242|VIII(a) Osteosarcomas|60516709|0-14|All Races|Male and Female|2006|||
~|~|~|~|VIII(b) Chondrosarcomas|60516709|0-14|All Races|Male and Female|2006|||
2.1|2.9|2.4|147|VIII(c) Ewing tumor and related sarcomas of bone|60516709|0-14|All Races|Male and Female|2006|||
0.2|0.5|0.3|18|VIII(d) Other specified malignant bone tumors|60516709|0-14|All Races|Male and Female|2006|||
~|~|~|~|VIII(e) Unspecified malignant bone tumors|60516709|0-14|All Races|Male and Female|2006|||
4.5|5.7|5.1|313|X Germ cell, trophoblastic tumors & neoplasms of gonads|60516709|0-14|All Races|Male and Female|2006|||
1.0|1.6|1.3|77|X(a) Intracranial & intraspinal germ cell tumors|60516709|0-14|All Races|Male and Female|2006|||
1.2|1.8|1.5|92|X(b) Malignant extracranial & extragonadal germ cell tumors|60516709|0-14|All Races|Male and Female|2006|||
1.7|2.5|2.1|128|X(c) Malignant gonadal germ cell tumors|60516709|0-14|All Races|Male and Female|2006|||
~|~|~|~|X(d) Gonadal carcinomas|60516709|0-14|All Races|Male and Female|2006|||
~|~|~|~|X(e) Other and unspecified malignant gonadal tumors|60516709|0-14|All Races|Male and Female|2006|||
6.8|8.2|7.5|457|XI Other malignant epithelial neoplasms and malignant melanomas|60516709|0-14|All Races|Male and Female|2006|||
~|~|~|~|XI(a) Adrenocortical carcinomas|60516709|0-14|All Races|Male and Female|2006|||
2.3|3.1|2.7|162|XI(b) Thyroid carcinomas|60516709|0-14|All Races|Male and Female|2006|||
0.2|0.5|0.3|18|XI(c) Nasopharyngeal carcinomas|60516709|0-14|All Races|Male and Female|2006|||
2.0|2.8|2.4|147|XI(d) Malignant melanomas|60516709|0-14|All Races|Male and Female|2006|||
~|~|~|~|XI(e) Skin carcinomas|60516709|0-14|All Races|Male and Female|2006|||
1.5|2.2|1.8|111|XI(f) Other and unspecified carcinomas|60516709|0-14|All Races|Male and Female|2006|||
0.5|1.0|0.8|46|XII Other and unspecified malignant neoplasms|60516709|0-14|All Races|Male and Female|2006|||
0.3|0.6|0.4|27|XII(a) Other specified malignant tumors|60516709|0-14|All Races|Male and Female|2006|||
0.2|0.5|0.3|19|XII(b) Other unspecified malignant tumors|60516709|0-14|All Races|Male and Female|2006|||
158.8|165.2|161.9|9897|All ICCC Groups Combined|60681615|0-14|All Races|Male and Female|2007|||
50.3|53.9|52.1|3177|I Leukemias, myeloproliferative & myelodysplastic diseases|60681615|0-14|All Races|Male and Female|2007|||
38.4|41.6|40.0|2435|I(a) Lymphoid leukemias|60681615|0-14|All Races|Male and Female|2007|||
7.0|8.4|7.7|473|I(b) Acute myeloid leukemias|60681615|0-14|All Races|Male and Female|2007|||
1.3|2.0|1.6|101|I(c) Chronic myeloproliferative diseases|60681615|0-14|All Races|Male and Female|2007|||
1.2|1.9|1.5|95|I(d) Myelodysplastic syndrome and other myeloproliferative diseases|60681615|0-14|All Races|Male and Female|2007|||
0.9|1.5|1.2|73|I(e) Unspecified and other specified leukemias|60681615|0-14|All Races|Male and Female|2007|||
15.7|17.8|16.7|1013|II Lymphomas and reticuloendothelial neoplasms|60681615|0-14|All Races|Male and Female|2007|||
4.9|6.1|5.5|331|II(a) Hodgkin lymphomas|60681615|0-14|All Races|Male and Female|2007|||
6.4|7.7|7.0|426|II(b) Non-Hodgkin lymphomas (except Burkitt lymphoma)|60681615|0-14|All Races|Male and Female|2007|||
2.3|3.1|2.7|161|II(c) Burkitt lymphoma|60681615|0-14|All Races|Male and Female|2007|||
1.0|1.6|1.3|82|II(d) Miscellaneous lymphoreticular neoplasms|60681615|0-14|All Races|Male and Female|2007|||
~|~|~|~|II(e) Unspecified lymphomas|60681615|0-14|All Races|Male and Female|2007|||
33.6|36.6|35.1|2134|III CNS and misc intracranial and intraspinal neoplasms|60681615|0-14|All Races|Male and Female|2007|||
2.5|3.4|2.9|177|III(a) Ependymomas and choroid plexus tumor|60681615|0-14|All Races|Male and Female|2007|||
15.7|17.7|16.7|1013|III(b) Astrocytomas|60681615|0-14|All Races|Male and Female|2007|||
7.1|8.5|7.8|472|III(c) Intracranial and intraspinal embryonal tumors|60681615|0-14|All Races|Male and Female|2007|||
5.9|7.2|6.5|395|III(d) Other gliomas|60681615|0-14|All Races|Male and Female|2007|||
0.5|1.0|0.7|45|III(e) Other specified intracranial & intraspinal neoplasms|60681615|0-14|All Races|Male and Female|2007|||
0.4|0.7|0.5|32|III(f) Unspecified intracranial and intraspinal neoplasms|60681615|0-14|All Races|Male and Female|2007|||
11.0|12.7|11.8|736|IV Neuroblastoma and other peripheral nervous cell tumors|60681615|0-14|All Races|Male and Female|2007|||
10.8|12.5|11.6|724|IV(a) Neuroblastoma and ganglioneuroblastoma|60681615|0-14|All Races|Male and Female|2007|||
~|~|~|~|IV(b) Other peripheral nervous cell tumors|60681615|0-14|All Races|Male and Female|2007|||
10.2|11.9|11.0|673|IX Soft tissue and other extraosseous sarcomas|60681615|0-14|All Races|Male and Female|2007|||
5.1|6.3|5.7|347|IX(a) Rhabdomyosarcomas|60681615|0-14|All Races|Male and Female|2007|||
0.9|1.5|1.2|72|IX(b) Fibrosarcomas, peripheral nerve sheath tumors & other fibrous neoplams|60681615|0-14|All Races|Male and Female|2007|||
~|~|~|~|IX(c) Kaposi sarcoma|60681615|0-14|All Races|Male and Female|2007|||
2.9|3.8|3.3|202|IX(d) Other specified soft tissue sarcomas|60681615|0-14|All Races|Male and Female|2007|||
0.6|1.1|0.8|51|IX(e) Unspecified soft tissue sarcomas|60681615|0-14|All Races|Male and Female|2007|||
~|~|~|~|Not classified by ICCC|60681615|0-14|All Races|Male and Female|2007|||
3.8|4.8|4.3|270|V Retinoblastoma|60681615|0-14|All Races|Male and Female|2007|||
7.9|9.4|8.6|529|VI Renal tumors|60681615|0-14|All Races|Male and Female|2007|||
7.5|8.9|8.2|502|VI(a) Nephroblastoma and other nonepithelial renal tumors|60681615|0-14|All Races|Male and Female|2007|||
0.3|0.6|0.4|26|VI(b) Renal carcinomas|60681615|0-14|All Races|Male and Female|2007|||
~|~|~|~|VI(c) Unspecified malignant renal tumors|60681615|0-14|All Races|Male and Female|2007|||
2.2|3.0|2.6|159|VII Hepatic tumors|60681615|0-14|All Races|Male and Female|2007|||
1.9|2.7|2.3|141|VII(a) Hepatoblastoma|60681615|0-14|All Races|Male and Female|2007|||
0.2|0.5|0.3|18|VII(b) Hepatic carcinomas|60681615|0-14|All Races|Male and Female|2007|||
~|~|~|~|VII(c) Unspecified malignant hepatic tumors|60681615|0-14|All Races|Male and Female|2007|||
6.2|7.5|6.8|414|VIII Malignant bone tumors|60681615|0-14|All Races|Male and Female|2007|||
3.2|4.2|3.7|222|VIII(a) Osteosarcomas|60681615|0-14|All Races|Male and Female|2007|||
~|~|~|~|VIII(b) Chondrosarcomas|60681615|0-14|All Races|Male and Female|2007|||
2.1|2.9|2.5|152|VIII(c) Ewing tumor and related sarcomas of bone|60681615|0-14|All Races|Male and Female|2007|||
0.2|0.4|0.3|16|VIII(d) Other specified malignant bone tumors|60681615|0-14|All Races|Male and Female|2007|||
~|~|~|~|VIII(e) Unspecified malignant bone tumors|60681615|0-14|All Races|Male and Female|2007|||
4.9|6.1|5.5|337|X Germ cell, trophoblastic tumors & neoplasms of gonads|60681615|0-14|All Races|Male and Female|2007|||
1.1|1.7|1.4|85|X(a) Intracranial & intraspinal germ cell tumors|60681615|0-14|All Races|Male and Female|2007|||
1.0|1.6|1.3|82|X(b) Malignant extracranial & extragonadal germ cell tumors|60681615|0-14|All Races|Male and Female|2007|||
2.2|3.0|2.6|157|X(c) Malignant gonadal germ cell tumors|60681615|0-14|All Races|Male and Female|2007|||
~|~|~|~|X(d) Gonadal carcinomas|60681615|0-14|All Races|Male and Female|2007|||
~|~|~|~|X(e) Other and unspecified malignant gonadal tumors|60681615|0-14|All Races|Male and Female|2007|||
6.0|7.3|6.6|403|XI Other malignant epithelial neoplasms and malignant melanomas|60681615|0-14|All Races|Male and Female|2007|||
~|~|~|~|XI(a) Adrenocortical carcinomas|60681615|0-14|All Races|Male and Female|2007|||
1.9|2.6|2.2|136|XI(b) Thyroid carcinomas|60681615|0-14|All Races|Male and Female|2007|||
0.2|0.4|0.3|17|XI(c) Nasopharyngeal carcinomas|60681615|0-14|All Races|Male and Female|2007|||
1.8|2.6|2.2|132|XI(d) Malignant melanomas|60681615|0-14|All Races|Male and Female|2007|||
~|~|~|~|XI(e) Skin carcinomas|60681615|0-14|All Races|Male and Female|2007|||
1.4|2.0|1.7|102|XI(f) Other and unspecified carcinomas|60681615|0-14|All Races|Male and Female|2007|||
0.5|0.9|0.7|42|XII Other and unspecified malignant neoplasms|60681615|0-14|All Races|Male and Female|2007|||
0.2|0.6|0.4|23|XII(a) Other specified malignant tumors|60681615|0-14|All Races|Male and Female|2007|||
0.2|0.5|0.3|19|XII(b) Other unspecified malignant tumors|60681615|0-14|All Races|Male and Female|2007|||
161.3|167.7|164.5|10091|All ICCC Groups Combined|60907384|0-14|All Races|Male and Female|2008|||
52.1|55.8|53.9|3310|I Leukemias, myeloproliferative & myelodysplastic diseases|60907384|0-14|All Races|Male and Female|2008|||
39.5|42.7|41.1|2518|I(a) Lymphoid leukemias|60907384|0-14|All Races|Male and Female|2008|||
7.3|8.7|8.0|490|I(b) Acute myeloid leukemias|60907384|0-14|All Races|Male and Female|2008|||
1.8|2.5|2.1|131|I(c) Chronic myeloproliferative diseases|60907384|0-14|All Races|Male and Female|2008|||
1.4|2.0|1.7|104|I(d) Myelodysplastic syndrome and other myeloproliferative diseases|60907384|0-14|All Races|Male and Female|2008|||
0.8|1.4|1.1|67|I(e) Unspecified and other specified leukemias|60907384|0-14|All Races|Male and Female|2008|||
16.1|18.2|17.1|1039|II Lymphomas and reticuloendothelial neoplasms|60907384|0-14|All Races|Male and Female|2008|||
5.7|7.0|6.3|381|II(a) Hodgkin lymphomas|60907384|0-14|All Races|Male and Female|2008|||
6.1|7.4|6.7|407|II(b) Non-Hodgkin lymphomas (except Burkitt lymphoma)|60907384|0-14|All Races|Male and Female|2008|||
2.3|3.1|2.7|163|II(c) Burkitt lymphoma|60907384|0-14|All Races|Male and Female|2008|||
0.9|1.5|1.2|74|II(d) Miscellaneous lymphoreticular neoplasms|60907384|0-14|All Races|Male and Female|2008|||
~|~|~|~|II(e) Unspecified lymphomas|60907384|0-14|All Races|Male and Female|2008|||
33.8|36.8|35.3|2153|III CNS and misc intracranial and intraspinal neoplasms|60907384|0-14|All Races|Male and Female|2008|||
2.3|3.1|2.7|163|III(a) Ependymomas and choroid plexus tumor|60907384|0-14|All Races|Male and Female|2008|||
16.4|18.5|17.4|1060|III(b) Astrocytomas|60907384|0-14|All Races|Male and Female|2008|||
7.5|8.9|8.2|502|III(c) Intracranial and intraspinal embryonal tumors|60907384|0-14|All Races|Male and Female|2008|||
5.4|6.6|6.0|362|III(d) Other gliomas|60907384|0-14|All Races|Male and Female|2008|||
0.5|1.0|0.7|44|III(e) Other specified intracranial & intraspinal neoplasms|60907384|0-14|All Races|Male and Female|2008|||
0.2|0.5|0.4|22|III(f) Unspecified intracranial and intraspinal neoplasms|60907384|0-14|All Races|Male and Female|2008|||
10.2|11.8|11.0|687|IV Neuroblastoma and other peripheral nervous cell tumors|60907384|0-14|All Races|Male and Female|2008|||
9.9|11.5|10.7|670|IV(a) Neuroblastoma and ganglioneuroblastoma|60907384|0-14|All Races|Male and Female|2008|||
0.2|0.4|0.3|17|IV(b) Other peripheral nervous cell tumors|60907384|0-14|All Races|Male and Female|2008|||
10.2|11.9|11.0|675|IX Soft tissue and other extraosseous sarcomas|60907384|0-14|All Races|Male and Female|2008|||
4.8|5.9|5.3|326|IX(a) Rhabdomyosarcomas|60907384|0-14|All Races|Male and Female|2008|||
0.7|1.2|0.9|58|IX(b) Fibrosarcomas, peripheral nerve sheath tumors & other fibrous neoplams|60907384|0-14|All Races|Male and Female|2008|||
~|~|~|~|IX(c) Kaposi sarcoma|60907384|0-14|All Races|Male and Female|2008|||
3.0|3.9|3.4|209|IX(d) Other specified soft tissue sarcomas|60907384|0-14|All Races|Male and Female|2008|||
1.0|1.6|1.3|81|IX(e) Unspecified soft tissue sarcomas|60907384|0-14|All Races|Male and Female|2008|||
0.2|0.4|0.3|17|Not classified by ICCC|60907384|0-14|All Races|Male and Female|2008|||
3.7|4.8|4.2|267|V Retinoblastoma|60907384|0-14|All Races|Male and Female|2008|||
8.3|9.8|9.0|558|VI Renal tumors|60907384|0-14|All Races|Male and Female|2008|||
7.9|9.3|8.6|532|VI(a) Nephroblastoma and other nonepithelial renal tumors|60907384|0-14|All Races|Male and Female|2008|||
0.3|0.6|0.4|24|VI(b) Renal carcinomas|60907384|0-14|All Races|Male and Female|2008|||
~|~|~|~|VI(c) Unspecified malignant renal tumors|60907384|0-14|All Races|Male and Female|2008|||
2.2|3.1|2.6|164|VII Hepatic tumors|60907384|0-14|All Races|Male and Female|2008|||
1.9|2.6|2.2|140|VII(a) Hepatoblastoma|60907384|0-14|All Races|Male and Female|2008|||
0.3|0.6|0.4|24|VII(b) Hepatic carcinomas|60907384|0-14|All Races|Male and Female|2008|||
~|~|~|~|VII(c) Unspecified malignant hepatic tumors|60907384|0-14|All Races|Male and Female|2008|||
6.2|7.5|6.8|413|VIII Malignant bone tumors|60907384|0-14|All Races|Male and Female|2008|||
3.4|4.4|3.8|232|VIII(a) Osteosarcomas|60907384|0-14|All Races|Male and Female|2008|||
~|~|~|~|VIII(b) Chondrosarcomas|60907384|0-14|All Races|Male and Female|2008|||
2.1|2.9|2.4|148|VIII(c) Ewing tumor and related sarcomas of bone|60907384|0-14|All Races|Male and Female|2008|||
~|~|~|~|VIII(d) Other specified malignant bone tumors|60907384|0-14|All Races|Male and Female|2008|||
~|~|~|~|VIII(e) Unspecified malignant bone tumors|60907384|0-14|All Races|Male and Female|2008|||
4.7|5.8|5.2|323|X Germ cell, trophoblastic tumors & neoplasms of gonads|60907384|0-14|All Races|Male and Female|2008|||
1.1|1.7|1.4|82|X(a) Intracranial & intraspinal germ cell tumors|60907384|0-14|All Races|Male and Female|2008|||
1.1|1.7|1.4|89|X(b) Malignant extracranial & extragonadal germ cell tumors|60907384|0-14|All Races|Male and Female|2008|||
1.9|2.7|2.3|141|X(c) Malignant gonadal germ cell tumors|60907384|0-14|All Races|Male and Female|2008|||
~|~|~|~|X(d) Gonadal carcinomas|60907384|0-14|All Races|Male and Female|2008|||
~|~|~|~|X(e) Other and unspecified malignant gonadal tumors|60907384|0-14|All Races|Male and Female|2008|||
6.7|8.0|7.3|446|XI Other malignant epithelial neoplasms and malignant melanomas|60907384|0-14|All Races|Male and Female|2008|||
~|~|~|~|XI(a) Adrenocortical carcinomas|60907384|0-14|All Races|Male and Female|2008|||
2.2|3.0|2.6|157|XI(b) Thyroid carcinomas|60907384|0-14|All Races|Male and Female|2008|||
0.2|0.4|0.3|17|XI(c) Nasopharyngeal carcinomas|60907384|0-14|All Races|Male and Female|2008|||
1.9|2.7|2.3|140|XI(d) Malignant melanomas|60907384|0-14|All Races|Male and Female|2008|||
~|~|~|~|XI(e) Skin carcinomas|60907384|0-14|All Races|Male and Female|2008|||
1.5|2.3|1.9|114|XI(f) Other and unspecified carcinomas|60907384|0-14|All Races|Male and Female|2008|||
0.4|0.9|0.6|39|XII Other and unspecified malignant neoplasms|60907384|0-14|All Races|Male and Female|2008|||
0.2|0.6|0.4|24|XII(a) Other specified malignant tumors|60907384|0-14|All Races|Male and Female|2008|||
~|~|~|~|XII(b) Other unspecified malignant tumors|60907384|0-14|All Races|Male and Female|2008|||
159.5|165.9|162.7|9995|All ICCC Groups Combined|61087581|0-14|All Races|Male and Female|2009|||
50.5|54.1|52.3|3223|I Leukemias, myeloproliferative & myelodysplastic diseases|61087581|0-14|All Races|Male and Female|2009|||
39.3|42.5|40.9|2519|I(a) Lymphoid leukemias|61087581|0-14|All Races|Male and Female|2009|||
6.6|7.9|7.2|446|I(b) Acute myeloid leukemias|61087581|0-14|All Races|Male and Female|2009|||
1.3|1.9|1.6|95|I(c) Chronic myeloproliferative diseases|61087581|0-14|All Races|Male and Female|2009|||
1.2|1.8|1.5|93|I(d) Myelodysplastic syndrome and other myeloproliferative diseases|61087581|0-14|All Races|Male and Female|2009|||
0.9|1.4|1.1|70|I(e) Unspecified and other specified leukemias|61087581|0-14|All Races|Male and Female|2009|||
15.8|17.9|16.9|1026|II Lymphomas and reticuloendothelial neoplasms|61087581|0-14|All Races|Male and Female|2009|||
5.1|6.4|5.7|347|II(a) Hodgkin lymphomas|61087581|0-14|All Races|Male and Female|2009|||
6.3|7.7|7.0|425|II(b) Non-Hodgkin lymphomas (except Burkitt lymphoma)|61087581|0-14|All Races|Male and Female|2009|||
2.0|2.8|2.4|143|II(c) Burkitt lymphoma|61087581|0-14|All Races|Male and Female|2009|||
1.3|2.0|1.6|100|II(d) Miscellaneous lymphoreticular neoplasms|61087581|0-14|All Races|Male and Female|2009|||
~|~|~|~|II(e) Unspecified lymphomas|61087581|0-14|All Races|Male and Female|2009|||
33.8|36.8|35.3|2159|III CNS and misc intracranial and intraspinal neoplasms|61087581|0-14|All Races|Male and Female|2009|||
2.2|3.0|2.5|157|III(a) Ependymomas and choroid plexus tumor|61087581|0-14|All Races|Male and Female|2009|||
16.4|18.5|17.4|1066|III(b) Astrocytomas|61087581|0-14|All Races|Male and Female|2009|||
6.9|8.3|7.6|467|III(c) Intracranial and intraspinal embryonal tumors|61087581|0-14|All Races|Male and Female|2009|||
6.0|7.3|6.6|404|III(d) Other gliomas|61087581|0-14|All Races|Male and Female|2009|||
0.4|0.8|0.6|34|III(e) Other specified intracranial & intraspinal neoplasms|61087581|0-14|All Races|Male and Female|2009|||
0.3|0.7|0.5|31|III(f) Unspecified intracranial and intraspinal neoplasms|61087581|0-14|All Races|Male and Female|2009|||
10.0|11.6|10.8|670|IV Neuroblastoma and other peripheral nervous cell tumors|61087581|0-14|All Races|Male and Female|2009|||
9.8|11.4|10.6|660|IV(a) Neuroblastoma and ganglioneuroblastoma|61087581|0-14|All Races|Male and Female|2009|||
~|~|~|~|IV(b) Other peripheral nervous cell tumors|61087581|0-14|All Races|Male and Female|2009|||
9.9|11.6|10.7|656|IX Soft tissue and other extraosseous sarcomas|61087581|0-14|All Races|Male and Female|2009|||
4.0|5.0|4.5|274|IX(a) Rhabdomyosarcomas|61087581|0-14|All Races|Male and Female|2009|||
1.0|1.6|1.3|78|IX(b) Fibrosarcomas, peripheral nerve sheath tumors & other fibrous neoplams|61087581|0-14|All Races|Male and Female|2009|||
~|~|~|~|IX(c) Kaposi sarcoma|61087581|0-14|All Races|Male and Female|2009|||
3.3|4.3|3.8|231|IX(d) Other specified soft tissue sarcomas|61087581|0-14|All Races|Male and Female|2009|||
0.9|1.5|1.2|73|IX(e) Unspecified soft tissue sarcomas|61087581|0-14|All Races|Male and Female|2009|||
0.2|0.6|0.4|23|Not classified by ICCC|61087581|0-14|All Races|Male and Female|2009|||
4.0|5.1|4.5|282|V Retinoblastoma|61087581|0-14|All Races|Male and Female|2009|||
8.5|10.0|9.2|573|VI Renal tumors|61087581|0-14|All Races|Male and Female|2009|||
7.9|9.4|8.6|535|VI(a) Nephroblastoma and other nonepithelial renal tumors|61087581|0-14|All Races|Male and Female|2009|||
0.4|0.8|0.6|36|VI(b) Renal carcinomas|61087581|0-14|All Races|Male and Female|2009|||
~|~|~|~|VI(c) Unspecified malignant renal tumors|61087581|0-14|All Races|Male and Female|2009|||
1.9|2.6|2.2|138|VII Hepatic tumors|61087581|0-14|All Races|Male and Female|2009|||
1.5|2.2|1.9|117|VII(a) Hepatoblastoma|61087581|0-14|All Races|Male and Female|2009|||
0.2|0.5|0.3|19|VII(b) Hepatic carcinomas|61087581|0-14|All Races|Male and Female|2009|||
~|~|~|~|VII(c) Unspecified malignant hepatic tumors|61087581|0-14|All Races|Male and Female|2009|||
6.4|7.7|7.0|427|VIII Malignant bone tumors|61087581|0-14|All Races|Male and Female|2009|||
3.5|4.5|4.0|241|VIII(a) Osteosarcomas|61087581|0-14|All Races|Male and Female|2009|||
~|~|~|~|VIII(b) Chondrosarcomas|61087581|0-14|All Races|Male and Female|2009|||
2.0|2.8|2.4|144|VIII(c) Ewing tumor and related sarcomas of bone|61087581|0-14|All Races|Male and Female|2009|||
0.3|0.6|0.4|24|VIII(d) Other specified malignant bone tumors|61087581|0-14|All Races|Male and Female|2009|||
~|~|~|~|VIII(e) Unspecified malignant bone tumors|61087581|0-14|All Races|Male and Female|2009|||
4.9|6.1|5.4|333|X Germ cell, trophoblastic tumors & neoplasms of gonads|61087581|0-14|All Races|Male and Female|2009|||
1.1|1.7|1.4|85|X(a) Intracranial & intraspinal germ cell tumors|61087581|0-14|All Races|Male and Female|2009|||
0.9|1.5|1.2|73|X(b) Malignant extracranial & extragonadal germ cell tumors|61087581|0-14|All Races|Male and Female|2009|||
2.2|3.0|2.6|160|X(c) Malignant gonadal germ cell tumors|61087581|0-14|All Races|Male and Female|2009|||
~|~|~|~|X(d) Gonadal carcinomas|61087581|0-14|All Races|Male and Female|2009|||
~|~|~|~|X(e) Other and unspecified malignant gonadal tumors|61087581|0-14|All Races|Male and Female|2009|||
6.5|7.9|7.2|436|XI Other malignant epithelial neoplasms and malignant melanomas|61087581|0-14|All Races|Male and Female|2009|||
~|~|~|~|XI(a) Adrenocortical carcinomas|61087581|0-14|All Races|Male and Female|2009|||
2.5|3.3|2.9|175|XI(b) Thyroid carcinomas|61087581|0-14|All Races|Male and Female|2009|||
0.3|0.6|0.4|25|XI(c) Nasopharyngeal carcinomas|61087581|0-14|All Races|Male and Female|2009|||
1.4|2.0|1.7|103|XI(d) Malignant melanomas|61087581|0-14|All Races|Male and Female|2009|||
~|~|~|~|XI(e) Skin carcinomas|61087581|0-14|All Races|Male and Female|2009|||
1.5|2.2|1.9|113|XI(f) Other and unspecified carcinomas|61087581|0-14|All Races|Male and Female|2009|||
0.6|1.0|0.8|49|XII Other and unspecified malignant neoplasms|61087581|0-14|All Races|Male and Female|2009|||
0.2|0.5|0.3|20|XII(a) Other specified malignant tumors|61087581|0-14|All Races|Male and Female|2009|||
0.3|0.7|0.5|29|XII(b) Other unspecified malignant tumors|61087581|0-14|All Races|Male and Female|2009|||
166.7|173.3|170.0|10452|All ICCC Groups Combined|61202414|0-14|All Races|Male and Female|2010|||
52.4|56.1|54.2|3341|I Leukemias, myeloproliferative & myelodysplastic diseases|61202414|0-14|All Races|Male and Female|2010|||
39.3|42.5|40.9|2521|I(a) Lymphoid leukemias|61202414|0-14|All Races|Male and Female|2010|||
7.1|8.5|7.7|476|I(b) Acute myeloid leukemias|61202414|0-14|All Races|Male and Female|2010|||
1.6|2.3|1.9|117|I(c) Chronic myeloproliferative diseases|61202414|0-14|All Races|Male and Female|2010|||
1.6|2.3|1.9|119|I(d) Myelodysplastic syndrome and other myeloproliferative diseases|61202414|0-14|All Races|Male and Female|2010|||
1.4|2.1|1.7|108|I(e) Unspecified and other specified leukemias|61202414|0-14|All Races|Male and Female|2010|||
18.9|21.1|20.0|1220|II Lymphomas and reticuloendothelial neoplasms|61202414|0-14|All Races|Male and Female|2010|||
4.8|5.9|5.3|323|II(a) Hodgkin lymphomas|61202414|0-14|All Races|Male and Female|2010|||
6.5|7.9|7.2|439|II(b) Non-Hodgkin lymphomas (except Burkitt lymphoma)|61202414|0-14|All Races|Male and Female|2010|||
2.1|2.9|2.5|151|II(c) Burkitt lymphoma|61202414|0-14|All Races|Male and Female|2010|||
4.3|5.4|4.8|297|II(d) Miscellaneous lymphoreticular neoplasms|61202414|0-14|All Races|Male and Female|2010|||
~|~|~|~|II(e) Unspecified lymphomas|61202414|0-14|All Races|Male and Female|2010|||
34.7|37.7|36.2|2222|III CNS and misc intracranial and intraspinal neoplasms|61202414|0-14|All Races|Male and Female|2010|||
2.8|3.7|3.3|202|III(a) Ependymomas and choroid plexus tumor|61202414|0-14|All Races|Male and Female|2010|||
17.4|19.6|18.5|1134|III(b) Astrocytomas|61202414|0-14|All Races|Male and Female|2010|||
6.7|8.1|7.3|452|III(c) Intracranial and intraspinal embryonal tumors|61202414|0-14|All Races|Male and Female|2010|||
5.5|6.7|6.1|372|III(d) Other gliomas|61202414|0-14|All Races|Male and Female|2010|||
0.5|0.9|0.6|39|III(e) Other specified intracranial & intraspinal neoplasms|61202414|0-14|All Races|Male and Female|2010|||
0.2|0.6|0.4|23|III(f) Unspecified intracranial and intraspinal neoplasms|61202414|0-14|All Races|Male and Female|2010|||
10.4|12.1|11.2|695|IV Neuroblastoma and other peripheral nervous cell tumors|61202414|0-14|All Races|Male and Female|2010|||
10.2|11.9|11.0|685|IV(a) Neuroblastoma and ganglioneuroblastoma|61202414|0-14|All Races|Male and Female|2010|||
~|~|~|~|IV(b) Other peripheral nervous cell tumors|61202414|0-14|All Races|Male and Female|2010|||
10.7|12.4|11.6|708|IX Soft tissue and other extraosseous sarcomas|61202414|0-14|All Races|Male and Female|2010|||
5.0|6.2|5.6|343|IX(a) Rhabdomyosarcomas|61202414|0-14|All Races|Male and Female|2010|||
0.6|1.0|0.8|48|IX(b) Fibrosarcomas, peripheral nerve sheath tumors & other fibrous neoplams|61202414|0-14|All Races|Male and Female|2010|||
~|~|~|~|IX(c) Kaposi sarcoma|61202414|0-14|All Races|Male and Female|2010|||
3.4|4.4|3.9|238|IX(d) Other specified soft tissue sarcomas|61202414|0-14|All Races|Male and Female|2010|||
1.0|1.6|1.3|79|IX(e) Unspecified soft tissue sarcomas|61202414|0-14|All Races|Male and Female|2010|||
0.1|0.4|0.3|16|Not classified by ICCC|61202414|0-14|All Races|Male and Female|2010|||
4.0|5.1|4.5|282|V Retinoblastoma|61202414|0-14|All Races|Male and Female|2010|||
7.8|9.3|8.5|528|VI Renal tumors|61202414|0-14|All Races|Male and Female|2010|||
7.4|8.9|8.1|506|VI(a) Nephroblastoma and other nonepithelial renal tumors|61202414|0-14|All Races|Male and Female|2010|||
0.2|0.5|0.3|20|VI(b) Renal carcinomas|61202414|0-14|All Races|Male and Female|2010|||
~|~|~|~|VI(c) Unspecified malignant renal tumors|61202414|0-14|All Races|Male and Female|2010|||
2.6|3.5|3.0|187|VII Hepatic tumors|61202414|0-14|All Races|Male and Female|2010|||
2.1|2.9|2.5|157|VII(a) Hepatoblastoma|61202414|0-14|All Races|Male and Female|2010|||
0.3|0.7|0.5|29|VII(b) Hepatic carcinomas|61202414|0-14|All Races|Male and Female|2010|||
~|~|~|~|VII(c) Unspecified malignant hepatic tumors|61202414|0-14|All Races|Male and Female|2010|||
6.1|7.4|6.7|408|VIII Malignant bone tumors|61202414|0-14|All Races|Male and Female|2010|||
3.2|4.2|3.7|225|VIII(a) Osteosarcomas|61202414|0-14|All Races|Male and Female|2010|||
~|~|~|~|VIII(b) Chondrosarcomas|61202414|0-14|All Races|Male and Female|2010|||
2.0|2.8|2.3|142|VIII(c) Ewing tumor and related sarcomas of bone|61202414|0-14|All Races|Male and Female|2010|||
0.2|0.5|0.3|20|VIII(d) Other specified malignant bone tumors|61202414|0-14|All Races|Male and Female|2010|||
~|~|~|~|VIII(e) Unspecified malignant bone tumors|61202414|0-14|All Races|Male and Female|2010|||
5.6|6.8|6.2|378|X Germ cell, trophoblastic tumors & neoplasms of gonads|61202414|0-14|All Races|Male and Female|2010|||
1.5|2.2|1.8|111|X(a) Intracranial & intraspinal germ cell tumors|61202414|0-14|All Races|Male and Female|2010|||
1.1|1.7|1.3|83|X(b) Malignant extracranial & extragonadal germ cell tumors|61202414|0-14|All Races|Male and Female|2010|||
2.2|3.1|2.6|160|X(c) Malignant gonadal germ cell tumors|61202414|0-14|All Races|Male and Female|2010|||
~|~|~|~|X(d) Gonadal carcinomas|61202414|0-14|All Races|Male and Female|2010|||
0.2|0.4|0.3|16|X(e) Other and unspecified malignant gonadal tumors|61202414|0-14|All Races|Male and Female|2010|||
6.4|7.8|7.1|429|XI Other malignant epithelial neoplasms and malignant melanomas|61202414|0-14|All Races|Male and Female|2010|||
~|~|~|~|XI(a) Adrenocortical carcinomas|61202414|0-14|All Races|Male and Female|2010|||
2.4|3.3|2.8|171|XI(b) Thyroid carcinomas|61202414|0-14|All Races|Male and Female|2010|||
0.2|0.4|0.3|17|XI(c) Nasopharyngeal carcinomas|61202414|0-14|All Races|Male and Female|2010|||
1.5|2.2|1.8|111|XI(d) Malignant melanomas|61202414|0-14|All Races|Male and Female|2010|||
~|~|~|~|XI(e) Skin carcinomas|61202414|0-14|All Races|Male and Female|2010|||
1.5|2.2|1.8|111|XI(f) Other and unspecified carcinomas|61202414|0-14|All Races|Male and Female|2010|||
0.4|0.8|0.6|38|XII Other and unspecified malignant neoplasms|61202414|0-14|All Races|Male and Female|2010|||
0.2|0.6|0.4|24|XII(a) Other specified malignant tumors|61202414|0-14|All Races|Male and Female|2010|||
~|~|~|~|XII(b) Other unspecified malignant tumors|61202414|0-14|All Races|Male and Female|2010|||
168.0|170.9|169.5|51480|All ICCC Groups Combined|302918297|0-14|All Races|Male and Female|2010-2014|||
51.3|53.0|52.2|15877|I Leukemias, myeloproliferative & myelodysplastic diseases|302918297|0-14|All Races|Male and Female|2010-2014|||
38.8|40.2|39.5|12030|I(a) Lymphoid leukemias|302918297|0-14|All Races|Male and Female|2010-2014|||
7.3|7.9|7.6|2312|I(b) Acute myeloid leukemias|302918297|0-14|All Races|Male and Female|2010-2014|||
1.5|1.8|1.7|509|I(c) Chronic myeloproliferative diseases|302918297|0-14|All Races|Male and Female|2010-2014|||
1.4|1.7|1.6|477|I(d) Myelodysplastic syndrome and other myeloproliferative diseases|302918297|0-14|All Races|Male and Female|2010-2014|||
1.7|2.0|1.8|549|I(e) Unspecified and other specified leukemias|302918297|0-14|All Races|Male and Female|2010-2014|||
20.6|21.7|21.2|6398|II Lymphomas and reticuloendothelial neoplasms|302918297|0-14|All Races|Male and Female|2010-2014|||
5.2|5.7|5.4|1632|II(a) Hodgkin lymphomas|302918297|0-14|All Races|Male and Female|2010-2014|||
7.0|7.7|7.3|2220|II(b) Non-Hodgkin lymphomas (except Burkitt lymphoma)|302918297|0-14|All Races|Male and Female|2010-2014|||
2.3|2.7|2.5|752|II(c) Burkitt lymphoma|302918297|0-14|All Races|Male and Female|2010-2014|||
5.4|5.9|5.6|1718|II(d) Miscellaneous lymphoreticular neoplasms|302918297|0-14|All Races|Male and Female|2010-2014|||
0.2|0.3|0.3|76|II(e) Unspecified lymphomas|302918297|0-14|All Races|Male and Female|2010-2014|||
34.7|36.0|35.4|10728|III CNS and misc intracranial and intraspinal neoplasms|302918297|0-14|All Races|Male and Female|2010-2014|||
3.0|3.4|3.2|960|III(a) Ependymomas and choroid plexus tumor|302918297|0-14|All Races|Male and Female|2010-2014|||
17.7|18.7|18.2|5513|III(b) Astrocytomas|302918297|0-14|All Races|Male and Female|2010-2014|||
6.8|7.4|7.1|2157|III(c) Intracranial and intraspinal embryonal tumors|302918297|0-14|All Races|Male and Female|2010-2014|||
5.5|6.0|5.8|1743|III(d) Other gliomas|302918297|0-14|All Races|Male and Female|2010-2014|||
0.6|0.7|0.6|194|III(e) Other specified intracranial & intraspinal neoplasms|302918297|0-14|All Races|Male and Female|2010-2014|||
0.5|0.6|0.5|161|III(f) Unspecified intracranial and intraspinal neoplasms|302918297|0-14|All Races|Male and Female|2010-2014|||
11.1|11.9|11.5|3505|IV Neuroblastoma and other peripheral nervous cell tumors|302918297|0-14|All Races|Male and Female|2010-2014|||
10.9|11.6|11.2|3438|IV(a) Neuroblastoma and ganglioneuroblastoma|302918297|0-14|All Races|Male and Female|2010-2014|||
0.2|0.3|0.2|67|IV(b) Other peripheral nervous cell tumors|302918297|0-14|All Races|Male and Female|2010-2014|||
10.8|11.5|11.2|3385|IX Soft tissue and other extraosseous sarcomas|302918297|0-14|All Races|Male and Female|2010-2014|||
4.9|5.5|5.2|1581|IX(a) Rhabdomyosarcomas|302918297|0-14|All Races|Male and Female|2010-2014|||
1.0|1.2|1.1|322|IX(b) Fibrosarcomas, peripheral nerve sheath tumors & other fibrous neoplams|302918297|0-14|All Races|Male and Female|2010-2014|||
~|~|~|~|IX(c) Kaposi sarcoma|302918297|0-14|All Races|Male and Female|2010-2014|||
3.5|3.9|3.7|1126|IX(d) Other specified soft tissue sarcomas|302918297|0-14|All Races|Male and Female|2010-2014|||
1.0|1.3|1.2|348|IX(e) Unspecified soft tissue sarcomas|302918297|0-14|All Races|Male and Female|2010-2014|||
0.2|0.3|0.3|79|Not classified by ICCC|302918297|0-14|All Races|Male and Female|2010-2014|||
4.1|4.6|4.3|1329|V Retinoblastoma|302918297|0-14|All Races|Male and Female|2010-2014|||
8.5|9.1|8.8|2687|VI Renal tumors|302918297|0-14|All Races|Male and Female|2010-2014|||
8.0|8.7|8.4|2560|VI(a) Nephroblastoma and other nonepithelial renal tumors|302918297|0-14|All Races|Male and Female|2010-2014|||
0.3|0.5|0.4|114|VI(b) Renal carcinomas|302918297|0-14|All Races|Male and Female|2010-2014|||
~|~|~|~|VI(c) Unspecified malignant renal tumors|302918297|0-14|All Races|Male and Female|2010-2014|||
2.9|3.3|3.1|934|VII Hepatic tumors|302918297|0-14|All Races|Male and Female|2010-2014|||
2.4|2.8|2.6|794|VII(a) Hepatoblastoma|302918297|0-14|All Races|Male and Female|2010-2014|||
0.4|0.5|0.4|130|VII(b) Hepatic carcinomas|302918297|0-14|All Races|Male and Female|2010-2014|||
~|~|~|~|VII(c) Unspecified malignant hepatic tumors|302918297|0-14|All Races|Male and Female|2010-2014|||
7.0|7.6|7.3|2212|VIII Malignant bone tumors|302918297|0-14|All Races|Male and Female|2010-2014|||
3.8|4.3|4.1|1220|VIII(a) Osteosarcomas|302918297|0-14|All Races|Male and Female|2010-2014|||
0.1|0.2|0.2|57|VIII(b) Chondrosarcomas|302918297|0-14|All Races|Male and Female|2010-2014|||
2.4|2.8|2.6|789|VIII(c) Ewing tumor and related sarcomas of bone|302918297|0-14|All Races|Male and Female|2010-2014|||
0.3|0.4|0.4|108|VIII(d) Other specified malignant bone tumors|302918297|0-14|All Races|Male and Female|2010-2014|||
0.1|0.2|0.1|38|VIII(e) Unspecified malignant bone tumors|302918297|0-14|All Races|Male and Female|2010-2014|||
5.3|5.8|5.6|1681|X Germ cell, trophoblastic tumors & neoplasms of gonads|302918297|0-14|All Races|Male and Female|2010-2014|||
1.4|1.7|1.6|477|X(a) Intracranial & intraspinal germ cell tumors|302918297|0-14|All Races|Male and Female|2010-2014|||
1.2|1.5|1.4|419|X(b) Malignant extracranial & extragonadal germ cell tumors|302918297|0-14|All Races|Male and Female|2010-2014|||
2.1|2.5|2.3|695|X(c) Malignant gonadal germ cell tumors|302918297|0-14|All Races|Male and Female|2010-2014|||
0.1|0.1|0.1|32|X(d) Gonadal carcinomas|302918297|0-14|All Races|Male and Female|2010-2014|||
0.1|0.2|0.2|58|X(e) Other and unspecified malignant gonadal tumors|302918297|0-14|All Races|Male and Female|2010-2014|||
7.8|8.5|8.2|2461|XI Other malignant epithelial neoplasms and malignant melanomas|302918297|0-14|All Races|Male and Female|2010-2014|||
0.2|0.3|0.2|67|XI(a) Adrenocortical carcinomas|302918297|0-14|All Races|Male and Female|2010-2014|||
3.2|3.6|3.4|1016|XI(b) Thyroid carcinomas|302918297|0-14|All Races|Male and Female|2010-2014|||
0.2|0.3|0.3|81|XI(c) Nasopharyngeal carcinomas|302918297|0-14|All Races|Male and Female|2010-2014|||
1.9|2.2|2.1|624|XI(d) Malignant melanomas|302918297|0-14|All Races|Male and Female|2010-2014|||
0.0|0.1|0.1|16|XI(e) Skin carcinomas|302918297|0-14|All Races|Male and Female|2010-2014|||
2.0|2.4|2.2|657|XI(f) Other and unspecified carcinomas|302918297|0-14|All Races|Male and Female|2010-2014|||
0.6|0.8|0.7|204|XII Other and unspecified malignant neoplasms|302918297|0-14|All Races|Male and Female|2010-2014|||
0.3|0.4|0.4|110|XII(a) Other specified malignant tumors|302918297|0-14|All Races|Male and Female|2010-2014|||
0.3|0.4|0.3|94|XII(b) Other unspecified malignant tumors|302918297|0-14|All Races|Male and Female|2010-2014|||
166.1|172.7|169.4|10310|All ICCC Groups Combined|60627093|0-14|All Races|Male and Female|2011|||
52.1|55.8|54.0|3292|I Leukemias, myeloproliferative & myelodysplastic diseases|60627093|0-14|All Races|Male and Female|2011|||
39.9|43.2|41.5|2535|I(a) Lymphoid leukemias|60627093|0-14|All Races|Male and Female|2011|||
7.0|8.4|7.7|469|I(b) Acute myeloid leukemias|60627093|0-14|All Races|Male and Female|2011|||
1.5|2.2|1.8|110|I(c) Chronic myeloproliferative diseases|60627093|0-14|All Races|Male and Female|2011|||
1.1|1.7|1.4|83|I(d) Myelodysplastic syndrome and other myeloproliferative diseases|60627093|0-14|All Races|Male and Female|2011|||
1.3|1.9|1.6|95|I(e) Unspecified and other specified leukemias|60627093|0-14|All Races|Male and Female|2011|||
19.0|21.2|20.1|1215|II Lymphomas and reticuloendothelial neoplasms|60627093|0-14|All Races|Male and Female|2011|||
4.6|5.8|5.2|313|II(a) Hodgkin lymphomas|60627093|0-14|All Races|Male and Female|2011|||
5.8|7.1|6.4|387|II(b) Non-Hodgkin lymphomas (except Burkitt lymphoma)|60627093|0-14|All Races|Male and Female|2011|||
2.2|3.1|2.6|158|II(c) Burkitt lymphoma|60627093|0-14|All Races|Male and Female|2011|||
5.1|6.3|5.7|345|II(d) Miscellaneous lymphoreticular neoplasms|60627093|0-14|All Races|Male and Female|2011|||
~|~|~|~|II(e) Unspecified lymphomas|60627093|0-14|All Races|Male and Female|2011|||
33.9|36.9|35.4|2151|III CNS and misc intracranial and intraspinal neoplasms|60627093|0-14|All Races|Male and Female|2011|||
3.0|3.9|3.4|210|III(a) Ependymomas and choroid plexus tumor|60627093|0-14|All Races|Male and Female|2011|||
16.8|18.9|17.8|1082|III(b) Astrocytomas|60627093|0-14|All Races|Male and Female|2011|||
6.3|7.7|7.0|425|III(c) Intracranial and intraspinal embryonal tumors|60627093|0-14|All Races|Male and Female|2011|||
5.6|6.8|6.2|374|III(d) Other gliomas|60627093|0-14|All Races|Male and Female|2011|||
0.3|0.7|0.5|30|III(e) Other specified intracranial & intraspinal neoplasms|60627093|0-14|All Races|Male and Female|2011|||
0.3|0.7|0.5|30|III(f) Unspecified intracranial and intraspinal neoplasms|60627093|0-14|All Races|Male and Female|2011|||
10.4|12.0|11.2|686|IV Neuroblastoma and other peripheral nervous cell tumors|60627093|0-14|All Races|Male and Female|2011|||
10.1|11.8|11.0|673|IV(a) Neuroblastoma and ganglioneuroblastoma|60627093|0-14|All Races|Male and Female|2011|||
~|~|~|~|IV(b) Other peripheral nervous cell tumors|60627093|0-14|All Races|Male and Female|2011|||
10.3|12.0|11.1|676|IX Soft tissue and other extraosseous sarcomas|60627093|0-14|All Races|Male and Female|2011|||
4.7|5.8|5.2|318|IX(a) Rhabdomyosarcomas|60627093|0-14|All Races|Male and Female|2011|||
0.8|1.4|1.1|65|IX(b) Fibrosarcomas, peripheral nerve sheath tumors & other fibrous neoplams|60627093|0-14|All Races|Male and Female|2011|||
~|~|~|~|IX(c) Kaposi sarcoma|60627093|0-14|All Races|Male and Female|2011|||
3.2|4.2|3.7|225|IX(d) Other specified soft tissue sarcomas|60627093|0-14|All Races|Male and Female|2011|||
0.8|1.4|1.1|65|IX(e) Unspecified soft tissue sarcomas|60627093|0-14|All Races|Male and Female|2011|||
~|~|~|~|Not classified by ICCC|60627093|0-14|All Races|Male and Female|2011|||
3.7|4.8|4.2|259|V Retinoblastoma|60627093|0-14|All Races|Male and Female|2011|||
8.3|9.8|9.0|554|VI Renal tumors|60627093|0-14|All Races|Male and Female|2011|||
7.9|9.4|8.6|531|VI(a) Nephroblastoma and other nonepithelial renal tumors|60627093|0-14|All Races|Male and Female|2011|||
0.2|0.6|0.4|22|VI(b) Renal carcinomas|60627093|0-14|All Races|Male and Female|2011|||
~|~|~|~|VI(c) Unspecified malignant renal tumors|60627093|0-14|All Races|Male and Female|2011|||
2.7|3.6|3.2|194|VII Hepatic tumors|60627093|0-14|All Races|Male and Female|2011|||
2.3|3.1|2.7|165|VII(a) Hepatoblastoma|60627093|0-14|All Races|Male and Female|2011|||
0.3|0.6|0.4|25|VII(b) Hepatic carcinomas|60627093|0-14|All Races|Male and Female|2011|||
~|~|~|~|VII(c) Unspecified malignant hepatic tumors|60627093|0-14|All Races|Male and Female|2011|||
6.8|8.2|7.4|449|VIII Malignant bone tumors|60627093|0-14|All Races|Male and Female|2011|||
3.6|4.7|4.1|249|VIII(a) Osteosarcomas|60627093|0-14|All Races|Male and Female|2011|||
~|~|~|~|VIII(b) Chondrosarcomas|60627093|0-14|All Races|Male and Female|2011|||
2.4|3.3|2.8|171|VIII(c) Ewing tumor and related sarcomas of bone|60627093|0-14|All Races|Male and Female|2011|||
~|~|~|~|VIII(d) Other specified malignant bone tumors|60627093|0-14|All Races|Male and Female|2011|||
~|~|~|~|VIII(e) Unspecified malignant bone tumors|60627093|0-14|All Races|Male and Female|2011|||
4.6|5.7|5.1|311|X Germ cell, trophoblastic tumors & neoplasms of gonads|60627093|0-14|All Races|Male and Female|2011|||
1.2|1.9|1.5|93|X(a) Intracranial & intraspinal germ cell tumors|60627093|0-14|All Races|Male and Female|2011|||
0.9|1.5|1.2|74|X(b) Malignant extracranial & extragonadal germ cell tumors|60627093|0-14|All Races|Male and Female|2011|||
1.8|2.6|2.2|131|X(c) Malignant gonadal germ cell tumors|60627093|0-14|All Races|Male and Female|2011|||
~|~|~|~|X(d) Gonadal carcinomas|60627093|0-14|All Races|Male and Female|2011|||
~|~|~|~|X(e) Other and unspecified malignant gonadal tumors|60627093|0-14|All Races|Male and Female|2011|||
7.1|8.5|7.8|470|XI Other malignant epithelial neoplasms and malignant melanomas|60627093|0-14|All Races|Male and Female|2011|||
~|~|~|~|XI(a) Adrenocortical carcinomas|60627093|0-14|All Races|Male and Female|2011|||
2.8|3.8|3.3|198|XI(b) Thyroid carcinomas|60627093|0-14|All Races|Male and Female|2011|||
0.2|0.5|0.3|19|XI(c) Nasopharyngeal carcinomas|60627093|0-14|All Races|Male and Female|2011|||
1.8|2.5|2.1|128|XI(d) Malignant melanomas|60627093|0-14|All Races|Male and Female|2011|||
~|~|~|~|XI(e) Skin carcinomas|60627093|0-14|All Races|Male and Female|2011|||
1.5|2.2|1.8|108|XI(f) Other and unspecified carcinomas|60627093|0-14|All Races|Male and Female|2011|||
0.5|0.9|0.6|39|XII Other and unspecified malignant neoplasms|60627093|0-14|All Races|Male and Female|2011|||
0.2|0.4|0.3|17|XII(a) Other specified malignant tumors|60627093|0-14|All Races|Male and Female|2011|||
0.2|0.5|0.4|22|XII(b) Other unspecified malignant tumors|60627093|0-14|All Races|Male and Female|2011|||
164.3|170.8|167.6|10273|All ICCC Groups Combined|61123600|0-14|All Races|Male and Female|2012|||
50.1|53.7|51.9|3187|I Leukemias, myeloproliferative & myelodysplastic diseases|61123600|0-14|All Races|Male and Female|2012|||
38.2|41.4|39.8|2446|I(a) Lymphoid leukemias|61123600|0-14|All Races|Male and Female|2012|||
6.5|7.8|7.1|436|I(b) Acute myeloid leukemias|61123600|0-14|All Races|Male and Female|2012|||
1.3|2.0|1.6|98|I(c) Chronic myeloproliferative diseases|61123600|0-14|All Races|Male and Female|2012|||
1.3|2.0|1.7|101|I(d) Myelodysplastic syndrome and other myeloproliferative diseases|61123600|0-14|All Races|Male and Female|2012|||
1.4|2.1|1.7|106|I(e) Unspecified and other specified leukemias|61123600|0-14|All Races|Male and Female|2012|||
20.3|22.6|21.4|1309|II Lymphomas and reticuloendothelial neoplasms|61123600|0-14|All Races|Male and Female|2012|||
5.1|6.3|5.7|347|II(a) Hodgkin lymphomas|61123600|0-14|All Races|Male and Female|2012|||
6.8|8.1|7.4|453|II(b) Non-Hodgkin lymphomas (except Burkitt lymphoma)|61123600|0-14|All Races|Male and Female|2012|||
2.0|2.8|2.3|143|II(c) Burkitt lymphoma|61123600|0-14|All Races|Male and Female|2012|||
5.0|6.2|5.6|342|II(d) Miscellaneous lymphoreticular neoplasms|61123600|0-14|All Races|Male and Female|2012|||
0.3|0.6|0.4|24|II(e) Unspecified lymphomas|61123600|0-14|All Races|Male and Female|2012|||
33.3|36.3|34.8|2131|III CNS and misc intracranial and intraspinal neoplasms|61123600|0-14|All Races|Male and Female|2012|||
2.5|3.4|2.9|181|III(a) Ependymomas and choroid plexus tumor|61123600|0-14|All Races|Male and Female|2012|||
17.2|19.4|18.3|1118|III(b) Astrocytomas|61123600|0-14|All Races|Male and Female|2012|||
6.5|7.8|7.1|437|III(c) Intracranial and intraspinal embryonal tumors|61123600|0-14|All Races|Male and Female|2012|||
4.6|5.8|5.2|316|III(d) Other gliomas|61123600|0-14|All Races|Male and Female|2012|||
0.4|0.8|0.6|34|III(e) Other specified intracranial & intraspinal neoplasms|61123600|0-14|All Races|Male and Female|2012|||
0.5|1.0|0.7|45|III(f) Unspecified intracranial and intraspinal neoplasms|61123600|0-14|All Races|Male and Female|2012|||
10.5|12.1|11.3|695|IV Neuroblastoma and other peripheral nervous cell tumors|61123600|0-14|All Races|Male and Female|2012|||
10.2|11.9|11.0|681|IV(a) Neuroblastoma and ganglioneuroblastoma|61123600|0-14|All Races|Male and Female|2012|||
~|~|~|~|IV(b) Other peripheral nervous cell tumors|61123600|0-14|All Races|Male and Female|2012|||
10.2|11.9|11.0|673|IX Soft tissue and other extraosseous sarcomas|61123600|0-14|All Races|Male and Female|2012|||
4.5|5.6|5.0|309|IX(a) Rhabdomyosarcomas|61123600|0-14|All Races|Male and Female|2012|||
0.9|1.5|1.2|71|IX(b) Fibrosarcomas, peripheral nerve sheath tumors & other fibrous neoplams|61123600|0-14|All Races|Male and Female|2012|||
~|~|~|~|IX(c) Kaposi sarcoma|61123600|0-14|All Races|Male and Female|2012|||
3.1|4.0|3.5|216|IX(d) Other specified soft tissue sarcomas|61123600|0-14|All Races|Male and Female|2012|||
1.0|1.5|1.2|74|IX(e) Unspecified soft tissue sarcomas|61123600|0-14|All Races|Male and Female|2012|||
~|~|~|~|Not classified by ICCC|61123600|0-14|All Races|Male and Female|2012|||
3.9|4.9|4.4|269|V Retinoblastoma|61123600|0-14|All Races|Male and Female|2012|||
7.8|9.3|8.5|527|VI Renal tumors|61123600|0-14|All Races|Male and Female|2012|||
7.4|8.9|8.1|502|VI(a) Nephroblastoma and other nonepithelial renal tumors|61123600|0-14|All Races|Male and Female|2012|||
0.2|0.5|0.3|20|VI(b) Renal carcinomas|61123600|0-14|All Races|Male and Female|2012|||
~|~|~|~|VI(c) Unspecified malignant renal tumors|61123600|0-14|All Races|Male and Female|2012|||
2.9|3.8|3.3|205|VII Hepatic tumors|61123600|0-14|All Races|Male and Female|2012|||
2.4|3.3|2.8|175|VII(a) Hepatoblastoma|61123600|0-14|All Races|Male and Female|2012|||
0.3|0.7|0.5|28|VII(b) Hepatic carcinomas|61123600|0-14|All Races|Male and Female|2012|||
~|~|~|~|VII(c) Unspecified malignant hepatic tumors|61123600|0-14|All Races|Male and Female|2012|||
6.5|7.9|7.2|438|VIII Malignant bone tumors|61123600|0-14|All Races|Male and Female|2012|||
3.9|4.9|4.4|265|VIII(a) Osteosarcomas|61123600|0-14|All Races|Male and Female|2012|||
~|~|~|~|VIII(b) Chondrosarcomas|61123600|0-14|All Races|Male and Female|2012|||
1.8|2.6|2.2|134|VIII(c) Ewing tumor and related sarcomas of bone|61123600|0-14|All Races|Male and Female|2012|||
0.2|0.5|0.3|19|VIII(d) Other specified malignant bone tumors|61123600|0-14|All Races|Male and Female|2012|||
~|~|~|~|VIII(e) Unspecified malignant bone tumors|61123600|0-14|All Races|Male and Female|2012|||
4.5|5.7|5.1|309|X Germ cell, trophoblastic tumors & neoplasms of gonads|61123600|0-14|All Races|Male and Female|2012|||
1.1|1.7|1.4|84|X(a) Intracranial & intraspinal germ cell tumors|61123600|0-14|All Races|Male and Female|2012|||
1.2|1.8|1.5|89|X(b) Malignant extracranial & extragonadal germ cell tumors|61123600|0-14|All Races|Male and Female|2012|||
1.7|2.4|2.0|122|X(c) Malignant gonadal germ cell tumors|61123600|0-14|All Races|Male and Female|2012|||
~|~|~|~|X(d) Gonadal carcinomas|61123600|0-14|All Races|Male and Female|2012|||
~|~|~|~|X(e) Other and unspecified malignant gonadal tumors|61123600|0-14|All Races|Male and Female|2012|||
7.0|8.4|7.7|467|XI Other malignant epithelial neoplasms and malignant melanomas|61123600|0-14|All Races|Male and Female|2012|||
~|~|~|~|XI(a) Adrenocortical carcinomas|61123600|0-14|All Races|Male and Female|2012|||
2.8|3.8|3.3|199|XI(b) Thyroid carcinomas|61123600|0-14|All Races|Male and Female|2012|||
~|~|~|~|XI(c) Nasopharyngeal carcinomas|61123600|0-14|All Races|Male and Female|2012|||
1.6|2.4|2.0|120|XI(d) Malignant melanomas|61123600|0-14|All Races|Male and Female|2012|||
~|~|~|~|XI(e) Skin carcinomas|61123600|0-14|All Races|Male and Female|2012|||
1.6|2.3|1.9|117|XI(f) Other and unspecified carcinomas|61123600|0-14|All Races|Male and Female|2012|||
0.6|1.1|0.8|50|XII Other and unspecified malignant neoplasms|61123600|0-14|All Races|Male and Female|2012|||
0.2|0.6|0.4|23|XII(a) Other specified malignant tumors|61123600|0-14|All Races|Male and Female|2012|||
0.3|0.6|0.4|27|XII(b) Other unspecified malignant tumors|61123600|0-14|All Races|Male and Female|2012|||
166.4|173.0|169.7|10381|All ICCC Groups Combined|61085889|0-14|All Races|Male and Female|2013|||
48.9|52.5|50.7|3104|I Leukemias, myeloproliferative & myelodysplastic diseases|61085889|0-14|All Races|Male and Female|2013|||
36.2|39.3|37.7|2313|I(a) Lymphoid leukemias|61085889|0-14|All Races|Male and Female|2013|||
7.1|8.5|7.8|475|I(b) Acute myeloid leukemias|61085889|0-14|All Races|Male and Female|2013|||
1.3|2.0|1.6|100|I(c) Chronic myeloproliferative diseases|61085889|0-14|All Races|Male and Female|2013|||
1.1|1.7|1.4|84|I(d) Myelodysplastic syndrome and other myeloproliferative diseases|61085889|0-14|All Races|Male and Female|2013|||
1.8|2.6|2.2|132|I(e) Unspecified and other specified leukemias|61085889|0-14|All Races|Male and Female|2013|||
20.3|22.7|21.5|1311|II Lymphomas and reticuloendothelial neoplasms|61085889|0-14|All Races|Male and Female|2013|||
4.9|6.1|5.5|335|II(a) Hodgkin lymphomas|61085889|0-14|All Races|Male and Female|2013|||
6.6|8.0|7.3|446|II(b) Non-Hodgkin lymphomas (except Burkitt lymphoma)|61085889|0-14|All Races|Male and Female|2013|||
1.9|2.7|2.3|140|II(c) Burkitt lymphoma|61085889|0-14|All Races|Male and Female|2013|||
5.5|6.8|6.1|376|II(d) Miscellaneous lymphoreticular neoplasms|61085889|0-14|All Races|Male and Female|2013|||
~|~|~|~|II(e) Unspecified lymphomas|61085889|0-14|All Races|Male and Female|2013|||
34.1|37.1|35.5|2173|III CNS and misc intracranial and intraspinal neoplasms|61085889|0-14|All Races|Male and Female|2013|||
2.6|3.5|3.0|185|III(a) Ependymomas and choroid plexus tumor|61085889|0-14|All Races|Male and Female|2013|||
17.6|19.7|18.6|1139|III(b) Astrocytomas|61085889|0-14|All Races|Male and Female|2013|||
6.2|7.5|6.8|417|III(c) Intracranial and intraspinal embryonal tumors|61085889|0-14|All Races|Male and Female|2013|||
5.3|6.5|5.9|360|III(d) Other gliomas|61085889|0-14|All Races|Male and Female|2013|||
0.5|0.9|0.7|43|III(e) Other specified intracranial & intraspinal neoplasms|61085889|0-14|All Races|Male and Female|2013|||
0.3|0.7|0.5|29|III(f) Unspecified intracranial and intraspinal neoplasms|61085889|0-14|All Races|Male and Female|2013|||
11.2|13.0|12.1|741|IV Neuroblastoma and other peripheral nervous cell tumors|61085889|0-14|All Races|Male and Female|2013|||
10.9|12.6|11.8|722|IV(a) Neuroblastoma and ganglioneuroblastoma|61085889|0-14|All Races|Male and Female|2013|||
0.2|0.5|0.3|19|IV(b) Other peripheral nervous cell tumors|61085889|0-14|All Races|Male and Female|2013|||
10.2|11.9|11.0|673|IX Soft tissue and other extraosseous sarcomas|61085889|0-14|All Races|Male and Female|2013|||
4.7|5.8|5.2|321|IX(a) Rhabdomyosarcomas|61085889|0-14|All Races|Male and Female|2013|||
0.9|1.5|1.2|72|IX(b) Fibrosarcomas, peripheral nerve sheath tumors & other fibrous neoplams|61085889|0-14|All Races|Male and Female|2013|||
~|~|~|~|IX(c) Kaposi sarcoma|61085889|0-14|All Races|Male and Female|2013|||
3.1|4.1|3.6|220|IX(d) Other specified soft tissue sarcomas|61085889|0-14|All Races|Male and Female|2013|||
0.7|1.2|1.0|59|IX(e) Unspecified soft tissue sarcomas|61085889|0-14|All Races|Male and Female|2013|||
0.2|0.5|0.3|18|Not classified by ICCC|61085889|0-14|All Races|Male and Female|2013|||
3.8|4.8|4.3|263|V Retinoblastoma|61085889|0-14|All Races|Male and Female|2013|||
8.2|9.7|8.9|549|VI Renal tumors|61085889|0-14|All Races|Male and Female|2013|||
7.8|9.2|8.5|521|VI(a) Nephroblastoma and other nonepithelial renal tumors|61085889|0-14|All Races|Male and Female|2013|||
0.3|0.6|0.4|25|VI(b) Renal carcinomas|61085889|0-14|All Races|Male and Female|2013|||
~|~|~|~|VI(c) Unspecified malignant renal tumors|61085889|0-14|All Races|Male and Female|2013|||
2.4|3.2|2.8|171|VII Hepatic tumors|61085889|0-14|All Races|Male and Female|2013|||
2.0|2.8|2.4|145|VII(a) Hepatoblastoma|61085889|0-14|All Races|Male and Female|2013|||
0.3|0.6|0.4|24|VII(b) Hepatic carcinomas|61085889|0-14|All Races|Male and Female|2013|||
~|~|~|~|VII(c) Unspecified malignant hepatic tumors|61085889|0-14|All Races|Male and Female|2013|||
6.7|8.0|7.3|446|VIII Malignant bone tumors|61085889|0-14|All Races|Male and Female|2013|||
3.2|4.2|3.7|226|VIII(a) Osteosarcomas|61085889|0-14|All Races|Male and Female|2013|||
~|~|~|~|VIII(b) Chondrosarcomas|61085889|0-14|All Races|Male and Female|2013|||
2.5|3.3|2.9|175|VIII(c) Ewing tumor and related sarcomas of bone|61085889|0-14|All Races|Male and Female|2013|||
0.3|0.6|0.4|26|VIII(d) Other specified malignant bone tumors|61085889|0-14|All Races|Male and Female|2013|||
~|~|~|~|VIII(e) Unspecified malignant bone tumors|61085889|0-14|All Races|Male and Female|2013|||
5.2|6.4|5.7|350|X Germ cell, trophoblastic tumors & neoplasms of gonads|61085889|0-14|All Races|Male and Female|2013|||
1.4|2.0|1.7|102|X(a) Intracranial & intraspinal germ cell tumors|61085889|0-14|All Races|Male and Female|2013|||
1.0|1.6|1.3|78|X(b) Malignant extracranial & extragonadal germ cell tumors|61085889|0-14|All Races|Male and Female|2013|||
2.1|2.9|2.4|149|X(c) Malignant gonadal germ cell tumors|61085889|0-14|All Races|Male and Female|2013|||
~|~|~|~|X(d) Gonadal carcinomas|61085889|0-14|All Races|Male and Female|2013|||
~|~|~|~|X(e) Other and unspecified malignant gonadal tumors|61085889|0-14|All Races|Male and Female|2013|||
8.2|9.7|8.9|542|XI Other malignant epithelial neoplasms and malignant melanomas|61085889|0-14|All Races|Male and Female|2013|||
~|~|~|~|XI(a) Adrenocortical carcinomas|61085889|0-14|All Races|Male and Female|2013|||
3.1|4.1|3.6|218|XI(b) Thyroid carcinomas|61085889|0-14|All Races|Male and Female|2013|||
0.2|0.6|0.4|23|XI(c) Nasopharyngeal carcinomas|61085889|0-14|All Races|Male and Female|2013|||
1.8|2.6|2.2|133|XI(d) Malignant melanomas|61085889|0-14|All Races|Male and Female|2013|||
~|~|~|~|XI(e) Skin carcinomas|61085889|0-14|All Races|Male and Female|2013|||
2.2|3.0|2.5|155|XI(f) Other and unspecified carcinomas|61085889|0-14|All Races|Male and Female|2013|||
0.5|0.9|0.7|40|XII Other and unspecified malignant neoplasms|61085889|0-14|All Races|Male and Female|2013|||
0.2|0.6|0.4|23|XII(a) Other specified malignant tumors|61085889|0-14|All Races|Male and Female|2013|||
0.2|0.4|0.3|17|XII(b) Other unspecified malignant tumors|61085889|0-14|All Races|Male and Female|2013|||
166.4|173.0|169.7|10381|All ICCC Groups Combined|61079313|0-14|All Races|Male and Female|2014|||
48.4|52.0|50.2|3075|I Leukemias, myeloproliferative & myelodysplastic diseases|61079313|0-14|All Races|Male and Female|2014|||
36.1|39.2|37.6|2304|I(a) Lymphoid leukemias|61079313|0-14|All Races|Male and Female|2014|||
7.0|8.4|7.7|471|I(b) Acute myeloid leukemias|61079313|0-14|All Races|Male and Female|2014|||
1.1|1.8|1.4|87|I(c) Chronic myeloproliferative diseases|61079313|0-14|All Races|Male and Female|2014|||
1.2|1.9|1.5|93|I(d) Myelodysplastic syndrome and other myeloproliferative diseases|61079313|0-14|All Races|Male and Female|2014|||
1.6|2.3|2.0|120|I(e) Unspecified and other specified leukemias|61079313|0-14|All Races|Male and Female|2014|||
21.5|23.9|22.7|1385|II Lymphomas and reticuloendothelial neoplasms|61079313|0-14|All Races|Male and Female|2014|||
4.8|6.0|5.4|329|II(a) Hodgkin lymphomas|61079313|0-14|All Races|Male and Female|2014|||
7.5|9.0|8.2|503|II(b) Non-Hodgkin lymphomas (except Burkitt lymphoma)|61079313|0-14|All Races|Male and Female|2014|||
2.4|3.2|2.8|168|II(c) Burkitt lymphoma|61079313|0-14|All Races|Male and Female|2014|||
5.4|6.6|6.0|367|II(d) Miscellaneous lymphoreticular neoplasms|61079313|0-14|All Races|Male and Female|2014|||
0.2|0.5|0.3|18|II(e) Unspecified lymphomas|61079313|0-14|All Races|Male and Female|2014|||
33.0|35.9|34.4|2105|III CNS and misc intracranial and intraspinal neoplasms|61079313|0-14|All Races|Male and Female|2014|||
2.7|3.6|3.1|189|III(a) Ependymomas and choroid plexus tumor|61079313|0-14|All Races|Male and Female|2014|||
16.4|18.5|17.4|1063|III(b) Astrocytomas|61079313|0-14|All Races|Male and Female|2014|||
6.5|7.9|7.2|438|III(c) Intracranial and intraspinal embryonal tumors|61079313|0-14|All Races|Male and Female|2014|||
4.8|6.0|5.4|328|III(d) Other gliomas|61079313|0-14|All Races|Male and Female|2014|||
0.6|1.1|0.8|49|III(e) Other specified intracranial & intraspinal neoplasms|61079313|0-14|All Races|Male and Female|2014|||
0.4|0.9|0.6|38|III(f) Unspecified intracranial and intraspinal neoplasms|61079313|0-14|All Races|Male and Female|2014|||
10.6|12.3|11.4|703|IV Neuroblastoma and other peripheral nervous cell tumors|61079313|0-14|All Races|Male and Female|2014|||
10.4|12.1|11.2|691|IV(a) Neuroblastoma and ganglioneuroblastoma|61079313|0-14|All Races|Male and Female|2014|||
~|~|~|~|IV(b) Other peripheral nervous cell tumors|61079313|0-14|All Races|Male and Female|2014|||
10.2|11.9|11.0|672|IX Soft tissue and other extraosseous sarcomas|61079313|0-14|All Races|Male and Female|2014|||
4.3|5.4|4.8|296|IX(a) Rhabdomyosarcomas|61079313|0-14|All Races|Male and Female|2014|||
0.9|1.4|1.1|69|IX(b) Fibrosarcomas, peripheral nerve sheath tumors & other fibrous neoplams|61079313|0-14|All Races|Male and Female|2014|||
~|~|~|~|IX(c) Kaposi sarcoma|61079313|0-14|All Races|Male and Female|2014|||
3.4|4.4|3.8|234|IX(d) Other specified soft tissue sarcomas|61079313|0-14|All Races|Male and Female|2014|||
0.9|1.5|1.2|72|IX(e) Unspecified soft tissue sarcomas|61079313|0-14|All Races|Male and Female|2014|||
0.2|0.5|0.3|19|Not classified by ICCC|61079313|0-14|All Races|Male and Female|2014|||
3.7|4.8|4.2|261|V Retinoblastoma|61079313|0-14|All Races|Male and Female|2014|||
8.2|9.7|9.0|550|VI Renal tumors|61079313|0-14|All Races|Male and Female|2014|||
7.8|9.2|8.5|521|VI(a) Nephroblastoma and other nonepithelial renal tumors|61079313|0-14|All Races|Male and Female|2014|||
0.3|0.6|0.4|27|VI(b) Renal carcinomas|61079313|0-14|All Races|Male and Female|2014|||
~|~|~|~|VI(c) Unspecified malignant renal tumors|61079313|0-14|All Races|Male and Female|2014|||
2.6|3.4|3.0|183|VII Hepatic tumors|61079313|0-14|All Races|Male and Female|2014|||
2.2|3.0|2.6|157|VII(a) Hepatoblastoma|61079313|0-14|All Races|Male and Female|2014|||
0.3|0.6|0.4|25|VII(b) Hepatic carcinomas|61079313|0-14|All Races|Male and Female|2014|||
~|~|~|~|VII(c) Unspecified malignant hepatic tumors|61079313|0-14|All Races|Male and Female|2014|||
7.3|8.7|8.0|485|VIII Malignant bone tumors|61079313|0-14|All Races|Male and Female|2014|||
3.9|4.9|4.4|266|VIII(a) Osteosarcomas|61079313|0-14|All Races|Male and Female|2014|||
~|~|~|~|VIII(b) Chondrosarcomas|61079313|0-14|All Races|Male and Female|2014|||
2.4|3.2|2.8|169|VIII(c) Ewing tumor and related sarcomas of bone|61079313|0-14|All Races|Male and Female|2014|||
0.3|0.7|0.5|29|VIII(d) Other specified malignant bone tumors|61079313|0-14|All Races|Male and Female|2014|||
~|~|~|~|VIII(e) Unspecified malignant bone tumors|61079313|0-14|All Races|Male and Female|2014|||
5.0|6.2|5.6|343|X Germ cell, trophoblastic tumors & neoplasms of gonads|61079313|0-14|All Races|Male and Female|2014|||
1.2|1.8|1.5|89|X(a) Intracranial & intraspinal germ cell tumors|61079313|0-14|All Races|Male and Female|2014|||
1.3|1.9|1.6|98|X(b) Malignant extracranial & extragonadal germ cell tumors|61079313|0-14|All Races|Male and Female|2014|||
1.9|2.7|2.2|137|X(c) Malignant gonadal germ cell tumors|61079313|0-14|All Races|Male and Female|2014|||
~|~|~|~|X(d) Gonadal carcinomas|61079313|0-14|All Races|Male and Female|2014|||
~|~|~|~|X(e) Other and unspecified malignant gonadal tumors|61079313|0-14|All Races|Male and Female|2014|||
8.5|10.0|9.2|561|XI Other malignant epithelial neoplasms and malignant melanomas|61079313|0-14|All Races|Male and Female|2014|||
~|~|~|~|XI(a) Adrenocortical carcinomas|61079313|0-14|All Races|Male and Female|2014|||
3.3|4.3|3.8|232|XI(b) Thyroid carcinomas|61079313|0-14|All Races|Male and Female|2014|||
~|~|~|~|XI(c) Nasopharyngeal carcinomas|61079313|0-14|All Races|Male and Female|2014|||
1.8|2.6|2.2|134|XI(d) Malignant melanomas|61079313|0-14|All Races|Male and Female|2014|||
~|~|~|~|XI(e) Skin carcinomas|61079313|0-14|All Races|Male and Female|2014|||
2.4|3.2|2.8|170|XI(f) Other and unspecified carcinomas|61079313|0-14|All Races|Male and Female|2014|||
0.5|0.9|0.6|39|XII Other and unspecified malignant neoplasms|61079313|0-14|All Races|Male and Female|2014|||
0.3|0.6|0.4|24|XII(a) Other specified malignant tumors|61079313|0-14|All Races|Male and Female|2014|||
~|~|~|~|XII(b) Other unspecified malignant tumors|61079313|0-14|All Races|Male and Female|2014|||
155.7|161.3|158.4|12363|All ICCC Groups Combined|78174581|0-19|All Races|Male and Female|1999|155.4|161.0|158.1
39.2|42.1|40.6|3174|I Leukemias, myeloproliferative & myelodysplastic diseases|78174581|0-19|All Races|Male and Female|1999|39.2|42.0|40.6
28.9|31.4|30.1|2355|I(a) Lymphoid leukemias|78174581|0-19|All Races|Male and Female|1999|28.9|31.4|30.1
7.4|8.7|8.0|624|I(b) Acute myeloid leukemias|78174581|0-19|All Races|Male and Female|1999|7.4|8.6|8.0
0.8|1.2|1.0|78|I(c) Chronic myeloproliferative diseases|78174581|0-19|All Races|Male and Female|1999|0.8|1.2|1.0
~|~|~|~|I(d) Myelodysplastic syndrome and other myeloproliferative diseases|78174581|0-19|All Races|Male and Female|1999|~|~|~
1.1|1.6|1.3|105|I(e) Unspecified and other specified leukemias|78174581|0-19|All Races|Male and Female|1999|1.1|1.6|1.3
22.2|24.3|23.3|1814|II Lymphomas and reticuloendothelial neoplasms|78174581|0-19|All Races|Male and Female|1999|22.1|24.3|23.2
11.1|12.7|11.9|926|II(a) Hodgkin lymphomas|78174581|0-19|All Races|Male and Female|1999|11.1|12.6|11.8
7.0|8.3|7.6|597|II(b) Non-Hodgkin lymphomas (except Burkitt lymphoma)|78174581|0-19|All Races|Male and Female|1999|7.0|8.3|7.6
2.1|2.8|2.4|188|II(c) Burkitt lymphoma|78174581|0-19|All Races|Male and Female|1999|2.1|2.8|2.4
0.5|0.9|0.7|54|II(d) Miscellaneous lymphoreticular neoplasms|78174581|0-19|All Races|Male and Female|1999|0.5|0.9|0.7
0.5|0.8|0.6|49|II(e) Unspecified lymphomas|78174581|0-19|All Races|Male and Female|1999|0.5|0.8|0.6
27.4|29.8|28.6|2235|III CNS and misc intracranial and intraspinal neoplasms|78174581|0-19|All Races|Male and Female|1999|27.4|29.8|28.6
2.3|3.0|2.6|204|III(a) Ependymomas and choroid plexus tumor|78174581|0-19|All Races|Male and Female|1999|2.3|3.0|2.6
12.8|14.4|13.6|1062|III(b) Astrocytomas|78174581|0-19|All Races|Male and Female|1999|12.8|14.4|13.6
6.1|7.2|6.6|519|III(c) Intracranial and intraspinal embryonal tumors|78174581|0-19|All Races|Male and Female|1999|6.1|7.2|6.6
4.2|5.1|4.6|363|III(d) Other gliomas|78174581|0-19|All Races|Male and Female|1999|4.2|5.1|4.6
0.4|0.7|0.5|39|III(e) Other specified intracranial & intraspinal neoplasms|78174581|0-19|All Races|Male and Female|1999|0.4|0.7|0.5
0.5|0.8|0.6|48|III(f) Unspecified intracranial and intraspinal neoplasms|78174581|0-19|All Races|Male and Female|1999|0.5|0.8|0.6
7.6|8.9|8.2|638|IV Neuroblastoma and other peripheral nervous cell tumors|78174581|0-19|All Races|Male and Female|1999|7.5|8.8|8.2
7.3|8.6|7.9|616|IV(a) Neuroblastoma and ganglioneuroblastoma|78174581|0-19|All Races|Male and Female|1999|7.3|8.5|7.9
0.2|0.4|0.3|22|IV(b) Other peripheral nervous cell tumors|78174581|0-19|All Races|Male and Female|1999|0.2|0.4|0.3
10.2|11.7|10.9|852|IX Soft tissue and other extraosseous sarcomas|78174581|0-19|All Races|Male and Female|1999|10.2|11.7|10.9
4.1|5.1|4.6|356|IX(a) Rhabdomyosarcomas|78174581|0-19|All Races|Male and Female|1999|4.1|5.1|4.6
0.9|1.4|1.1|88|IX(b) Fibrosarcomas, peripheral nerve sheath tumors & other fibrous neoplams|78174581|0-19|All Races|Male and Female|1999|0.9|1.4|1.1
~|~|~|~|IX(c) Kaposi sarcoma|78174581|0-19|All Races|Male and Female|1999|~|~|~
3.5|4.4|3.9|308|IX(d) Other specified soft tissue sarcomas|78174581|0-19|All Races|Male and Female|1999|3.5|4.4|3.9
1.0|1.5|1.2|97|IX(e) Unspecified soft tissue sarcomas|78174581|0-19|All Races|Male and Female|1999|1.0|1.5|1.2
0.2|0.4|0.3|22|Not classified by ICCC|78174581|0-19|All Races|Male and Female|1999|0.2|0.4|0.3
2.8|3.6|3.1|244|V Retinoblastoma|78174581|0-19|All Races|Male and Female|1999|2.7|3.5|3.1
5.8|6.9|6.3|495|VI Renal tumors|78174581|0-19|All Races|Male and Female|1999|5.8|6.9|6.3
5.3|6.3|5.8|451|VI(a) Nephroblastoma and other nonepithelial renal tumors|78174581|0-19|All Races|Male and Female|1999|5.2|6.3|5.8
0.4|0.7|0.5|40|VI(b) Renal carcinomas|78174581|0-19|All Races|Male and Female|1999|0.4|0.7|0.5
~|~|~|~|VI(c) Unspecified malignant renal tumors|78174581|0-19|All Races|Male and Female|1999|~|~|~
1.7|2.3|2.0|155|VII Hepatic tumors|78174581|0-19|All Races|Male and Female|1999|1.7|2.3|2.0
1.1|1.6|1.3|102|VII(a) Hepatoblastoma|78174581|0-19|All Races|Male and Female|1999|1.1|1.6|1.3
0.5|0.9|0.7|52|VII(b) Hepatic carcinomas|78174581|0-19|All Races|Male and Female|1999|0.5|0.9|0.7
~|~|~|~|VII(c) Unspecified malignant hepatic tumors|78174581|0-19|All Races|Male and Female|1999|~|~|~
8.2|9.6|8.9|693|VIII Malignant bone tumors|78174581|0-19|All Races|Male and Female|1999|8.2|9.6|8.9
4.6|5.7|5.1|400|VIII(a) Osteosarcomas|78174581|0-19|All Races|Male and Female|1999|4.6|5.6|5.1
0.2|0.5|0.4|28|VIII(b) Chondrosarcomas|78174581|0-19|All Races|Male and Female|1999|0.2|0.5|0.4
2.4|3.1|2.7|213|VIII(c) Ewing tumor and related sarcomas of bone|78174581|0-19|All Races|Male and Female|1999|2.4|3.1|2.7
0.4|0.7|0.5|40|VIII(d) Other specified malignant bone tumors|78174581|0-19|All Races|Male and Female|1999|0.4|0.7|0.5
~|~|~|~|VIII(e) Unspecified malignant bone tumors|78174581|0-19|All Races|Male and Female|1999|~|~|~
9.4|10.8|10.1|787|X Germ cell, trophoblastic tumors & neoplasms of gonads|78174581|0-19|All Races|Male and Female|1999|9.4|10.8|10.1
1.1|1.7|1.4|109|X(a) Intracranial & intraspinal germ cell tumors|78174581|0-19|All Races|Male and Female|1999|1.1|1.7|1.4
1.1|1.7|1.4|106|X(b) Malignant extracranial & extragonadal germ cell tumors|78174581|0-19|All Races|Male and Female|1999|1.1|1.6|1.4
6.1|7.3|6.7|521|X(c) Malignant gonadal germ cell tumors|78174581|0-19|All Races|Male and Female|1999|6.1|7.3|6.7
0.3|0.6|0.4|32|X(d) Gonadal carcinomas|78174581|0-19|All Races|Male and Female|1999|0.3|0.6|0.4
0.1|0.4|0.2|19|X(e) Other and unspecified malignant gonadal tumors|78174581|0-19|All Races|Male and Female|1999|0.1|0.4|0.2
14.4|16.2|15.3|1190|XI Other malignant epithelial neoplasms and malignant melanomas|78174581|0-19|All Races|Male and Female|1999|14.4|16.1|15.2
0.1|0.4|0.2|18|XI(a) Adrenocortical carcinomas|78174581|0-19|All Races|Male and Female|1999|0.1|0.4|0.2
5.3|6.3|5.8|451|XI(b) Thyroid carcinomas|78174581|0-19|All Races|Male and Female|1999|5.2|6.3|5.8
0.4|0.7|0.5|41|XI(c) Nasopharyngeal carcinomas|78174581|0-19|All Races|Male and Female|1999|0.4|0.7|0.5
4.3|5.2|4.7|369|XI(d) Malignant melanomas|78174581|0-19|All Races|Male and Female|1999|4.3|5.2|4.7
~|~|~|~|XI(e) Skin carcinomas|78174581|0-19|All Races|Male and Female|1999|~|~|~
3.5|4.4|3.9|304|XI(f) Other and unspecified carcinomas|78174581|0-19|All Races|Male and Female|1999|3.5|4.4|3.9
0.6|1.0|0.8|64|XII Other and unspecified malignant neoplasms|78174581|0-19|All Races|Male and Female|1999|0.6|1.0|0.8
0.1|0.3|0.2|17|XII(a) Other specified malignant tumors|78174581|0-19|All Races|Male and Female|1999|0.1|0.3|0.2
0.4|0.8|0.6|47|XII(b) Other unspecified malignant tumors|78174581|0-19|All Races|Male and Female|1999|0.4|0.8|0.6
160.9|166.6|163.8|12869|All ICCC Groups Combined|78714159|0-19|All Races|Male and Female|2000|160.7|166.3|163.5
40.0|42.8|41.4|3246|I Leukemias, myeloproliferative & myelodysplastic diseases|78714159|0-19|All Races|Male and Female|2000|39.8|42.7|41.2
30.6|33.1|31.8|2495|I(a) Lymphoid leukemias|78714159|0-19|All Races|Male and Female|2000|30.5|33.0|31.7
6.6|7.7|7.1|560|I(b) Acute myeloid leukemias|78714159|0-19|All Races|Male and Female|2000|6.5|7.7|7.1
0.7|1.2|0.9|73|I(c) Chronic myeloproliferative diseases|78714159|0-19|All Races|Male and Female|2000|0.7|1.2|0.9
~|~|~|~|I(d) Myelodysplastic syndrome and other myeloproliferative diseases|78714159|0-19|All Races|Male and Female|2000|~|~|~
1.1|1.6|1.4|107|I(e) Unspecified and other specified leukemias|78714159|0-19|All Races|Male and Female|2000|1.1|1.6|1.4
23.7|25.9|24.8|1951|II Lymphomas and reticuloendothelial neoplasms|78714159|0-19|All Races|Male and Female|2000|23.7|25.9|24.8
11.5|13.1|12.3|969|II(a) Hodgkin lymphomas|78714159|0-19|All Races|Male and Female|2000|11.5|13.1|12.3
7.5|8.8|8.1|642|II(b) Non-Hodgkin lymphomas (except Burkitt lymphoma)|78714159|0-19|All Races|Male and Female|2000|7.5|8.8|8.2
2.3|3.1|2.7|211|II(c) Burkitt lymphoma|78714159|0-19|All Races|Male and Female|2000|2.3|3.1|2.7
0.8|1.2|1.0|78|II(d) Miscellaneous lymphoreticular neoplasms|78714159|0-19|All Races|Male and Female|2000|0.8|1.2|1.0
0.5|0.9|0.6|51|II(e) Unspecified lymphomas|78714159|0-19|All Races|Male and Female|2000|0.5|0.9|0.6
29.0|31.5|30.2|2378|III CNS and misc intracranial and intraspinal neoplasms|78714159|0-19|All Races|Male and Female|2000|29.0|31.4|30.2
2.0|2.7|2.3|184|III(a) Ependymomas and choroid plexus tumor|78714159|0-19|All Races|Male and Female|2000|2.0|2.7|2.3
14.9|16.7|15.8|1241|III(b) Astrocytomas|78714159|0-19|All Races|Male and Female|2000|14.9|16.7|15.8
5.9|7.1|6.5|509|III(c) Intracranial and intraspinal embryonal tumors|78714159|0-19|All Races|Male and Female|2000|5.9|7.1|6.5
4.1|5.0|4.5|358|III(d) Other gliomas|78714159|0-19|All Races|Male and Female|2000|4.1|5.0|4.5
0.3|0.6|0.4|35|III(e) Other specified intracranial & intraspinal neoplasms|78714159|0-19|All Races|Male and Female|2000|0.3|0.6|0.4
0.5|0.9|0.6|51|III(f) Unspecified intracranial and intraspinal neoplasms|78714159|0-19|All Races|Male and Female|2000|0.5|0.9|0.6
7.1|8.3|7.7|599|IV Neuroblastoma and other peripheral nervous cell tumors|78714159|0-19|All Races|Male and Female|2000|7.0|8.2|7.6
6.9|8.2|7.5|589|IV(a) Neuroblastoma and ganglioneuroblastoma|78714159|0-19|All Races|Male and Female|2000|6.9|8.1|7.5
~|~|~|~|IV(b) Other peripheral nervous cell tumors|78714159|0-19|All Races|Male and Female|2000|~|~|~
11.2|12.7|11.9|940|IX Soft tissue and other extraosseous sarcomas|78714159|0-19|All Races|Male and Female|2000|11.2|12.7|11.9
4.4|5.4|4.9|383|IX(a) Rhabdomyosarcomas|78714159|0-19|All Races|Male and Female|2000|4.4|5.4|4.9
1.0|1.5|1.2|94|IX(b) Fibrosarcomas, peripheral nerve sheath tumors & other fibrous neoplams|78714159|0-19|All Races|Male and Female|2000|1.0|1.5|1.2
~|~|~|~|IX(c) Kaposi sarcoma|78714159|0-19|All Races|Male and Female|2000|~|~|~
4.0|5.0|4.5|354|IX(d) Other specified soft tissue sarcomas|78714159|0-19|All Races|Male and Female|2000|4.0|5.0|4.5
1.1|1.6|1.3|105|IX(e) Unspecified soft tissue sarcomas|78714159|0-19|All Races|Male and Female|2000|1.1|1.6|1.3
0.1|0.3|0.2|17|Not classified by ICCC|78714159|0-19|All Races|Male and Female|2000|0.1|0.3|0.2
2.9|3.7|3.3|257|V Retinoblastoma|78714159|0-19|All Races|Male and Female|2000|2.9|3.7|3.3
6.3|7.5|6.9|538|VI Renal tumors|78714159|0-19|All Races|Male and Female|2000|6.3|7.4|6.8
5.8|7.0|6.4|499|VI(a) Nephroblastoma and other nonepithelial renal tumors|78714159|0-19|All Races|Male and Female|2000|5.8|6.9|6.3
0.3|0.6|0.5|37|VI(b) Renal carcinomas|78714159|0-19|All Races|Male and Female|2000|0.3|0.6|0.5
~|~|~|~|VI(c) Unspecified malignant renal tumors|78714159|0-19|All Races|Male and Female|2000|~|~|~
1.6|2.2|1.8|144|VII Hepatic tumors|78714159|0-19|All Races|Male and Female|2000|1.5|2.2|1.8
1.2|1.7|1.4|113|VII(a) Hepatoblastoma|78714159|0-19|All Races|Male and Female|2000|1.2|1.7|1.4
0.2|0.5|0.4|29|VII(b) Hepatic carcinomas|78714159|0-19|All Races|Male and Female|2000|0.2|0.5|0.4
~|~|~|~|VII(c) Unspecified malignant hepatic tumors|78714159|0-19|All Races|Male and Female|2000|~|~|~
7.7|9.0|8.4|661|VIII Malignant bone tumors|78714159|0-19|All Races|Male and Female|2000|7.8|9.1|8.4
4.3|5.2|4.7|373|VIII(a) Osteosarcomas|78714159|0-19|All Races|Male and Female|2000|4.3|5.2|4.7
~|~|~|~|VIII(b) Chondrosarcomas|78714159|0-19|All Races|Male and Female|2000|~|~|~
2.7|3.4|3.0|239|VIII(c) Ewing tumor and related sarcomas of bone|78714159|0-19|All Races|Male and Female|2000|2.7|3.4|3.0
0.1|0.4|0.2|19|VIII(d) Other specified malignant bone tumors|78714159|0-19|All Races|Male and Female|2000|0.1|0.4|0.2
0.1|0.3|0.2|16|VIII(e) Unspecified malignant bone tumors|78714159|0-19|All Races|Male and Female|2000|0.1|0.3|0.2
10.0|11.5|10.7|843|X Germ cell, trophoblastic tumors & neoplasms of gonads|78714159|0-19|All Races|Male and Female|2000|10.0|11.5|10.7
1.4|2.0|1.6|130|X(a) Intracranial & intraspinal germ cell tumors|78714159|0-19|All Races|Male and Female|2000|1.4|2.0|1.7
1.1|1.7|1.4|109|X(b) Malignant extracranial & extragonadal germ cell tumors|78714159|0-19|All Races|Male and Female|2000|1.1|1.7|1.4
6.4|7.6|7.0|552|X(c) Malignant gonadal germ cell tumors|78714159|0-19|All Races|Male and Female|2000|6.4|7.6|7.0
0.3|0.6|0.4|34|X(d) Gonadal carcinomas|78714159|0-19|All Races|Male and Female|2000|0.3|0.6|0.4
0.1|0.4|0.2|18|X(e) Other and unspecified malignant gonadal tumors|78714159|0-19|All Races|Male and Female|2000|0.1|0.4|0.2
14.8|16.5|15.6|1230|XI Other malignant epithelial neoplasms and malignant melanomas|78714159|0-19|All Races|Male and Female|2000|14.8|16.5|15.6
0.2|0.5|0.3|25|XI(a) Adrenocortical carcinomas|78714159|0-19|All Races|Male and Female|2000|0.2|0.5|0.3
5.1|6.2|5.6|445|XI(b) Thyroid carcinomas|78714159|0-19|All Races|Male and Female|2000|5.1|6.2|5.7
0.4|0.7|0.5|40|XI(c) Nasopharyngeal carcinomas|78714159|0-19|All Races|Male and Female|2000|0.4|0.7|0.5
4.7|5.7|5.2|410|XI(d) Malignant melanomas|78714159|0-19|All Races|Male and Female|2000|4.7|5.7|5.2
~|~|~|~|XI(e) Skin carcinomas|78714159|0-19|All Races|Male and Female|2000|~|~|~
3.4|4.3|3.9|304|XI(f) Other and unspecified carcinomas|78714159|0-19|All Races|Male and Female|2000|3.4|4.3|3.9
0.6|1.1|0.8|65|XII Other and unspecified malignant neoplasms|78714159|0-19|All Races|Male and Female|2000|0.6|1.1|0.8
~|~|~|~|XII(a) Other specified malignant tumors|78714159|0-19|All Races|Male and Female|2000|~|~|~
0.5|0.8|0.6|50|XII(b) Other unspecified malignant tumors|78714159|0-19|All Races|Male and Female|2000|0.5|0.8|0.6
167.5|173.2|170.3|13630|All ICCC Groups Combined|80042731|0-19|All Races|Male and Female|2001|167.4|173.2|170.3
44.1|47.1|45.6|3631|I Leukemias, myeloproliferative & myelodysplastic diseases|80042731|0-19|All Races|Male and Female|2001|43.9|46.9|45.4
31.6|34.1|32.9|2609|I(a) Lymphoid leukemias|80042731|0-19|All Races|Male and Female|2001|31.4|33.9|32.6
7.1|8.4|7.7|620|I(b) Acute myeloid leukemias|80042731|0-19|All Races|Male and Female|2001|7.1|8.4|7.7
1.9|2.6|2.2|180|I(c) Chronic myeloproliferative diseases|80042731|0-19|All Races|Male and Female|2001|1.9|2.6|2.2
1.2|1.8|1.5|118|I(d) Myelodysplastic syndrome and other myeloproliferative diseases|80042731|0-19|All Races|Male and Female|2001|1.2|1.8|1.5
1.1|1.6|1.3|104|I(e) Unspecified and other specified leukemias|80042731|0-19|All Races|Male and Female|2001|1.1|1.6|1.3
23.6|25.7|24.6|1980|II Lymphomas and reticuloendothelial neoplasms|80042731|0-19|All Races|Male and Female|2001|23.7|25.9|24.7
11.7|13.3|12.5|1003|II(a) Hodgkin lymphomas|80042731|0-19|All Races|Male and Female|2001|11.8|13.3|12.5
8.1|9.4|8.7|698|II(b) Non-Hodgkin lymphomas (except Burkitt lymphoma)|80042731|0-19|All Races|Male and Female|2001|8.1|9.4|8.7
1.9|2.5|2.2|174|II(c) Burkitt lymphoma|80042731|0-19|All Races|Male and Female|2001|1.9|2.5|2.2
0.6|1.0|0.8|65|II(d) Miscellaneous lymphoreticular neoplasms|80042731|0-19|All Races|Male and Female|2001|0.6|1.0|0.8
0.4|0.7|0.5|40|II(e) Unspecified lymphomas|80042731|0-19|All Races|Male and Female|2001|0.4|0.7|0.5
28.8|31.2|30.0|2394|III CNS and misc intracranial and intraspinal neoplasms|80042731|0-19|All Races|Male and Female|2001|28.7|31.1|29.9
2.1|2.8|2.4|194|III(a) Ependymomas and choroid plexus tumor|80042731|0-19|All Races|Male and Female|2001|2.1|2.8|2.4
14.2|15.9|15.0|1200|III(b) Astrocytomas|80042731|0-19|All Races|Male and Female|2001|14.2|15.9|15.0
6.0|7.1|6.6|523|III(c) Intracranial and intraspinal embryonal tumors|80042731|0-19|All Races|Male and Female|2001|6.0|7.1|6.5
4.5|5.5|5.0|399|III(d) Other gliomas|80042731|0-19|All Races|Male and Female|2001|4.5|5.5|5.0
0.5|0.8|0.6|49|III(e) Other specified intracranial & intraspinal neoplasms|80042731|0-19|All Races|Male and Female|2001|0.5|0.8|0.6
0.2|0.5|0.4|29|III(f) Unspecified intracranial and intraspinal neoplasms|80042731|0-19|All Races|Male and Female|2001|0.2|0.5|0.4
8.2|9.5|8.9|708|IV Neuroblastoma and other peripheral nervous cell tumors|80042731|0-19|All Races|Male and Female|2001|8.2|9.5|8.8
8.0|9.3|8.7|693|IV(a) Neuroblastoma and ganglioneuroblastoma|80042731|0-19|All Races|Male and Female|2001|8.0|9.3|8.7
~|~|~|~|IV(b) Other peripheral nervous cell tumors|80042731|0-19|All Races|Male and Female|2001|~|~|~
11.2|12.7|11.9|954|IX Soft tissue and other extraosseous sarcomas|80042731|0-19|All Races|Male and Female|2001|11.2|12.7|11.9
4.6|5.6|5.0|401|IX(a) Rhabdomyosarcomas|80042731|0-19|All Races|Male and Female|2001|4.5|5.5|5.0
1.2|1.7|1.4|115|IX(b) Fibrosarcomas, peripheral nerve sheath tumors & other fibrous neoplams|80042731|0-19|All Races|Male and Female|2001|1.2|1.7|1.4
~|~|~|~|IX(c) Kaposi sarcoma|80042731|0-19|All Races|Male and Female|2001|~|~|~
3.7|4.6|4.1|332|IX(d) Other specified soft tissue sarcomas|80042731|0-19|All Races|Male and Female|2001|3.7|4.6|4.1
1.0|1.5|1.3|103|IX(e) Unspecified soft tissue sarcomas|80042731|0-19|All Races|Male and Female|2001|1.1|1.6|1.3
0.2|0.4|0.3|22|Not classified by ICCC|80042731|0-19|All Races|Male and Female|2001|0.2|0.4|0.3
2.9|3.7|3.3|266|V Retinoblastoma|80042731|0-19|All Races|Male and Female|2001|2.9|3.7|3.3
6.3|7.4|6.8|542|VI Renal tumors|80042731|0-19|All Races|Male and Female|2001|6.2|7.4|6.8
5.7|6.8|6.2|494|VI(a) Nephroblastoma and other nonepithelial renal tumors|80042731|0-19|All Races|Male and Female|2001|5.6|6.7|6.2
0.4|0.7|0.6|45|VI(b) Renal carcinomas|80042731|0-19|All Races|Male and Female|2001|0.4|0.8|0.6
~|~|~|~|VI(c) Unspecified malignant renal tumors|80042731|0-19|All Races|Male and Female|2001|~|~|~
1.5|2.1|1.8|145|VII Hepatic tumors|80042731|0-19|All Races|Male and Female|2001|1.5|2.1|1.8
1.0|1.5|1.3|101|VII(a) Hepatoblastoma|80042731|0-19|All Races|Male and Female|2001|1.0|1.5|1.3
0.4|0.7|0.5|43|VII(b) Hepatic carcinomas|80042731|0-19|All Races|Male and Female|2001|0.4|0.7|0.5
~|~|~|~|VII(c) Unspecified malignant hepatic tumors|80042731|0-19|All Races|Male and Female|2001|~|~|~
8.8|10.1|9.4|760|VIII Malignant bone tumors|80042731|0-19|All Races|Male and Female|2001|8.8|10.2|9.5
4.7|5.7|5.2|419|VIII(a) Osteosarcomas|80042731|0-19|All Races|Male and Female|2001|4.7|5.8|5.2
0.2|0.5|0.4|29|VIII(b) Chondrosarcomas|80042731|0-19|All Races|Male and Female|2001|0.2|0.5|0.4
2.9|3.7|3.3|266|VIII(c) Ewing tumor and related sarcomas of bone|80042731|0-19|All Races|Male and Female|2001|2.9|3.7|3.3
0.3|0.6|0.4|35|VIII(d) Other specified malignant bone tumors|80042731|0-19|All Races|Male and Female|2001|0.3|0.6|0.4
~|~|~|~|VIII(e) Unspecified malignant bone tumors|80042731|0-19|All Races|Male and Female|2001|~|~|~
9.7|11.1|10.3|834|X Germ cell, trophoblastic tumors & neoplasms of gonads|80042731|0-19|All Races|Male and Female|2001|9.7|11.2|10.4
1.3|1.9|1.6|128|X(a) Intracranial & intraspinal germ cell tumors|80042731|0-19|All Races|Male and Female|2001|1.3|1.9|1.6
1.3|1.9|1.6|127|X(b) Malignant extracranial & extragonadal germ cell tumors|80042731|0-19|All Races|Male and Female|2001|1.3|1.9|1.6
6.0|7.2|6.6|530|X(c) Malignant gonadal germ cell tumors|80042731|0-19|All Races|Male and Female|2001|6.1|7.2|6.6
0.2|0.5|0.3|26|X(d) Gonadal carcinomas|80042731|0-19|All Races|Male and Female|2001|0.2|0.5|0.3
0.2|0.4|0.3|23|X(e) Other and unspecified malignant gonadal tumors|80042731|0-19|All Races|Male and Female|2001|0.2|0.4|0.3
15.6|17.3|16.4|1324|XI Other malignant epithelial neoplasms and malignant melanomas|80042731|0-19|All Races|Male and Female|2001|15.7|17.5|16.5
0.1|0.4|0.2|18|XI(a) Adrenocortical carcinomas|80042731|0-19|All Races|Male and Female|2001|0.1|0.4|0.2
5.3|6.3|5.8|467|XI(b) Thyroid carcinomas|80042731|0-19|All Races|Male and Female|2001|5.3|6.4|5.8
0.4|0.7|0.5|44|XI(c) Nasopharyngeal carcinomas|80042731|0-19|All Races|Male and Female|2001|0.4|0.7|0.5
5.3|6.3|5.8|465|XI(d) Malignant melanomas|80042731|0-19|All Races|Male and Female|2001|5.3|6.4|5.8
~|~|~|~|XI(e) Skin carcinomas|80042731|0-19|All Races|Male and Female|2001|~|~|~
3.6|4.5|4.0|325|XI(f) Other and unspecified carcinomas|80042731|0-19|All Races|Male and Female|2001|3.6|4.5|4.1
0.7|1.1|0.9|70|XII Other and unspecified malignant neoplasms|80042731|0-19|All Races|Male and Female|2001|0.7|1.1|0.9
0.3|0.5|0.4|30|XII(a) Other specified malignant tumors|80042731|0-19|All Races|Male and Female|2001|0.3|0.5|0.4
0.4|0.7|0.5|40|XII(b) Other unspecified malignant tumors|80042731|0-19|All Races|Male and Female|2001|0.4|0.7|0.5
167.5|173.3|170.4|13672|All ICCC Groups Combined|80182530|0-19|All Races|Male and Female|2002|167.7|173.4|170.5
43.3|46.2|44.7|3570|I Leukemias, myeloproliferative & myelodysplastic diseases|80182530|0-19|All Races|Male and Female|2002|43.1|46.0|44.5
30.6|33.1|31.8|2535|I(a) Lymphoid leukemias|80182530|0-19|All Races|Male and Female|2002|30.4|32.9|31.6
7.5|8.8|8.1|655|I(b) Acute myeloid leukemias|80182530|0-19|All Races|Male and Female|2002|7.6|8.8|8.2
1.7|2.4|2.0|165|I(c) Chronic myeloproliferative diseases|80182530|0-19|All Races|Male and Female|2002|1.8|2.4|2.1
1.2|1.8|1.5|119|I(d) Myelodysplastic syndrome and other myeloproliferative diseases|80182530|0-19|All Races|Male and Female|2002|1.2|1.8|1.5
1.0|1.5|1.2|96|I(e) Unspecified and other specified leukemias|80182530|0-19|All Races|Male and Female|2002|1.0|1.5|1.2
23.4|25.5|24.4|1972|II Lymphomas and reticuloendothelial neoplasms|80182530|0-19|All Races|Male and Female|2002|23.5|25.7|24.6
11.5|13.1|12.3|997|II(a) Hodgkin lymphomas|80182530|0-19|All Races|Male and Female|2002|11.7|13.2|12.4
7.6|8.8|8.2|660|II(b) Non-Hodgkin lymphomas (except Burkitt lymphoma)|80182530|0-19|All Races|Male and Female|2002|7.6|8.9|8.2
2.4|3.1|2.7|219|II(c) Burkitt lymphoma|80182530|0-19|All Races|Male and Female|2002|2.4|3.1|2.7
0.7|1.1|0.9|69|II(d) Miscellaneous lymphoreticular neoplasms|80182530|0-19|All Races|Male and Female|2002|0.7|1.1|0.9
0.2|0.5|0.3|27|II(e) Unspecified lymphomas|80182530|0-19|All Races|Male and Female|2002|0.2|0.5|0.3
30.1|32.6|31.3|2502|III CNS and misc intracranial and intraspinal neoplasms|80182530|0-19|All Races|Male and Female|2002|30.0|32.5|31.2
2.6|3.4|3.0|236|III(a) Ependymomas and choroid plexus tumor|80182530|0-19|All Races|Male and Female|2002|2.6|3.3|2.9
14.5|16.2|15.3|1225|III(b) Astrocytomas|80182530|0-19|All Races|Male and Female|2002|14.4|16.2|15.3
5.8|6.9|6.4|507|III(c) Intracranial and intraspinal embryonal tumors|80182530|0-19|All Races|Male and Female|2002|5.8|6.9|6.3
5.0|6.1|5.6|443|III(d) Other gliomas|80182530|0-19|All Races|Male and Female|2002|5.0|6.1|5.5
0.5|0.9|0.7|58|III(e) Other specified intracranial & intraspinal neoplasms|80182530|0-19|All Races|Male and Female|2002|0.5|0.9|0.7
0.3|0.6|0.4|33|III(f) Unspecified intracranial and intraspinal neoplasms|80182530|0-19|All Races|Male and Female|2002|0.3|0.6|0.4
7.8|9.1|8.5|675|IV Neuroblastoma and other peripheral nervous cell tumors|80182530|0-19|All Races|Male and Female|2002|7.8|9.1|8.4
7.6|8.9|8.2|656|IV(a) Neuroblastoma and ganglioneuroblastoma|80182530|0-19|All Races|Male and Female|2002|7.6|8.8|8.2
0.1|0.4|0.2|19|IV(b) Other peripheral nervous cell tumors|80182530|0-19|All Races|Male and Female|2002|0.1|0.4|0.2
11.1|12.6|11.8|949|IX Soft tissue and other extraosseous sarcomas|80182530|0-19|All Races|Male and Female|2002|11.1|12.6|11.8
4.4|5.4|4.9|389|IX(a) Rhabdomyosarcomas|80182530|0-19|All Races|Male and Female|2002|4.4|5.4|4.9
0.9|1.4|1.2|94|IX(b) Fibrosarcomas, peripheral nerve sheath tumors & other fibrous neoplams|80182530|0-19|All Races|Male and Female|2002|0.9|1.4|1.2
~|~|~|~|IX(c) Kaposi sarcoma|80182530|0-19|All Races|Male and Female|2002|~|~|~
4.3|5.3|4.8|387|IX(d) Other specified soft tissue sarcomas|80182530|0-19|All Races|Male and Female|2002|4.4|5.3|4.8
0.8|1.2|1.0|79|IX(e) Unspecified soft tissue sarcomas|80182530|0-19|All Races|Male and Female|2002|0.8|1.2|1.0
0.2|0.5|0.3|25|Not classified by ICCC|80182530|0-19|All Races|Male and Female|2002|0.2|0.5|0.3
2.4|3.2|2.8|224|V Retinoblastoma|80182530|0-19|All Races|Male and Female|2002|2.4|3.2|2.8
6.0|7.1|6.5|518|VI Renal tumors|80182530|0-19|All Races|Male and Female|2002|5.9|7.0|6.5
5.5|6.6|6.1|481|VI(a) Nephroblastoma and other nonepithelial renal tumors|80182530|0-19|All Races|Male and Female|2002|5.5|6.6|6.0
0.3|0.6|0.4|36|VI(b) Renal carcinomas|80182530|0-19|All Races|Male and Female|2002|0.3|0.6|0.4
~|~|~|~|VI(c) Unspecified malignant renal tumors|80182530|0-19|All Races|Male and Female|2002|~|~|~
1.4|2.0|1.7|136|VII Hepatic tumors|80182530|0-19|All Races|Male and Female|2002|1.4|2.0|1.7
0.9|1.4|1.2|93|VII(a) Hepatoblastoma|80182530|0-19|All Races|Male and Female|2002|0.9|1.4|1.2
0.4|0.7|0.5|42|VII(b) Hepatic carcinomas|80182530|0-19|All Races|Male and Female|2002|0.4|0.7|0.5
~|~|~|~|VII(c) Unspecified malignant hepatic tumors|80182530|0-19|All Races|Male and Female|2002|~|~|~
8.5|9.8|9.1|738|VIII Malignant bone tumors|80182530|0-19|All Races|Male and Female|2002|8.6|9.9|9.2
4.4|5.4|4.9|397|VIII(a) Osteosarcomas|80182530|0-19|All Races|Male and Female|2002|4.5|5.5|5.0
0.3|0.6|0.5|38|VIII(b) Chondrosarcomas|80182530|0-19|All Races|Male and Female|2002|0.3|0.7|0.5
2.7|3.5|3.1|250|VIII(c) Ewing tumor and related sarcomas of bone|80182530|0-19|All Races|Male and Female|2002|2.7|3.5|3.1
0.4|0.7|0.5|40|VIII(d) Other specified malignant bone tumors|80182530|0-19|All Races|Male and Female|2002|0.4|0.7|0.5
~|~|~|~|VIII(e) Unspecified malignant bone tumors|80182530|0-19|All Races|Male and Female|2002|~|~|~
10.3|11.8|11.0|890|X Germ cell, trophoblastic tumors & neoplasms of gonads|80182530|0-19|All Races|Male and Female|2002|10.4|11.9|11.1
1.4|1.9|1.6|132|X(a) Intracranial & intraspinal germ cell tumors|80182530|0-19|All Races|Male and Female|2002|1.4|2.0|1.6
1.3|1.8|1.5|125|X(b) Malignant extracranial & extragonadal germ cell tumors|80182530|0-19|All Races|Male and Female|2002|1.3|1.9|1.6
6.6|7.8|7.2|580|X(c) Malignant gonadal germ cell tumors|80182530|0-19|All Races|Male and Female|2002|6.7|7.8|7.2
0.2|0.5|0.4|29|X(d) Gonadal carcinomas|80182530|0-19|All Races|Male and Female|2002|0.2|0.5|0.4
0.2|0.4|0.3|24|X(e) Other and unspecified malignant gonadal tumors|80182530|0-19|All Races|Male and Female|2002|0.2|0.4|0.3
16.4|18.2|17.3|1400|XI Other malignant epithelial neoplasms and malignant melanomas|80182530|0-19|All Races|Male and Female|2002|16.6|18.4|17.5
0.1|0.4|0.2|19|XI(a) Adrenocortical carcinomas|80182530|0-19|All Races|Male and Female|2002|0.1|0.4|0.2
5.3|6.4|5.8|471|XI(b) Thyroid carcinomas|80182530|0-19|All Races|Male and Female|2002|5.4|6.4|5.9
0.4|0.8|0.6|49|XI(c) Nasopharyngeal carcinomas|80182530|0-19|All Races|Male and Female|2002|0.5|0.8|0.6
6.0|7.1|6.5|526|XI(d) Malignant melanomas|80182530|0-19|All Races|Male and Female|2002|6.0|7.1|6.6
~|~|~|~|XI(e) Skin carcinomas|80182530|0-19|All Races|Male and Female|2002|~|~|~
3.6|4.5|4.0|327|XI(f) Other and unspecified carcinomas|80182530|0-19|All Races|Male and Female|2002|3.6|4.5|4.1
0.7|1.1|0.9|73|XII Other and unspecified malignant neoplasms|80182530|0-19|All Races|Male and Female|2002|0.7|1.1|0.9
0.3|0.6|0.5|37|XII(a) Other specified malignant tumors|80182530|0-19|All Races|Male and Female|2002|0.3|0.6|0.5
0.3|0.6|0.4|36|XII(b) Other unspecified malignant tumors|80182530|0-19|All Races|Male and Female|2002|0.3|0.6|0.4
164.6|170.2|167.4|13668|All ICCC Groups Combined|81425816|0-19|All Races|Male and Female|2003|165.1|170.7|167.9
41.9|44.8|43.3|3514|I Leukemias, myeloproliferative & myelodysplastic diseases|81425816|0-19|All Races|Male and Female|2003|41.7|44.6|43.2
29.5|31.9|30.7|2476|I(a) Lymphoid leukemias|81425816|0-19|All Races|Male and Female|2003|29.2|31.6|30.4
7.2|8.4|7.8|638|I(b) Acute myeloid leukemias|81425816|0-19|All Races|Male and Female|2003|7.2|8.5|7.8
1.9|2.6|2.2|184|I(c) Chronic myeloproliferative diseases|81425816|0-19|All Races|Male and Female|2003|1.9|2.6|2.3
1.4|1.9|1.6|134|I(d) Myelodysplastic syndrome and other myeloproliferative diseases|81425816|0-19|All Races|Male and Female|2003|1.4|1.9|1.6
0.8|1.2|1.0|82|I(e) Unspecified and other specified leukemias|81425816|0-19|All Races|Male and Female|2003|0.8|1.3|1.0
23.2|25.3|24.2|1986|II Lymphomas and reticuloendothelial neoplasms|81425816|0-19|All Races|Male and Female|2003|23.3|25.5|24.4
11.7|13.2|12.4|1026|II(a) Hodgkin lymphomas|81425816|0-19|All Races|Male and Female|2003|11.8|13.4|12.6
7.5|8.7|8.1|660|II(b) Non-Hodgkin lymphomas (except Burkitt lymphoma)|81425816|0-19|All Races|Male and Female|2003|7.5|8.7|8.1
2.3|3.0|2.6|211|II(c) Burkitt lymphoma|81425816|0-19|All Races|Male and Female|2003|2.3|3.0|2.6
0.7|1.1|0.9|72|II(d) Miscellaneous lymphoreticular neoplasms|81425816|0-19|All Races|Male and Female|2003|0.7|1.1|0.9
0.1|0.3|0.2|17|II(e) Unspecified lymphomas|81425816|0-19|All Races|Male and Female|2003|0.1|0.3|0.2
28.9|31.3|30.1|2442|III CNS and misc intracranial and intraspinal neoplasms|81425816|0-19|All Races|Male and Female|2003|28.8|31.2|30.0
2.0|2.7|2.3|189|III(a) Ependymomas and choroid plexus tumor|81425816|0-19|All Races|Male and Female|2003|2.0|2.7|2.3
14.4|16.1|15.3|1241|III(b) Astrocytomas|81425816|0-19|All Races|Male and Female|2003|14.4|16.1|15.2
5.6|6.7|6.1|493|III(c) Intracranial and intraspinal embryonal tumors|81425816|0-19|All Races|Male and Female|2003|5.5|6.6|6.1
4.7|5.7|5.2|422|III(d) Other gliomas|81425816|0-19|All Races|Male and Female|2003|4.7|5.7|5.2
0.7|1.1|0.8|68|III(e) Other specified intracranial & intraspinal neoplasms|81425816|0-19|All Races|Male and Female|2003|0.6|1.1|0.8
0.2|0.5|0.4|29|III(f) Unspecified intracranial and intraspinal neoplasms|81425816|0-19|All Races|Male and Female|2003|0.2|0.5|0.4
7.6|8.9|8.2|669|IV Neuroblastoma and other peripheral nervous cell tumors|81425816|0-19|All Races|Male and Female|2003|7.6|8.9|8.2
7.4|8.7|8.0|654|IV(a) Neuroblastoma and ganglioneuroblastoma|81425816|0-19|All Races|Male and Female|2003|7.4|8.7|8.0
~|~|~|~|IV(b) Other peripheral nervous cell tumors|81425816|0-19|All Races|Male and Female|2003|~|~|~
11.4|12.9|12.1|993|IX Soft tissue and other extraosseous sarcomas|81425816|0-19|All Races|Male and Female|2003|11.4|13.0|12.2
4.3|5.3|4.8|390|IX(a) Rhabdomyosarcomas|81425816|0-19|All Races|Male and Female|2003|4.3|5.3|4.8
1.2|1.7|1.4|116|IX(b) Fibrosarcomas, peripheral nerve sheath tumors & other fibrous neoplams|81425816|0-19|All Races|Male and Female|2003|1.2|1.7|1.4
~|~|~|~|IX(c) Kaposi sarcoma|81425816|0-19|All Races|Male and Female|2003|~|~|~
4.2|5.1|4.6|382|IX(d) Other specified soft tissue sarcomas|81425816|0-19|All Races|Male and Female|2003|4.2|5.2|4.7
1.0|1.5|1.2|102|IX(e) Unspecified soft tissue sarcomas|81425816|0-19|All Races|Male and Female|2003|1.0|1.5|1.3
0.2|0.4|0.3|22|Not classified by ICCC|81425816|0-19|All Races|Male and Female|2003|0.2|0.4|0.3
2.7|3.5|3.1|251|V Retinoblastoma|81425816|0-19|All Races|Male and Female|2003|2.7|3.5|3.1
6.2|7.3|6.7|543|VI Renal tumors|81425816|0-19|All Races|Male and Female|2003|6.1|7.3|6.7
5.6|6.7|6.1|494|VI(a) Nephroblastoma and other nonepithelial renal tumors|81425816|0-19|All Races|Male and Female|2003|5.5|6.6|6.1
0.4|0.7|0.5|45|VI(b) Renal carcinomas|81425816|0-19|All Races|Male and Female|2003|0.4|0.7|0.6
~|~|~|~|VI(c) Unspecified malignant renal tumors|81425816|0-19|All Races|Male and Female|2003|~|~|~
1.8|2.5|2.1|174|VII Hepatic tumors|81425816|0-19|All Races|Male and Female|2003|1.8|2.5|2.1
1.3|1.8|1.5|124|VII(a) Hepatoblastoma|81425816|0-19|All Races|Male and Female|2003|1.3|1.8|1.5
0.5|0.8|0.6|50|VII(b) Hepatic carcinomas|81425816|0-19|All Races|Male and Female|2003|0.5|0.8|0.6
~|~|~|~|VII(c) Unspecified malignant hepatic tumors|81425816|0-19|All Races|Male and Female|2003|~|~|~
8.0|9.3|8.7|714|VIII Malignant bone tumors|81425816|0-19|All Races|Male and Female|2003|8.1|9.4|8.8
4.8|5.8|5.3|436|VIII(a) Osteosarcomas|81425816|0-19|All Races|Male and Female|2003|4.9|5.9|5.4
0.2|0.4|0.3|21|VIII(b) Chondrosarcomas|81425816|0-19|All Races|Male and Female|2003|0.2|0.4|0.3
2.2|2.9|2.6|212|VIII(c) Ewing tumor and related sarcomas of bone|81425816|0-19|All Races|Male and Female|2003|2.3|3.0|2.6
0.2|0.5|0.3|28|VIII(d) Other specified malignant bone tumors|81425816|0-19|All Races|Male and Female|2003|0.2|0.5|0.3
0.1|0.3|0.2|17|VIII(e) Unspecified malignant bone tumors|81425816|0-19|All Races|Male and Female|2003|0.1|0.3|0.2
9.6|11.0|10.3|847|X Germ cell, trophoblastic tumors & neoplasms of gonads|81425816|0-19|All Races|Male and Female|2003|9.7|11.1|10.4
1.1|1.6|1.4|113|X(a) Intracranial & intraspinal germ cell tumors|81425816|0-19|All Races|Male and Female|2003|1.1|1.7|1.4
1.2|1.7|1.4|118|X(b) Malignant extracranial & extragonadal germ cell tumors|81425816|0-19|All Races|Male and Female|2003|1.2|1.7|1.4
6.2|7.3|6.7|554|X(c) Malignant gonadal germ cell tumors|81425816|0-19|All Races|Male and Female|2003|6.2|7.4|6.8
0.2|0.5|0.4|30|X(d) Gonadal carcinomas|81425816|0-19|All Races|Male and Female|2003|0.2|0.5|0.4
0.3|0.5|0.4|32|X(e) Other and unspecified malignant gonadal tumors|81425816|0-19|All Races|Male and Female|2003|0.3|0.6|0.4
16.3|18.1|17.2|1425|XI Other malignant epithelial neoplasms and malignant melanomas|81425816|0-19|All Races|Male and Female|2003|16.6|18.4|17.5
0.1|0.4|0.2|20|XI(a) Adrenocortical carcinomas|81425816|0-19|All Races|Male and Female|2003|0.2|0.4|0.2
5.6|6.7|6.1|507|XI(b) Thyroid carcinomas|81425816|0-19|All Races|Male and Female|2003|5.7|6.8|6.2
0.5|0.9|0.7|54|XI(c) Nasopharyngeal carcinomas|81425816|0-19|All Races|Male and Female|2003|0.5|0.9|0.7
5.4|6.4|5.9|487|XI(d) Malignant melanomas|81425816|0-19|All Races|Male and Female|2003|5.5|6.5|6.0
~|~|~|~|XI(e) Skin carcinomas|81425816|0-19|All Races|Male and Female|2003|~|~|~
3.8|4.7|4.2|348|XI(f) Other and unspecified carcinomas|81425816|0-19|All Races|Male and Female|2003|3.8|4.7|4.3
0.9|1.3|1.1|88|XII Other and unspecified malignant neoplasms|81425816|0-19|All Races|Male and Female|2003|0.9|1.3|1.1
0.3|0.6|0.5|39|XII(a) Other specified malignant tumors|81425816|0-19|All Races|Male and Female|2003|0.3|0.7|0.5
0.4|0.8|0.6|49|XII(b) Other unspecified malignant tumors|81425816|0-19|All Races|Male and Female|2003|0.4|0.8|0.6
171.2|177.0|174.1|14303|All ICCC Groups Combined|81754354|0-19|All Races|Male and Female|2004|172.1|177.8|175.0
44.6|47.6|46.1|3757|I Leukemias, myeloproliferative & myelodysplastic diseases|81754354|0-19|All Races|Male and Female|2004|44.5|47.4|46.0
31.9|34.4|33.2|2693|I(a) Lymphoid leukemias|81754354|0-19|All Races|Male and Female|2004|31.7|34.2|32.9
7.6|8.8|8.2|675|I(b) Acute myeloid leukemias|81754354|0-19|All Races|Male and Female|2004|7.6|8.9|8.3
1.8|2.5|2.1|176|I(c) Chronic myeloproliferative diseases|81754354|0-19|All Races|Male and Female|2004|1.8|2.5|2.2
1.1|1.6|1.4|112|I(d) Myelodysplastic syndrome and other myeloproliferative diseases|81754354|0-19|All Races|Male and Female|2004|1.1|1.6|1.4
1.0|1.5|1.2|101|I(e) Unspecified and other specified leukemias|81754354|0-19|All Races|Male and Female|2004|1.0|1.5|1.2
23.0|25.1|24.1|1992|II Lymphomas and reticuloendothelial neoplasms|81754354|0-19|All Races|Male and Female|2004|23.3|25.5|24.4
11.1|12.6|11.8|985|II(a) Hodgkin lymphomas|81754354|0-19|All Races|Male and Female|2004|11.3|12.8|12.0
7.9|9.2|8.5|703|II(b) Non-Hodgkin lymphomas (except Burkitt lymphoma)|81754354|0-19|All Races|Male and Female|2004|8.0|9.3|8.6
2.0|2.7|2.3|191|II(c) Burkitt lymphoma|81754354|0-19|All Races|Male and Female|2004|2.0|2.7|2.3
0.9|1.3|1.1|87|II(d) Miscellaneous lymphoreticular neoplasms|81754354|0-19|All Races|Male and Female|2004|0.9|1.3|1.1
0.2|0.5|0.3|26|II(e) Unspecified lymphomas|81754354|0-19|All Races|Male and Female|2004|0.2|0.5|0.3
30.9|33.4|32.1|2612|III CNS and misc intracranial and intraspinal neoplasms|81754354|0-19|All Races|Male and Female|2004|30.7|33.2|31.9
2.4|3.1|2.7|223|III(a) Ependymomas and choroid plexus tumor|81754354|0-19|All Races|Male and Female|2004|2.4|3.1|2.7
15.6|17.3|16.4|1340|III(b) Astrocytomas|81754354|0-19|All Races|Male and Female|2004|15.5|17.3|16.4
6.0|7.2|6.6|534|III(c) Intracranial and intraspinal embryonal tumors|81754354|0-19|All Races|Male and Female|2004|6.0|7.1|6.5
4.6|5.6|5.1|413|III(d) Other gliomas|81754354|0-19|All Races|Male and Female|2004|4.6|5.6|5.1
0.5|0.9|0.7|59|III(e) Other specified intracranial & intraspinal neoplasms|81754354|0-19|All Races|Male and Female|2004|0.5|0.9|0.7
0.4|0.7|0.5|43|III(f) Unspecified intracranial and intraspinal neoplasms|81754354|0-19|All Races|Male and Female|2004|0.4|0.7|0.5
7.9|9.1|8.5|695|IV Neuroblastoma and other peripheral nervous cell tumors|81754354|0-19|All Races|Male and Female|2004|7.9|9.2|8.5
7.6|8.8|8.2|671|IV(a) Neuroblastoma and ganglioneuroblastoma|81754354|0-19|All Races|Male and Female|2004|7.6|8.9|8.2
0.2|0.4|0.3|24|IV(b) Other peripheral nervous cell tumors|81754354|0-19|All Races|Male and Female|2004|0.2|0.4|0.3
11.3|12.9|12.1|996|IX Soft tissue and other extraosseous sarcomas|81754354|0-19|All Races|Male and Female|2004|11.4|13.0|12.2
3.9|4.8|4.3|354|IX(a) Rhabdomyosarcomas|81754354|0-19|All Races|Male and Female|2004|3.9|4.8|4.3
1.1|1.6|1.4|113|IX(b) Fibrosarcomas, peripheral nerve sheath tumors & other fibrous neoplams|81754354|0-19|All Races|Male and Female|2004|1.1|1.7|1.4
~|~|~|~|IX(c) Kaposi sarcoma|81754354|0-19|All Races|Male and Female|2004|~|~|~
4.6|5.6|5.1|424|IX(d) Other specified soft tissue sarcomas|81754354|0-19|All Races|Male and Female|2004|4.7|5.7|5.2
1.0|1.5|1.2|101|IX(e) Unspecified soft tissue sarcomas|81754354|0-19|All Races|Male and Female|2004|1.0|1.5|1.2
0.2|0.4|0.3|25|Not classified by ICCC|81754354|0-19|All Races|Male and Female|2004|0.2|0.5|0.3
2.9|3.6|3.2|266|V Retinoblastoma|81754354|0-19|All Races|Male and Female|2004|2.9|3.7|3.3
6.0|7.1|6.5|529|VI Renal tumors|81754354|0-19|All Races|Male and Female|2004|5.9|7.0|6.5
5.4|6.5|5.9|479|VI(a) Nephroblastoma and other nonepithelial renal tumors|81754354|0-19|All Races|Male and Female|2004|5.3|6.4|5.9
0.4|0.8|0.6|47|VI(b) Renal carcinomas|81754354|0-19|All Races|Male and Female|2004|0.4|0.8|0.6
~|~|~|~|VI(c) Unspecified malignant renal tumors|81754354|0-19|All Races|Male and Female|2004|~|~|~
2.1|2.8|2.4|197|VII Hepatic tumors|81754354|0-19|All Races|Male and Female|2004|2.1|2.8|2.4
1.5|2.1|1.8|144|VII(a) Hepatoblastoma|81754354|0-19|All Races|Male and Female|2004|1.5|2.1|1.8
0.4|0.8|0.6|48|VII(b) Hepatic carcinomas|81754354|0-19|All Races|Male and Female|2004|0.4|0.8|0.6
~|~|~|~|VII(c) Unspecified malignant hepatic tumors|81754354|0-19|All Races|Male and Female|2004|~|~|~
8.4|9.7|9.0|748|VIII Malignant bone tumors|81754354|0-19|All Races|Male and Female|2004|8.5|9.8|9.1
4.7|5.6|5.1|425|VIII(a) Osteosarcomas|81754354|0-19|All Races|Male and Female|2004|4.7|5.7|5.2
0.4|0.7|0.5|41|VIII(b) Chondrosarcomas|81754354|0-19|All Races|Male and Female|2004|0.4|0.7|0.5
2.4|3.1|2.7|227|VIII(c) Ewing tumor and related sarcomas of bone|81754354|0-19|All Races|Male and Female|2004|2.4|3.2|2.8
0.4|0.7|0.5|42|VIII(d) Other specified malignant bone tumors|81754354|0-19|All Races|Male and Female|2004|0.4|0.7|0.5
~|~|~|~|VIII(e) Unspecified malignant bone tumors|81754354|0-19|All Races|Male and Female|2004|~|~|~
10.4|11.8|11.1|926|X Germ cell, trophoblastic tumors & neoplasms of gonads|81754354|0-19|All Races|Male and Female|2004|10.6|12.1|11.3
1.5|2.1|1.8|148|X(a) Intracranial & intraspinal germ cell tumors|81754354|0-19|All Races|Male and Female|2004|1.5|2.1|1.8
1.1|1.6|1.3|110|X(b) Malignant extracranial & extragonadal germ cell tumors|81754354|0-19|All Races|Male and Female|2004|1.1|1.6|1.3
6.7|7.9|7.3|608|X(c) Malignant gonadal germ cell tumors|81754354|0-19|All Races|Male and Female|2004|6.9|8.1|7.4
0.3|0.6|0.4|33|X(d) Gonadal carcinomas|81754354|0-19|All Races|Male and Female|2004|0.3|0.6|0.4
0.2|0.5|0.3|27|X(e) Other and unspecified malignant gonadal tumors|81754354|0-19|All Races|Male and Female|2004|0.2|0.5|0.3
17.0|18.8|17.9|1489|XI Other malignant epithelial neoplasms and malignant melanomas|81754354|0-19|All Races|Male and Female|2004|17.3|19.2|18.2
0.1|0.4|0.2|19|XI(a) Adrenocortical carcinomas|81754354|0-19|All Races|Male and Female|2004|0.1|0.4|0.2
6.2|7.4|6.8|566|XI(b) Thyroid carcinomas|81754354|0-19|All Races|Male and Female|2004|6.4|7.5|6.9
0.4|0.7|0.5|46|XI(c) Nasopharyngeal carcinomas|81754354|0-19|All Races|Male and Female|2004|0.4|0.8|0.6
5.9|7.0|6.5|539|XI(d) Malignant melanomas|81754354|0-19|All Races|Male and Female|2004|6.0|7.2|6.6
~|~|~|~|XI(e) Skin carcinomas|81754354|0-19|All Races|Male and Female|2004|~|~|~
3.3|4.2|3.7|311|XI(f) Other and unspecified carcinomas|81754354|0-19|All Races|Male and Female|2004|3.4|4.3|3.8
0.7|1.1|0.9|71|XII Other and unspecified malignant neoplasms|81754354|0-19|All Races|Male and Female|2004|0.7|1.1|0.9
0.2|0.5|0.3|28|XII(a) Other specified malignant tumors|81754354|0-19|All Races|Male and Female|2004|0.2|0.5|0.3
0.4|0.7|0.5|43|XII(b) Other unspecified malignant tumors|81754354|0-19|All Races|Male and Female|2004|0.4|0.7|0.5
169.4|175.1|172.2|14234|All ICCC Groups Combined|82005260|0-19|All Races|Male and Female|2005|170.7|176.4|173.6
43.0|45.9|44.4|3639|I Leukemias, myeloproliferative & myelodysplastic diseases|82005260|0-19|All Races|Male and Female|2005|42.9|45.8|44.4
30.8|33.3|32.0|2611|I(a) Lymphoid leukemias|82005260|0-19|All Races|Male and Female|2005|30.6|33.1|31.8
7.0|8.2|7.5|624|I(b) Acute myeloid leukemias|82005260|0-19|All Races|Male and Female|2005|7.0|8.2|7.6
1.7|2.3|2.0|167|I(c) Chronic myeloproliferative diseases|82005260|0-19|All Races|Male and Female|2005|1.7|2.4|2.0
1.3|1.9|1.6|130|I(d) Myelodysplastic syndrome and other myeloproliferative diseases|82005260|0-19|All Races|Male and Female|2005|1.3|1.9|1.6
1.1|1.6|1.3|107|I(e) Unspecified and other specified leukemias|82005260|0-19|All Races|Male and Female|2005|1.1|1.6|1.3
24.7|26.9|25.8|2152|II Lymphomas and reticuloendothelial neoplasms|82005260|0-19|All Races|Male and Female|2005|25.1|27.4|26.2
11.9|13.5|12.7|1068|II(a) Hodgkin lymphomas|82005260|0-19|All Races|Male and Female|2005|12.3|13.8|13.0
8.3|9.7|9.0|746|II(b) Non-Hodgkin lymphomas (except Burkitt lymphoma)|82005260|0-19|All Races|Male and Female|2005|8.5|9.8|9.1
2.2|2.9|2.5|205|II(c) Burkitt lymphoma|82005260|0-19|All Races|Male and Female|2005|2.2|2.9|2.5
1.0|1.5|1.3|104|II(d) Miscellaneous lymphoreticular neoplasms|82005260|0-19|All Races|Male and Female|2005|1.0|1.5|1.3
0.2|0.5|0.3|29|II(e) Unspecified lymphomas|82005260|0-19|All Races|Male and Female|2005|0.2|0.5|0.4
28.9|31.2|30.0|2450|III CNS and misc intracranial and intraspinal neoplasms|82005260|0-19|All Races|Male and Female|2005|28.7|31.1|29.9
2.6|3.3|2.9|241|III(a) Ependymomas and choroid plexus tumor|82005260|0-19|All Races|Male and Female|2005|2.6|3.3|2.9
14.5|16.2|15.3|1251|III(b) Astrocytomas|82005260|0-19|All Races|Male and Female|2005|14.4|16.1|15.3
5.3|6.4|5.9|475|III(c) Intracranial and intraspinal embryonal tumors|82005260|0-19|All Races|Male and Female|2005|5.3|6.3|5.8
4.4|5.4|4.8|395|III(d) Other gliomas|82005260|0-19|All Races|Male and Female|2005|4.4|5.3|4.8
0.5|0.8|0.6|51|III(e) Other specified intracranial & intraspinal neoplasms|82005260|0-19|All Races|Male and Female|2005|0.5|0.8|0.6
0.3|0.6|0.5|37|III(f) Unspecified intracranial and intraspinal neoplasms|82005260|0-19|All Races|Male and Female|2005|0.3|0.6|0.5
8.4|9.7|9.1|746|IV Neuroblastoma and other peripheral nervous cell tumors|82005260|0-19|All Races|Male and Female|2005|8.5|9.8|9.1
8.2|9.5|8.9|728|IV(a) Neuroblastoma and ganglioneuroblastoma|82005260|0-19|All Races|Male and Female|2005|8.2|9.5|8.9
0.1|0.3|0.2|18|IV(b) Other peripheral nervous cell tumors|82005260|0-19|All Races|Male and Female|2005|0.1|0.3|0.2
11.6|13.1|12.3|1020|IX Soft tissue and other extraosseous sarcomas|82005260|0-19|All Races|Male and Female|2005|11.7|13.2|12.4
4.4|5.4|4.9|400|IX(a) Rhabdomyosarcomas|82005260|0-19|All Races|Male and Female|2005|4.4|5.4|4.9
1.2|1.7|1.4|117|IX(b) Fibrosarcomas, peripheral nerve sheath tumors & other fibrous neoplams|82005260|0-19|All Races|Male and Female|2005|1.2|1.7|1.4
~|~|~|~|IX(c) Kaposi sarcoma|82005260|0-19|All Races|Male and Female|2005|~|~|~
4.4|5.4|4.9|410|IX(d) Other specified soft tissue sarcomas|82005260|0-19|All Races|Male and Female|2005|4.5|5.5|5.0
0.9|1.3|1.1|89|IX(e) Unspecified soft tissue sarcomas|82005260|0-19|All Races|Male and Female|2005|0.9|1.3|1.1
0.2|0.4|0.3|24|Not classified by ICCC|82005260|0-19|All Races|Male and Female|2005|0.2|0.4|0.3
2.6|3.3|2.9|242|V Retinoblastoma|82005260|0-19|All Races|Male and Female|2005|2.6|3.3|3.0
6.2|7.3|6.7|548|VI Renal tumors|82005260|0-19|All Races|Male and Female|2005|6.1|7.3|6.7
5.5|6.6|6.1|494|VI(a) Nephroblastoma and other nonepithelial renal tumors|82005260|0-19|All Races|Male and Female|2005|5.5|6.6|6.0
0.4|0.8|0.6|50|VI(b) Renal carcinomas|82005260|0-19|All Races|Male and Female|2005|0.5|0.8|0.6
~|~|~|~|VI(c) Unspecified malignant renal tumors|82005260|0-19|All Races|Male and Female|2005|~|~|~
1.7|2.4|2.0|168|VII Hepatic tumors|82005260|0-19|All Races|Male and Female|2005|1.8|2.4|2.0
1.2|1.7|1.4|117|VII(a) Hepatoblastoma|82005260|0-19|All Races|Male and Female|2005|1.2|1.7|1.4
0.4|0.8|0.6|49|VII(b) Hepatic carcinomas|82005260|0-19|All Races|Male and Female|2005|0.4|0.8|0.6
~|~|~|~|VII(c) Unspecified malignant hepatic tumors|82005260|0-19|All Races|Male and Female|2005|~|~|~
8.2|9.5|8.9|737|VIII Malignant bone tumors|82005260|0-19|All Races|Male and Female|2005|8.4|9.7|9.0
4.6|5.5|5.0|419|VIII(a) Osteosarcomas|82005260|0-19|All Races|Male and Female|2005|4.6|5.6|5.1
0.2|0.4|0.3|23|VIII(b) Chondrosarcomas|82005260|0-19|All Races|Male and Female|2005|0.2|0.4|0.3
2.6|3.3|2.9|242|VIII(c) Ewing tumor and related sarcomas of bone|82005260|0-19|All Races|Male and Female|2005|2.6|3.3|3.0
0.3|0.6|0.4|36|VIII(d) Other specified malignant bone tumors|82005260|0-19|All Races|Male and Female|2005|0.3|0.6|0.4
0.1|0.3|0.2|17|VIII(e) Unspecified malignant bone tumors|82005260|0-19|All Races|Male and Female|2005|0.1|0.3|0.2
10.7|12.2|11.4|963|X Germ cell, trophoblastic tumors & neoplasms of gonads|82005260|0-19|All Races|Male and Female|2005|11.0|12.5|11.7
1.3|1.9|1.6|133|X(a) Intracranial & intraspinal germ cell tumors|82005260|0-19|All Races|Male and Female|2005|1.4|1.9|1.6
1.3|1.9|1.6|134|X(b) Malignant extracranial & extragonadal germ cell tumors|82005260|0-19|All Races|Male and Female|2005|1.4|1.9|1.6
6.9|8.1|7.5|636|X(c) Malignant gonadal germ cell tumors|82005260|0-19|All Races|Male and Female|2005|7.2|8.4|7.8
0.3|0.5|0.4|32|X(d) Gonadal carcinomas|82005260|0-19|All Races|Male and Female|2005|0.3|0.6|0.4
0.2|0.5|0.3|28|X(e) Other and unspecified malignant gonadal tumors|82005260|0-19|All Races|Male and Female|2005|0.2|0.5|0.3
16.5|18.3|17.4|1469|XI Other malignant epithelial neoplasms and malignant melanomas|82005260|0-19|All Races|Male and Female|2005|17.0|18.9|17.9
~|~|~|~|XI(a) Adrenocortical carcinomas|82005260|0-19|All Races|Male and Female|2005|~|~|~
5.6|6.6|6.1|513|XI(b) Thyroid carcinomas|82005260|0-19|All Races|Male and Female|2005|5.7|6.8|6.3
0.3|0.5|0.4|33|XI(c) Nasopharyngeal carcinomas|82005260|0-19|All Races|Male and Female|2005|0.3|0.6|0.4
6.0|7.1|6.5|549|XI(d) Malignant melanomas|82005260|0-19|All Races|Male and Female|2005|6.1|7.3|6.7
~|~|~|~|XI(e) Skin carcinomas|82005260|0-19|All Races|Male and Female|2005|~|~|~
3.8|4.7|4.2|355|XI(f) Other and unspecified carcinomas|82005260|0-19|All Races|Male and Female|2005|3.9|4.8|4.3
0.7|1.1|0.9|76|XII Other and unspecified malignant neoplasms|82005260|0-19|All Races|Male and Female|2005|0.7|1.2|0.9
0.3|0.5|0.4|32|XII(a) Other specified malignant tumors|82005260|0-19|All Races|Male and Female|2005|0.3|0.6|0.4
0.4|0.7|0.5|44|XII(b) Other unspecified malignant tumors|82005260|0-19|All Races|Male and Female|2005|0.4|0.7|0.5
169.7|175.3|172.5|14315|All ICCC Groups Combined|82324418|0-19|All Races|Male and Female|2006|171.0|176.8|173.9
45.3|48.3|46.8|3847|I Leukemias, myeloproliferative & myelodysplastic diseases|82324418|0-19|All Races|Male and Female|2006|45.3|48.2|46.7
32.0|34.5|33.3|2720|I(a) Lymphoid leukemias|82324418|0-19|All Races|Male and Female|2006|31.8|34.3|33.0
7.6|8.8|8.2|680|I(b) Acute myeloid leukemias|82324418|0-19|All Races|Male and Female|2006|7.7|8.9|8.3
2.0|2.7|2.3|196|I(c) Chronic myeloproliferative diseases|82324418|0-19|All Races|Male and Female|2006|2.1|2.7|2.4
1.4|1.9|1.6|134|I(d) Myelodysplastic syndrome and other myeloproliferative diseases|82324418|0-19|All Races|Male and Female|2006|1.4|1.9|1.6
1.2|1.7|1.4|117|I(e) Unspecified and other specified leukemias|82324418|0-19|All Races|Male and Female|2006|1.2|1.7|1.4
24.0|26.1|25.0|2101|II Lymphomas and reticuloendothelial neoplasms|82324418|0-19|All Races|Male and Female|2006|24.4|26.6|25.5
11.7|13.2|12.5|1055|II(a) Hodgkin lymphomas|82324418|0-19|All Races|Male and Female|2006|12.1|13.6|12.8
8.1|9.4|8.7|726|II(b) Non-Hodgkin lymphomas (except Burkitt lymphoma)|82324418|0-19|All Races|Male and Female|2006|8.2|9.5|8.8
2.1|2.8|2.4|200|II(c) Burkitt lymphoma|82324418|0-19|All Races|Male and Female|2006|2.1|2.8|2.4
1.0|1.4|1.2|97|II(d) Miscellaneous lymphoreticular neoplasms|82324418|0-19|All Races|Male and Female|2006|1.0|1.4|1.2
0.2|0.4|0.3|23|II(e) Unspecified lymphomas|82324418|0-19|All Races|Male and Female|2006|0.2|0.4|0.3
29.9|32.3|31.1|2549|III CNS and misc intracranial and intraspinal neoplasms|82324418|0-19|All Races|Male and Female|2006|29.8|32.2|31.0
2.5|3.2|2.8|231|III(a) Ependymomas and choroid plexus tumor|82324418|0-19|All Races|Male and Female|2006|2.5|3.2|2.8
14.5|16.2|15.4|1261|III(b) Astrocytomas|82324418|0-19|All Races|Male and Female|2006|14.5|16.2|15.3
5.8|6.9|6.3|515|III(c) Intracranial and intraspinal embryonal tumors|82324418|0-19|All Races|Male and Female|2006|5.7|6.8|6.3
4.9|6.0|5.4|443|III(d) Other gliomas|82324418|0-19|All Races|Male and Female|2006|4.9|5.9|5.4
0.4|0.8|0.6|48|III(e) Other specified intracranial & intraspinal neoplasms|82324418|0-19|All Races|Male and Female|2006|0.4|0.8|0.6
0.5|0.8|0.6|51|III(f) Unspecified intracranial and intraspinal neoplasms|82324418|0-19|All Races|Male and Female|2006|0.5|0.8|0.6
7.3|8.5|7.9|648|IV Neuroblastoma and other peripheral nervous cell tumors|82324418|0-19|All Races|Male and Female|2006|7.3|8.5|7.9
7.1|8.3|7.7|635|IV(a) Neuroblastoma and ganglioneuroblastoma|82324418|0-19|All Races|Male and Female|2006|7.1|8.3|7.7
~|~|~|~|IV(b) Other peripheral nervous cell tumors|82324418|0-19|All Races|Male and Female|2006|~|~|~
10.9|12.4|11.7|968|IX Soft tissue and other extraosseous sarcomas|82324418|0-19|All Races|Male and Female|2006|11.0|12.5|11.8
4.1|5.1|4.6|375|IX(a) Rhabdomyosarcomas|82324418|0-19|All Races|Male and Female|2006|4.1|5.0|4.6
1.1|1.6|1.3|110|IX(b) Fibrosarcomas, peripheral nerve sheath tumors & other fibrous neoplams|82324418|0-19|All Races|Male and Female|2006|1.1|1.6|1.3
~|~|~|~|IX(c) Kaposi sarcoma|82324418|0-19|All Races|Male and Female|2006|~|~|~
4.1|5.0|4.5|376|IX(d) Other specified soft tissue sarcomas|82324418|0-19|All Races|Male and Female|2006|4.1|5.1|4.6
1.0|1.5|1.2|102|IX(e) Unspecified soft tissue sarcomas|82324418|0-19|All Races|Male and Female|2006|1.0|1.5|1.2
0.2|0.4|0.3|23|Not classified by ICCC|82324418|0-19|All Races|Male and Female|2006|0.2|0.4|0.3
2.7|3.5|3.1|256|V Retinoblastoma|82324418|0-19|All Races|Male and Female|2006|2.7|3.5|3.1
6.2|7.3|6.7|549|VI Renal tumors|82324418|0-19|All Races|Male and Female|2006|6.1|7.3|6.7
5.5|6.5|6.0|487|VI(a) Nephroblastoma and other nonepithelial renal tumors|82324418|0-19|All Races|Male and Female|2006|5.4|6.5|5.9
0.5|0.9|0.7|57|VI(b) Renal carcinomas|82324418|0-19|All Races|Male and Female|2006|0.5|0.9|0.7
~|~|~|~|VI(c) Unspecified malignant renal tumors|82324418|0-19|All Races|Male and Female|2006|~|~|~
2.0|2.6|2.3|191|VII Hepatic tumors|82324418|0-19|All Races|Male and Female|2006|2.0|2.7|2.3
1.4|1.9|1.6|135|VII(a) Hepatoblastoma|82324418|0-19|All Races|Male and Female|2006|1.4|1.9|1.6
0.5|0.8|0.6|52|VII(b) Hepatic carcinomas|82324418|0-19|All Races|Male and Female|2006|0.5|0.8|0.6
~|~|~|~|VII(c) Unspecified malignant hepatic tumors|82324418|0-19|All Races|Male and Female|2006|~|~|~
8.6|10.0|9.3|774|VIII Malignant bone tumors|82324418|0-19|All Races|Male and Female|2006|8.8|10.1|9.4
4.9|5.9|5.4|449|VIII(a) Osteosarcomas|82324418|0-19|All Races|Male and Female|2006|5.0|6.0|5.5
0.1|0.3|0.2|17|VIII(b) Chondrosarcomas|82324418|0-19|All Races|Male and Female|2006|0.1|0.3|0.2
2.7|3.4|3.0|251|VIII(c) Ewing tumor and related sarcomas of bone|82324418|0-19|All Races|Male and Female|2006|2.7|3.5|3.0
0.4|0.7|0.5|43|VIII(d) Other specified malignant bone tumors|82324418|0-19|All Races|Male and Female|2006|0.4|0.7|0.5
~|~|~|~|VIII(e) Unspecified malignant bone tumors|82324418|0-19|All Races|Male and Female|2006|~|~|~
9.5|10.9|10.2|868|X Germ cell, trophoblastic tumors & neoplasms of gonads|82324418|0-19|All Races|Male and Female|2006|9.9|11.3|10.5
1.3|1.8|1.5|126|X(a) Intracranial & intraspinal germ cell tumors|82324418|0-19|All Races|Male and Female|2006|1.3|1.8|1.5
1.2|1.8|1.5|126|X(b) Malignant extracranial & extragonadal germ cell tumors|82324418|0-19|All Races|Male and Female|2006|1.3|1.8|1.5
5.9|6.9|6.4|545|X(c) Malignant gonadal germ cell tumors|82324418|0-19|All Races|Male and Female|2006|6.1|7.2|6.6
0.4|0.7|0.5|42|X(d) Gonadal carcinomas|82324418|0-19|All Races|Male and Female|2006|0.4|0.7|0.5
0.2|0.5|0.3|29|X(e) Other and unspecified malignant gonadal tumors|82324418|0-19|All Races|Male and Female|2006|0.2|0.5|0.4
16.4|18.2|17.3|1467|XI Other malignant epithelial neoplasms and malignant melanomas|82324418|0-19|All Races|Male and Female|2006|16.9|18.8|17.8
0.1|0.3|0.2|16|XI(a) Adrenocortical carcinomas|82324418|0-19|All Races|Male and Female|2006|0.1|0.3|0.2
6.2|7.3|6.7|571|XI(b) Thyroid carcinomas|82324418|0-19|All Races|Male and Female|2006|6.4|7.5|6.9
0.5|0.8|0.6|55|XI(c) Nasopharyngeal carcinomas|82324418|0-19|All Races|Male and Female|2006|0.5|0.9|0.7
4.9|5.9|5.4|461|XI(d) Malignant melanomas|82324418|0-19|All Races|Male and Female|2006|5.1|6.1|5.6
~|~|~|~|XI(e) Skin carcinomas|82324418|0-19|All Races|Male and Female|2006|~|~|~
3.8|4.7|4.2|357|XI(f) Other and unspecified carcinomas|82324418|0-19|All Races|Male and Female|2006|3.9|4.8|4.3
0.7|1.1|0.9|74|XII Other and unspecified malignant neoplasms|82324418|0-19|All Races|Male and Female|2006|0.7|1.1|0.9
0.4|0.7|0.5|41|XII(a) Other specified malignant tumors|82324418|0-19|All Races|Male and Female|2006|0.4|0.7|0.5
0.3|0.6|0.4|33|XII(b) Other unspecified malignant tumors|82324418|0-19|All Races|Male and Female|2006|0.3|0.6|0.4
173.8|179.5|176.6|14758|All ICCC Groups Combined|82749431|0-19|All Races|Male and Female|2007|175.5|181.2|178.3
45.8|48.8|47.3|3906|I Leukemias, myeloproliferative & myelodysplastic diseases|82749431|0-19|All Races|Male and Female|2007|45.7|48.7|47.2
33.0|35.6|34.3|2816|I(a) Lymphoid leukemias|82749431|0-19|All Races|Male and Female|2007|32.8|35.3|34.0
7.4|8.6|8.0|666|I(b) Acute myeloid leukemias|82749431|0-19|All Races|Male and Female|2007|7.4|8.7|8.0
2.1|2.8|2.4|208|I(c) Chronic myeloproliferative diseases|82749431|0-19|All Races|Male and Female|2007|2.2|2.9|2.5
1.2|1.7|1.4|121|I(d) Myelodysplastic syndrome and other myeloproliferative diseases|82749431|0-19|All Races|Male and Female|2007|1.2|1.7|1.5
0.9|1.4|1.1|95|I(e) Unspecified and other specified leukemias|82749431|0-19|All Races|Male and Female|2007|0.9|1.4|1.1
23.9|26.1|25.0|2109|II Lymphomas and reticuloendothelial neoplasms|82749431|0-19|All Races|Male and Female|2007|24.4|26.6|25.5
11.4|12.9|12.1|1035|II(a) Hodgkin lymphomas|82749431|0-19|All Races|Male and Female|2007|11.8|13.3|12.5
8.1|9.4|8.7|731|II(b) Non-Hodgkin lymphomas (except Burkitt lymphoma)|82749431|0-19|All Races|Male and Female|2007|8.2|9.5|8.8
2.3|3.0|2.6|216|II(c) Burkitt lymphoma|82749431|0-19|All Races|Male and Female|2007|2.3|3.0|2.6
0.9|1.4|1.1|92|II(d) Miscellaneous lymphoreticular neoplasms|82749431|0-19|All Races|Male and Female|2007|0.9|1.4|1.1
0.3|0.6|0.4|35|II(e) Unspecified lymphomas|82749431|0-19|All Races|Male and Female|2007|0.3|0.6|0.4
30.5|33.0|31.8|2614|III CNS and misc intracranial and intraspinal neoplasms|82749431|0-19|All Races|Male and Female|2007|30.4|32.8|31.6
2.2|2.9|2.5|207|III(a) Ependymomas and choroid plexus tumor|82749431|0-19|All Races|Male and Female|2007|2.2|2.9|2.5
15.0|16.8|15.9|1311|III(b) Astrocytomas|82749431|0-19|All Races|Male and Female|2007|15.0|16.7|15.8
6.0|7.1|6.5|533|III(c) Intracranial and intraspinal embryonal tumors|82749431|0-19|All Races|Male and Female|2007|5.9|7.0|6.4
5.2|6.3|5.7|467|III(d) Other gliomas|82749431|0-19|All Races|Male and Female|2007|5.1|6.2|5.6
0.5|0.9|0.7|57|III(e) Other specified intracranial & intraspinal neoplasms|82749431|0-19|All Races|Male and Female|2007|0.5|0.9|0.7
0.3|0.6|0.5|39|III(f) Unspecified intracranial and intraspinal neoplasms|82749431|0-19|All Races|Male and Female|2007|0.3|0.6|0.5
8.4|9.7|9.0|754|IV Neuroblastoma and other peripheral nervous cell tumors|82749431|0-19|All Races|Male and Female|2007|8.5|9.8|9.1
8.2|9.5|8.8|735|IV(a) Neuroblastoma and ganglioneuroblastoma|82749431|0-19|All Races|Male and Female|2007|8.3|9.5|8.9
0.1|0.4|0.2|19|IV(b) Other peripheral nervous cell tumors|82749431|0-19|All Races|Male and Female|2007|0.1|0.4|0.2
11.8|13.3|12.6|1050|IX Soft tissue and other extraosseous sarcomas|82749431|0-19|All Races|Male and Female|2007|11.9|13.5|12.7
4.7|5.7|5.2|427|IX(a) Rhabdomyosarcomas|82749431|0-19|All Races|Male and Female|2007|4.7|5.7|5.2
1.1|1.7|1.4|117|IX(b) Fibrosarcomas, peripheral nerve sheath tumors & other fibrous neoplams|82749431|0-19|All Races|Male and Female|2007|1.2|1.7|1.4
~|~|~|~|IX(c) Kaposi sarcoma|82749431|0-19|All Races|Male and Female|2007|~|~|~
4.3|5.3|4.8|403|IX(d) Other specified soft tissue sarcomas|82749431|0-19|All Races|Male and Female|2007|4.4|5.4|4.9
1.0|1.4|1.2|99|IX(e) Unspecified soft tissue sarcomas|82749431|0-19|All Races|Male and Female|2007|1.0|1.5|1.2
0.1|0.4|0.2|19|Not classified by ICCC|82749431|0-19|All Races|Male and Female|2007|0.1|0.4|0.2
2.8|3.6|3.2|270|V Retinoblastoma|82749431|0-19|All Races|Male and Female|2007|2.9|3.7|3.3
6.3|7.5|6.9|569|VI Renal tumors|82749431|0-19|All Races|Male and Female|2007|6.3|7.5|6.9
5.7|6.8|6.2|513|VI(a) Nephroblastoma and other nonepithelial renal tumors|82749431|0-19|All Races|Male and Female|2007|5.7|6.8|6.2
0.5|0.8|0.6|54|VI(b) Renal carcinomas|82749431|0-19|All Races|Male and Female|2007|0.5|0.9|0.7
~|~|~|~|VI(c) Unspecified malignant renal tumors|82749431|0-19|All Races|Male and Female|2007|~|~|~
2.0|2.7|2.3|194|VII Hepatic tumors|82749431|0-19|All Races|Male and Female|2007|2.0|2.7|2.3
1.4|2.0|1.7|142|VII(a) Hepatoblastoma|82749431|0-19|All Races|Male and Female|2007|1.4|2.0|1.7
0.5|0.8|0.6|52|VII(b) Hepatic carcinomas|82749431|0-19|All Races|Male and Female|2007|0.5|0.8|0.6
~|~|~|~|VII(c) Unspecified malignant hepatic tumors|82749431|0-19|All Races|Male and Female|2007|~|~|~
8.2|9.4|8.8|736|VIII Malignant bone tumors|82749431|0-19|All Races|Male and Female|2007|8.3|9.6|8.9
4.2|5.2|4.7|393|VIII(a) Osteosarcomas|82749431|0-19|All Races|Male and Female|2007|4.3|5.2|4.7
0.3|0.5|0.4|32|VIII(b) Chondrosarcomas|82749431|0-19|All Races|Male and Female|2007|0.3|0.5|0.4
2.7|3.5|3.1|258|VIII(c) Ewing tumor and related sarcomas of bone|82749431|0-19|All Races|Male and Female|2007|2.7|3.5|3.1
0.3|0.5|0.4|31|VIII(d) Other specified malignant bone tumors|82749431|0-19|All Races|Male and Female|2007|0.3|0.5|0.4
0.2|0.4|0.3|22|VIII(e) Unspecified malignant bone tumors|82749431|0-19|All Races|Male and Female|2007|0.2|0.4|0.3
10.4|11.8|11.1|952|X Germ cell, trophoblastic tumors & neoplasms of gonads|82749431|0-19|All Races|Male and Female|2007|10.8|12.3|11.5
1.3|1.9|1.6|134|X(a) Intracranial & intraspinal germ cell tumors|82749431|0-19|All Races|Male and Female|2007|1.4|1.9|1.6
1.1|1.7|1.4|118|X(b) Malignant extracranial & extragonadal germ cell tumors|82749431|0-19|All Races|Male and Female|2007|1.2|1.7|1.4
6.9|8.1|7.5|644|X(c) Malignant gonadal germ cell tumors|82749431|0-19|All Races|Male and Female|2007|7.2|8.4|7.8
0.2|0.5|0.4|31|X(d) Gonadal carcinomas|82749431|0-19|All Races|Male and Female|2007|0.3|0.5|0.4
0.2|0.4|0.3|25|X(e) Other and unspecified malignant gonadal tumors|82749431|0-19|All Races|Male and Female|2007|0.2|0.4|0.3
16.8|18.6|17.6|1516|XI Other malignant epithelial neoplasms and malignant melanomas|82749431|0-19|All Races|Male and Female|2007|17.4|19.3|18.3
~|~|~|~|XI(a) Adrenocortical carcinomas|82749431|0-19|All Races|Male and Female|2007|~|~|~
6.7|7.9|7.3|630|XI(b) Thyroid carcinomas|82749431|0-19|All Races|Male and Female|2007|7.0|8.2|7.6
0.5|0.8|0.6|52|XI(c) Nasopharyngeal carcinomas|82749431|0-19|All Races|Male and Female|2007|0.5|0.8|0.6
4.9|5.9|5.4|459|XI(d) Malignant melanomas|82749431|0-19|All Races|Male and Female|2007|5.1|6.1|5.5
~|~|~|~|XI(e) Skin carcinomas|82749431|0-19|All Races|Male and Female|2007|~|~|~
3.7|4.6|4.1|352|XI(f) Other and unspecified carcinomas|82749431|0-19|All Races|Male and Female|2007|3.8|4.7|4.3
0.6|1.0|0.8|69|XII Other and unspecified malignant neoplasms|82749431|0-19|All Races|Male and Female|2007|0.6|1.1|0.8
0.2|0.5|0.3|29|XII(a) Other specified malignant tumors|82749431|0-19|All Races|Male and Female|2007|0.2|0.5|0.4
0.3|0.6|0.5|40|XII(b) Other unspecified malignant tumors|82749431|0-19|All Races|Male and Female|2007|0.3|0.7|0.5
175.7|181.4|178.5|14987|All ICCC Groups Combined|83118264|0-19|All Races|Male and Female|2008|177.4|183.2|180.3
47.2|50.2|48.7|4047|I Leukemias, myeloproliferative & myelodysplastic diseases|83118264|0-19|All Races|Male and Female|2008|47.2|50.2|48.7
33.8|36.4|35.1|2900|I(a) Lymphoid leukemias|83118264|0-19|All Races|Male and Female|2008|33.6|36.2|34.9
7.7|8.9|8.3|696|I(b) Acute myeloid leukemias|83118264|0-19|All Races|Male and Female|2008|7.8|9.0|8.4
2.3|3.0|2.7|227|I(c) Chronic myeloproliferative diseases|83118264|0-19|All Races|Male and Female|2008|2.4|3.1|2.7
1.3|1.9|1.6|132|I(d) Myelodysplastic syndrome and other myeloproliferative diseases|83118264|0-19|All Races|Male and Female|2008|1.3|1.9|1.6
0.9|1.3|1.1|92|I(e) Unspecified and other specified leukemias|83118264|0-19|All Races|Male and Female|2008|0.9|1.4|1.1
24.4|26.5|25.4|2154|II Lymphomas and reticuloendothelial neoplasms|83118264|0-19|All Races|Male and Female|2008|24.8|27.0|25.9
12.1|13.7|12.9|1103|II(a) Hodgkin lymphomas|83118264|0-19|All Races|Male and Female|2008|12.5|14.1|13.3
8.1|9.4|8.7|736|II(b) Non-Hodgkin lymphomas (except Burkitt lymphoma)|83118264|0-19|All Races|Male and Female|2008|8.2|9.5|8.9
2.2|2.9|2.6|211|II(c) Burkitt lymphoma|83118264|0-19|All Races|Male and Female|2008|2.2|2.9|2.5
0.7|1.2|0.9|78|II(d) Miscellaneous lymphoreticular neoplasms|83118264|0-19|All Races|Male and Female|2008|0.7|1.2|0.9
0.2|0.5|0.3|26|II(e) Unspecified lymphomas|83118264|0-19|All Races|Male and Female|2008|0.2|0.5|0.3
30.9|33.4|32.1|2660|III CNS and misc intracranial and intraspinal neoplasms|83118264|0-19|All Races|Male and Female|2008|30.8|33.2|32.0
2.0|2.7|2.4|196|III(a) Ependymomas and choroid plexus tumor|83118264|0-19|All Races|Male and Female|2008|2.0|2.7|2.4
15.3|17.1|16.2|1339|III(b) Astrocytomas|83118264|0-19|All Races|Male and Female|2008|15.3|17.0|16.1
6.2|7.3|6.8|558|III(c) Intracranial and intraspinal embryonal tumors|83118264|0-19|All Races|Male and Female|2008|6.2|7.3|6.7
5.2|6.3|5.7|475|III(d) Other gliomas|83118264|0-19|All Races|Male and Female|2008|5.2|6.3|5.7
0.5|0.9|0.7|59|III(e) Other specified intracranial & intraspinal neoplasms|83118264|0-19|All Races|Male and Female|2008|0.5|0.9|0.7
0.3|0.6|0.4|33|III(f) Unspecified intracranial and intraspinal neoplasms|83118264|0-19|All Races|Male and Female|2008|0.3|0.6|0.4
7.8|9.1|8.4|705|IV Neuroblastoma and other peripheral nervous cell tumors|83118264|0-19|All Races|Male and Female|2008|7.9|9.1|8.5
7.5|8.7|8.1|678|IV(a) Neuroblastoma and ganglioneuroblastoma|83118264|0-19|All Races|Male and Female|2008|7.6|8.8|8.2
0.2|0.5|0.3|27|IV(b) Other peripheral nervous cell tumors|83118264|0-19|All Races|Male and Female|2008|0.2|0.5|0.3
11.6|13.1|12.3|1033|IX Soft tissue and other extraosseous sarcomas|83118264|0-19|All Races|Male and Female|2008|11.7|13.2|12.4
4.6|5.6|5.1|425|IX(a) Rhabdomyosarcomas|83118264|0-19|All Races|Male and Female|2008|4.6|5.6|5.1
0.9|1.3|1.1|92|IX(b) Fibrosarcomas, peripheral nerve sheath tumors & other fibrous neoplams|83118264|0-19|All Races|Male and Female|2008|0.9|1.4|1.1
~|~|~|~|IX(c) Kaposi sarcoma|83118264|0-19|All Races|Male and Female|2008|~|~|~
4.1|5.0|4.6|385|IX(d) Other specified soft tissue sarcomas|83118264|0-19|All Races|Male and Female|2008|4.2|5.1|4.6
1.3|1.8|1.5|129|IX(e) Unspecified soft tissue sarcomas|83118264|0-19|All Races|Male and Female|2008|1.3|1.8|1.6
0.2|0.4|0.3|24|Not classified by ICCC|83118264|0-19|All Races|Male and Female|2008|0.2|0.4|0.3
2.8|3.6|3.2|267|V Retinoblastoma|83118264|0-19|All Races|Male and Female|2008|2.8|3.6|3.2
6.7|7.8|7.2|602|VI Renal tumors|83118264|0-19|All Races|Male and Female|2008|6.7|7.8|7.2
5.9|7.0|6.5|537|VI(a) Nephroblastoma and other nonepithelial renal tumors|83118264|0-19|All Races|Male and Female|2008|5.9|7.0|6.5
0.6|0.9|0.7|62|VI(b) Renal carcinomas|83118264|0-19|All Races|Male and Female|2008|0.6|1.0|0.7
~|~|~|~|VI(c) Unspecified malignant renal tumors|83118264|0-19|All Races|Male and Female|2008|~|~|~
1.9|2.6|2.3|190|VII Hepatic tumors|83118264|0-19|All Races|Male and Female|2008|2.0|2.6|2.3
1.4|2.0|1.7|142|VII(a) Hepatoblastoma|83118264|0-19|All Races|Male and Female|2008|1.4|2.0|1.7
0.4|0.7|0.6|47|VII(b) Hepatic carcinomas|83118264|0-19|All Races|Male and Female|2008|0.4|0.8|0.6
~|~|~|~|VII(c) Unspecified malignant hepatic tumors|83118264|0-19|All Races|Male and Female|2008|~|~|~
8.1|9.4|8.8|735|VIII Malignant bone tumors|83118264|0-19|All Races|Male and Female|2008|8.2|9.5|8.8
4.5|5.4|4.9|414|VIII(a) Osteosarcomas|83118264|0-19|All Races|Male and Female|2008|4.5|5.5|5.0
0.3|0.6|0.4|34|VIII(b) Chondrosarcomas|83118264|0-19|All Races|Male and Female|2008|0.3|0.6|0.4
2.4|3.2|2.8|232|VIII(c) Ewing tumor and related sarcomas of bone|83118264|0-19|All Races|Male and Female|2008|2.4|3.2|2.8
0.3|0.5|0.4|33|VIII(d) Other specified malignant bone tumors|83118264|0-19|All Races|Male and Female|2008|0.3|0.6|0.4
0.2|0.4|0.3|22|VIII(e) Unspecified malignant bone tumors|83118264|0-19|All Races|Male and Female|2008|0.2|0.4|0.3
10.2|11.6|10.9|941|X Germ cell, trophoblastic tumors & neoplasms of gonads|83118264|0-19|All Races|Male and Female|2008|10.6|12.1|11.3
1.5|2.0|1.7|145|X(a) Intracranial & intraspinal germ cell tumors|83118264|0-19|All Races|Male and Female|2008|1.5|2.1|1.7
1.2|1.7|1.4|123|X(b) Malignant extracranial & extragonadal germ cell tumors|83118264|0-19|All Races|Male and Female|2008|1.2|1.8|1.5
6.7|7.8|7.3|630|X(c) Malignant gonadal germ cell tumors|83118264|0-19|All Races|Male and Female|2008|7.0|8.2|7.6
0.2|0.5|0.3|29|X(d) Gonadal carcinomas|83118264|0-19|All Races|Male and Female|2008|0.2|0.5|0.3
~|~|~|~|X(e) Other and unspecified malignant gonadal tumors|83118264|0-19|All Races|Male and Female|2008|~|~|~
17.3|19.1|18.2|1566|XI Other malignant epithelial neoplasms and malignant melanomas|83118264|0-19|All Races|Male and Female|2008|17.9|19.8|18.8
0.1|0.4|0.2|19|XI(a) Adrenocortical carcinomas|83118264|0-19|All Races|Male and Female|2008|0.1|0.4|0.2
7.5|8.7|8.0|696|XI(b) Thyroid carcinomas|83118264|0-19|All Races|Male and Female|2008|7.8|9.0|8.4
0.4|0.7|0.5|46|XI(c) Nasopharyngeal carcinomas|83118264|0-19|All Races|Male and Female|2008|0.4|0.7|0.6
4.4|5.4|4.9|421|XI(d) Malignant melanomas|83118264|0-19|All Races|Male and Female|2008|4.6|5.6|5.1
~|~|~|~|XI(e) Skin carcinomas|83118264|0-19|All Races|Male and Female|2008|~|~|~
4.0|4.9|4.4|379|XI(f) Other and unspecified carcinomas|83118264|0-19|All Races|Male and Female|2008|4.1|5.0|4.6
0.6|1.0|0.7|63|XII Other and unspecified malignant neoplasms|83118264|0-19|All Races|Male and Female|2008|0.6|1.0|0.8
0.3|0.5|0.4|32|XII(a) Other specified malignant tumors|83118264|0-19|All Races|Male and Female|2008|0.3|0.5|0.4
0.2|0.5|0.4|31|XII(b) Other unspecified malignant tumors|83118264|0-19|All Races|Male and Female|2008|0.3|0.5|0.4
174.6|180.3|177.5|14908|All ICCC Groups Combined|83280391|0-19|All Races|Male and Female|2009|176.1|181.9|179.0
45.7|48.6|47.1|3927|I Leukemias, myeloproliferative & myelodysplastic diseases|83280391|0-19|All Races|Male and Female|2009|45.7|48.7|47.2
33.3|35.9|34.6|2872|I(a) Lymphoid leukemias|83280391|0-19|All Races|Male and Female|2009|33.2|35.8|34.5
7.0|8.2|7.6|639|I(b) Acute myeloid leukemias|83280391|0-19|All Races|Male and Female|2009|7.1|8.3|7.7
2.0|2.6|2.3|194|I(c) Chronic myeloproliferative diseases|83280391|0-19|All Races|Male and Female|2009|2.0|2.7|2.3
1.2|1.8|1.5|125|I(d) Myelodysplastic syndrome and other myeloproliferative diseases|83280391|0-19|All Races|Male and Female|2009|1.2|1.8|1.5
0.9|1.4|1.2|97|I(e) Unspecified and other specified leukemias|83280391|0-19|All Races|Male and Female|2009|0.9|1.4|1.2
24.2|26.4|25.3|2144|II Lymphomas and reticuloendothelial neoplasms|83280391|0-19|All Races|Male and Female|2009|24.7|26.9|25.7
11.9|13.4|12.6|1081|II(a) Hodgkin lymphomas|83280391|0-19|All Races|Male and Female|2009|12.2|13.8|13.0
8.2|9.5|8.9|745|II(b) Non-Hodgkin lymphomas (except Burkitt lymphoma)|83280391|0-19|All Races|Male and Female|2009|8.3|9.6|8.9
1.9|2.6|2.2|184|II(c) Burkitt lymphoma|83280391|0-19|All Races|Male and Female|2009|1.9|2.6|2.2
1.1|1.6|1.3|109|II(d) Miscellaneous lymphoreticular neoplasms|83280391|0-19|All Races|Male and Female|2009|1.1|1.6|1.3
0.2|0.4|0.3|25|II(e) Unspecified lymphomas|83280391|0-19|All Races|Male and Female|2009|0.2|0.4|0.3
30.7|33.1|31.9|2642|III CNS and misc intracranial and intraspinal neoplasms|83280391|0-19|All Races|Male and Female|2009|30.5|33.0|31.7
2.1|2.8|2.4|204|III(a) Ependymomas and choroid plexus tumor|83280391|0-19|All Races|Male and Female|2009|2.1|2.8|2.4
15.2|16.9|16.0|1332|III(b) Astrocytomas|83280391|0-19|All Races|Male and Female|2009|15.1|16.9|16.0
5.8|6.9|6.3|524|III(c) Intracranial and intraspinal embryonal tumors|83280391|0-19|All Races|Male and Female|2009|5.8|6.9|6.3
5.5|6.5|6.0|495|III(d) Other gliomas|83280391|0-19|All Races|Male and Female|2009|5.4|6.5|5.9
0.4|0.8|0.6|49|III(e) Other specified intracranial & intraspinal neoplasms|83280391|0-19|All Races|Male and Female|2009|0.4|0.8|0.6
0.3|0.6|0.5|38|III(f) Unspecified intracranial and intraspinal neoplasms|83280391|0-19|All Races|Male and Female|2009|0.3|0.6|0.5
7.6|8.9|8.2|686|IV Neuroblastoma and other peripheral nervous cell tumors|83280391|0-19|All Races|Male and Female|2009|7.6|8.9|8.2
7.4|8.6|8.0|665|IV(a) Neuroblastoma and ganglioneuroblastoma|83280391|0-19|All Races|Male and Female|2009|7.4|8.6|8.0
0.2|0.4|0.2|21|IV(b) Other peripheral nervous cell tumors|83280391|0-19|All Races|Male and Female|2009|0.2|0.4|0.3
11.4|12.9|12.2|1021|IX Soft tissue and other extraosseous sarcomas|83280391|0-19|All Races|Male and Female|2009|11.5|13.0|12.3
3.8|4.7|4.2|352|IX(a) Rhabdomyosarcomas|83280391|0-19|All Races|Male and Female|2009|3.8|4.7|4.2
1.3|1.8|1.5|130|IX(b) Fibrosarcomas, peripheral nerve sheath tumors & other fibrous neoplams|83280391|0-19|All Races|Male and Female|2009|1.3|1.9|1.6
~|~|~|~|IX(c) Kaposi sarcoma|83280391|0-19|All Races|Male and Female|2009|~|~|~
4.5|5.5|5.0|418|IX(d) Other specified soft tissue sarcomas|83280391|0-19|All Races|Male and Female|2009|4.5|5.5|5.0
1.1|1.6|1.4|114|IX(e) Unspecified soft tissue sarcomas|83280391|0-19|All Races|Male and Female|2009|1.1|1.6|1.4
0.3|0.5|0.4|31|Not classified by ICCC|83280391|0-19|All Races|Male and Female|2009|0.3|0.5|0.4
3.0|3.8|3.4|282|V Retinoblastoma|83280391|0-19|All Races|Male and Female|2009|3.0|3.8|3.4
6.8|8.0|7.4|614|VI Renal tumors|83280391|0-19|All Races|Male and Female|2009|6.8|8.0|7.4
6.0|7.1|6.6|545|VI(a) Nephroblastoma and other nonepithelial renal tumors|83280391|0-19|All Races|Male and Female|2009|6.0|7.1|6.5
0.6|1.0|0.8|67|VI(b) Renal carcinomas|83280391|0-19|All Races|Male and Female|2009|0.6|1.0|0.8
~|~|~|~|VI(c) Unspecified malignant renal tumors|83280391|0-19|All Races|Male and Female|2009|~|~|~
1.7|2.3|2.0|168|VII Hepatic tumors|83280391|0-19|All Races|Male and Female|2009|1.7|2.3|2.0
1.2|1.7|1.4|117|VII(a) Hepatoblastoma|83280391|0-19|All Races|Male and Female|2009|1.2|1.7|1.4
0.4|0.8|0.6|49|VII(b) Hepatic carcinomas|83280391|0-19|All Races|Male and Female|2009|0.4|0.8|0.6
~|~|~|~|VII(c) Unspecified malignant hepatic tumors|83280391|0-19|All Races|Male and Female|2009|~|~|~
8.4|9.7|9.0|760|VIII Malignant bone tumors|83280391|0-19|All Races|Male and Female|2009|8.5|9.8|9.1
4.6|5.6|5.1|425|VIII(a) Osteosarcomas|83280391|0-19|All Races|Male and Female|2009|4.6|5.6|5.1
0.2|0.5|0.3|27|VIII(b) Chondrosarcomas|83280391|0-19|All Races|Male and Female|2009|0.2|0.5|0.3
2.6|3.3|2.9|247|VIII(c) Ewing tumor and related sarcomas of bone|83280391|0-19|All Races|Male and Female|2009|2.6|3.4|3.0
0.4|0.7|0.5|42|VIII(d) Other specified malignant bone tumors|83280391|0-19|All Races|Male and Female|2009|0.4|0.7|0.5
0.1|0.4|0.2|19|VIII(e) Unspecified malignant bone tumors|83280391|0-19|All Races|Male and Female|2009|0.1|0.4|0.2
10.8|12.3|11.5|990|X Germ cell, trophoblastic tumors & neoplasms of gonads|83280391|0-19|All Races|Male and Female|2009|11.2|12.7|11.9
1.4|2.0|1.7|141|X(a) Intracranial & intraspinal germ cell tumors|83280391|0-19|All Races|Male and Female|2009|1.4|2.0|1.7
1.1|1.6|1.4|115|X(b) Malignant extracranial & extragonadal germ cell tumors|83280391|0-19|All Races|Male and Female|2009|1.1|1.7|1.4
7.0|8.1|7.5|653|X(c) Malignant gonadal germ cell tumors|83280391|0-19|All Races|Male and Female|2009|7.3|8.5|7.8
0.5|0.8|0.6|53|X(d) Gonadal carcinomas|83280391|0-19|All Races|Male and Female|2009|0.5|0.8|0.6
0.2|0.5|0.3|28|X(e) Other and unspecified malignant gonadal tumors|83280391|0-19|All Races|Male and Female|2009|0.2|0.5|0.3
17.3|19.1|18.2|1567|XI Other malignant epithelial neoplasms and malignant melanomas|83280391|0-19|All Races|Male and Female|2009|17.9|19.8|18.8
0.2|0.4|0.2|21|XI(a) Adrenocortical carcinomas|83280391|0-19|All Races|Male and Female|2009|0.2|0.4|0.3
7.6|8.9|8.2|711|XI(b) Thyroid carcinomas|83280391|0-19|All Races|Male and Female|2009|7.9|9.2|8.5
0.5|0.9|0.7|59|XI(c) Nasopharyngeal carcinomas|83280391|0-19|All Races|Male and Female|2009|0.5|0.9|0.7
4.0|4.9|4.4|384|XI(d) Malignant melanomas|83280391|0-19|All Races|Male and Female|2009|4.2|5.1|4.6
~|~|~|~|XI(e) Skin carcinomas|83280391|0-19|All Races|Male and Female|2009|~|~|~
4.0|4.9|4.5|383|XI(f) Other and unspecified carcinomas|83280391|0-19|All Races|Male and Female|2009|4.1|5.1|4.6
0.7|1.1|0.9|76|XII Other and unspecified malignant neoplasms|83280391|0-19|All Races|Male and Female|2009|0.7|1.1|0.9
0.2|0.5|0.4|30|XII(a) Other specified malignant tumors|83280391|0-19|All Races|Male and Female|2009|0.2|0.5|0.4
0.4|0.7|0.5|46|XII(b) Other unspecified malignant tumors|83280391|0-19|All Races|Male and Female|2009|0.4|0.7|0.6
178.6|184.3|181.4|15189|All ICCC Groups Combined|83185451|0-19|All Races|Male and Female|2010|179.7|185.5|182.6
47.4|50.4|48.9|4070|I Leukemias, myeloproliferative & myelodysplastic diseases|83185451|0-19|All Races|Male and Female|2010|47.4|50.5|48.9
33.3|35.8|34.5|2865|I(a) Lymphoid leukemias|83185451|0-19|All Races|Male and Female|2010|33.2|35.7|34.4
7.7|9.0|8.4|700|I(b) Acute myeloid leukemias|83185451|0-19|All Races|Male and Female|2010|7.8|9.1|8.4
2.3|3.0|2.6|219|I(c) Chronic myeloproliferative diseases|83185451|0-19|All Races|Male and Female|2010|2.3|3.0|2.6
1.5|2.1|1.8|151|I(d) Myelodysplastic syndrome and other myeloproliferative diseases|83185451|0-19|All Races|Male and Female|2010|1.5|2.1|1.8
1.4|1.9|1.6|135|I(e) Unspecified and other specified leukemias|83185451|0-19|All Races|Male and Female|2010|1.4|1.9|1.6
26.4|28.6|27.5|2315|II Lymphomas and reticuloendothelial neoplasms|83185451|0-19|All Races|Male and Female|2010|26.7|29.0|27.8
11.3|12.8|12.1|1030|II(a) Hodgkin lymphomas|83185451|0-19|All Races|Male and Female|2010|11.6|13.2|12.4
8.1|9.4|8.7|729|II(b) Non-Hodgkin lymphomas (except Burkitt lymphoma)|83185451|0-19|All Races|Male and Female|2010|8.1|9.4|8.8
2.1|2.8|2.4|203|II(c) Burkitt lymphoma|83185451|0-19|All Races|Male and Female|2010|2.1|2.8|2.4
3.5|4.4|3.9|324|II(d) Miscellaneous lymphoreticular neoplasms|83185451|0-19|All Races|Male and Female|2010|3.5|4.3|3.9
0.2|0.5|0.3|29|II(e) Unspecified lymphomas|83185451|0-19|All Races|Male and Female|2010|0.2|0.5|0.3
31.0|33.5|32.3|2673|III CNS and misc intracranial and intraspinal neoplasms|83185451|0-19|All Races|Male and Female|2010|30.9|33.4|32.1
2.5|3.2|2.8|236|III(a) Ependymomas and choroid plexus tumor|83185451|0-19|All Races|Male and Female|2010|2.5|3.2|2.8
16.0|17.8|16.9|1398|III(b) Astrocytomas|83185451|0-19|All Races|Male and Female|2010|15.9|17.7|16.8
5.5|6.6|6.0|499|III(c) Intracranial and intraspinal embryonal tumors|83185451|0-19|All Races|Male and Female|2010|5.5|6.5|6.0
5.1|6.1|5.6|463|III(d) Other gliomas|83185451|0-19|All Races|Male and Female|2010|5.1|6.1|5.6
0.4|0.8|0.6|50|III(e) Other specified intracranial & intraspinal neoplasms|83185451|0-19|All Races|Male and Female|2010|0.4|0.8|0.6
0.2|0.5|0.3|27|III(f) Unspecified intracranial and intraspinal neoplasms|83185451|0-19|All Races|Male and Female|2010|0.2|0.5|0.3
8.0|9.2|8.6|713|IV Neuroblastoma and other peripheral nervous cell tumors|83185451|0-19|All Races|Male and Female|2010|8.0|9.2|8.6
7.8|9.0|8.4|696|IV(a) Neuroblastoma and ganglioneuroblastoma|83185451|0-19|All Races|Male and Female|2010|7.8|9.0|8.4
0.1|0.3|0.2|17|IV(b) Other peripheral nervous cell tumors|83185451|0-19|All Races|Male and Female|2010|0.1|0.3|0.2
12.0|13.6|12.8|1069|IX Soft tissue and other extraosseous sarcomas|83185451|0-19|All Races|Male and Female|2010|12.1|13.6|12.9
4.8|5.8|5.3|439|IX(a) Rhabdomyosarcomas|83185451|0-19|All Races|Male and Female|2010|4.8|5.8|5.3
0.8|1.3|1.0|86|IX(b) Fibrosarcomas, peripheral nerve sheath tumors & other fibrous neoplams|83185451|0-19|All Races|Male and Female|2010|0.8|1.3|1.0
~|~|~|~|IX(c) Kaposi sarcoma|83185451|0-19|All Races|Male and Female|2010|~|~|~
4.3|5.2|4.7|398|IX(d) Other specified soft tissue sarcomas|83185451|0-19|All Races|Male and Female|2010|4.3|5.3|4.8
1.4|2.0|1.7|143|IX(e) Unspecified soft tissue sarcomas|83185451|0-19|All Races|Male and Female|2010|1.4|2.0|1.7
0.2|0.4|0.3|21|Not classified by ICCC|83185451|0-19|All Races|Male and Female|2010|0.2|0.4|0.3
3.0|3.8|3.4|282|V Retinoblastoma|83185451|0-19|All Races|Male and Female|2010|3.0|3.8|3.4
6.1|7.3|6.7|557|VI Renal tumors|83185451|0-19|All Races|Male and Female|2010|6.2|7.3|6.7
5.6|6.7|6.2|513|VI(a) Nephroblastoma and other nonepithelial renal tumors|83185451|0-19|All Races|Male and Female|2010|5.6|6.7|6.2
0.4|0.7|0.5|42|VI(b) Renal carcinomas|83185451|0-19|All Races|Male and Female|2010|0.4|0.7|0.5
~|~|~|~|VI(c) Unspecified malignant renal tumors|83185451|0-19|All Races|Male and Female|2010|~|~|~
2.3|3.0|2.6|221|VII Hepatic tumors|83185451|0-19|All Races|Male and Female|2010|2.3|3.0|2.7
1.6|2.2|1.9|160|VII(a) Hepatoblastoma|83185451|0-19|All Races|Male and Female|2010|1.6|2.2|1.9
0.5|0.9|0.7|59|VII(b) Hepatic carcinomas|83185451|0-19|All Races|Male and Female|2010|0.5|0.9|0.7
~|~|~|~|VII(c) Unspecified malignant hepatic tumors|83185451|0-19|All Races|Male and Female|2010|~|~|~
7.7|9.0|8.3|696|VIII Malignant bone tumors|83185451|0-19|All Races|Male and Female|2010|7.8|9.0|8.4
4.3|5.2|4.7|397|VIII(a) Osteosarcomas|83185451|0-19|All Races|Male and Female|2010|4.3|5.3|4.8
0.2|0.5|0.4|31|VIII(b) Chondrosarcomas|83185451|0-19|All Races|Male and Female|2010|0.3|0.5|0.4
2.3|3.0|2.6|216|VIII(c) Ewing tumor and related sarcomas of bone|83185451|0-19|All Races|Male and Female|2010|2.3|3.0|2.6
0.3|0.6|0.4|36|VIII(d) Other specified malignant bone tumors|83185451|0-19|All Races|Male and Female|2010|0.3|0.6|0.4
0.1|0.3|0.2|16|VIII(e) Unspecified malignant bone tumors|83185451|0-19|All Races|Male and Female|2010|0.1|0.3|0.2
10.8|12.3|11.5|981|X Germ cell, trophoblastic tumors & neoplasms of gonads|83185451|0-19|All Races|Male and Female|2010|11.1|12.6|11.8
1.7|2.3|2.0|166|X(a) Intracranial & intraspinal germ cell tumors|83185451|0-19|All Races|Male and Female|2010|1.7|2.3|2.0
1.1|1.6|1.3|111|X(b) Malignant extracranial & extragonadal germ cell tumors|83185451|0-19|All Races|Male and Female|2010|1.1|1.6|1.3
6.7|7.9|7.3|626|X(c) Malignant gonadal germ cell tumors|83185451|0-19|All Races|Male and Female|2010|6.9|8.1|7.5
0.4|0.7|0.5|44|X(d) Gonadal carcinomas|83185451|0-19|All Races|Male and Female|2010|0.4|0.7|0.5
0.3|0.6|0.4|34|X(e) Other and unspecified malignant gonadal tumors|83185451|0-19|All Races|Male and Female|2010|0.3|0.6|0.4
17.0|18.9|17.9|1535|XI Other malignant epithelial neoplasms and malignant melanomas|83185451|0-19|All Races|Male and Female|2010|17.5|19.4|18.5
0.2|0.4|0.3|21|XI(a) Adrenocortical carcinomas|83185451|0-19|All Races|Male and Female|2010|0.2|0.4|0.3
7.9|9.2|8.6|734|XI(b) Thyroid carcinomas|83185451|0-19|All Races|Male and Female|2010|8.2|9.5|8.8
0.4|0.8|0.6|49|XI(c) Nasopharyngeal carcinomas|83185451|0-19|All Races|Male and Female|2010|0.4|0.8|0.6
3.6|4.5|4.0|345|XI(d) Malignant melanomas|83185451|0-19|All Races|Male and Female|2010|3.7|4.6|4.1
~|~|~|~|XI(e) Skin carcinomas|83185451|0-19|All Races|Male and Female|2010|~|~|~
4.0|4.9|4.4|377|XI(f) Other and unspecified carcinomas|83185451|0-19|All Races|Male and Female|2010|4.1|5.0|4.5
0.5|0.9|0.7|56|XII Other and unspecified malignant neoplasms|83185451|0-19|All Races|Male and Female|2010|0.5|0.9|0.7
0.3|0.5|0.4|32|XII(a) Other specified malignant tumors|83185451|0-19|All Races|Male and Female|2010|0.3|0.5|0.4
0.2|0.4|0.3|24|XII(b) Other unspecified malignant tumors|83185451|0-19|All Races|Male and Female|2010|0.2|0.4|0.3
181.7|184.3|183.0|75229|All ICCC Groups Combined|409325715|0-19|All Races|Male and Female|2010-2014|182.5|185.1|183.8
46.9|48.2|47.5|19470|I Leukemias, myeloproliferative & myelodysplastic diseases|409325715|0-19|All Races|Male and Female|2010-2014|46.9|48.2|47.6
33.1|34.3|33.7|13777|I(a) Lymphoid leukemias|409325715|0-19|All Races|Male and Female|2010-2014|33.1|34.2|33.7
7.9|8.5|8.2|3378|I(b) Acute myeloid leukemias|409325715|0-19|All Races|Male and Female|2010-2014|8.0|8.5|8.3
2.2|2.5|2.4|980|I(c) Chronic myeloproliferative diseases|409325715|0-19|All Races|Male and Female|2010-2014|2.2|2.5|2.4
1.4|1.6|1.5|623|I(d) Myelodysplastic syndrome and other myeloproliferative diseases|409325715|0-19|All Races|Male and Female|2010-2014|1.4|1.6|1.5
1.6|1.9|1.7|712|I(e) Unspecified and other specified leukemias|409325715|0-19|All Races|Male and Female|2010-2014|1.6|1.9|1.7
28.1|29.2|28.7|11826|II Lymphomas and reticuloendothelial neoplasms|409325715|0-19|All Races|Male and Female|2010-2014|28.4|29.4|28.9
11.6|12.3|11.9|4959|II(a) Hodgkin lymphomas|409325715|0-19|All Races|Male and Female|2010-2014|11.8|12.5|12.1
9.0|9.6|9.3|3829|II(b) Non-Hodgkin lymphomas (except Burkitt lymphoma)|409325715|0-19|All Races|Male and Female|2010-2014|9.1|9.7|9.4
2.3|2.6|2.4|993|II(c) Burkitt lymphoma|409325715|0-19|All Races|Male and Female|2010-2014|2.3|2.6|2.4
4.4|4.8|4.6|1890|II(d) Miscellaneous lymphoreticular neoplasms|409325715|0-19|All Races|Male and Female|2010-2014|4.4|4.8|4.6
0.3|0.4|0.4|155|II(e) Unspecified lymphomas|409325715|0-19|All Races|Male and Female|2010-2014|0.3|0.4|0.4
31.6|32.7|32.2|13146|III CNS and misc intracranial and intraspinal neoplasms|409325715|0-19|All Races|Male and Female|2010-2014|31.6|32.7|32.1
2.6|2.9|2.7|1119|III(a) Ependymomas and choroid plexus tumor|409325715|0-19|All Races|Male and Female|2010-2014|2.6|2.9|2.7
16.6|17.4|17.0|6936|III(b) Astrocytomas|409325715|0-19|All Races|Male and Female|2010-2014|16.5|17.3|16.9
5.7|6.1|5.9|2407|III(c) Intracranial and intraspinal embryonal tumors|409325715|0-19|All Races|Male and Female|2010-2014|5.6|6.1|5.9
5.2|5.7|5.4|2224|III(d) Other gliomas|409325715|0-19|All Races|Male and Female|2010-2014|5.2|5.7|5.4
0.6|0.7|0.6|260|III(e) Other specified intracranial & intraspinal neoplasms|409325715|0-19|All Races|Male and Female|2010-2014|0.6|0.7|0.6
0.4|0.6|0.5|200|III(f) Unspecified intracranial and intraspinal neoplasms|409325715|0-19|All Races|Male and Female|2010-2014|0.4|0.6|0.5
8.5|9.1|8.8|3597|IV Neuroblastoma and other peripheral nervous cell tumors|409325715|0-19|All Races|Male and Female|2010-2014|8.5|9.1|8.8
8.3|8.8|8.5|3487|IV(a) Neuroblastoma and ganglioneuroblastoma|409325715|0-19|All Races|Male and Female|2010-2014|8.2|8.8|8.5
0.2|0.3|0.3|110|IV(b) Other peripheral nervous cell tumors|409325715|0-19|All Races|Male and Female|2010-2014|0.2|0.3|0.3
11.8|12.5|12.1|4974|IX Soft tissue and other extraosseous sarcomas|409325715|0-19|All Races|Male and Female|2010-2014|11.8|12.5|12.2
4.5|5.0|4.7|1941|IX(a) Rhabdomyosarcomas|409325715|0-19|All Races|Male and Female|2010-2014|4.5|5.0|4.7
1.1|1.4|1.3|514|IX(b) Fibrosarcomas, peripheral nerve sheath tumors & other fibrous neoplams|409325715|0-19|All Races|Male and Female|2010-2014|1.1|1.4|1.3
0.0|0.1|0.1|23|IX(c) Kaposi sarcoma|409325715|0-19|All Races|Male and Female|2010-2014|0.0|0.1|0.1
4.5|4.9|4.7|1919|IX(d) Other specified soft tissue sarcomas|409325715|0-19|All Races|Male and Female|2010-2014|4.5|4.9|4.7
1.3|1.5|1.4|577|IX(e) Unspecified soft tissue sarcomas|409325715|0-19|All Races|Male and Female|2010-2014|1.3|1.5|1.4
0.2|0.3|0.3|115|Not classified by ICCC|409325715|0-19|All Races|Male and Female|2010-2014|0.2|0.3|0.3
3.1|3.4|3.3|1330|V Retinoblastoma|409325715|0-19|All Races|Male and Female|2010-2014|3.1|3.4|3.2
6.8|7.3|7.1|2895|VI Renal tumors|409325715|0-19|All Races|Male and Female|2010-2014|6.8|7.3|7.1
6.1|6.6|6.4|2601|VI(a) Nephroblastoma and other nonepithelial renal tumors|409325715|0-19|All Races|Male and Female|2010-2014|6.1|6.6|6.4
0.6|0.8|0.7|281|VI(b) Renal carcinomas|409325715|0-19|All Races|Male and Female|2010-2014|0.6|0.8|0.7
~|~|~|~|VI(c) Unspecified malignant renal tumors|409325715|0-19|All Races|Male and Female|2010-2014|~|~|~
2.4|2.7|2.6|1060|VII Hepatic tumors|409325715|0-19|All Races|Male and Female|2010-2014|2.4|2.8|2.6
1.8|2.1|2.0|799|VII(a) Hepatoblastoma|409325715|0-19|All Races|Male and Female|2010-2014|1.8|2.1|2.0
0.5|0.7|0.6|249|VII(b) Hepatic carcinomas|409325715|0-19|All Races|Male and Female|2010-2014|0.5|0.7|0.6
~|~|~|~|VII(c) Unspecified malignant hepatic tumors|409325715|0-19|All Races|Male and Female|2010-2014|~|~|~
8.7|9.2|8.9|3673|VIII Malignant bone tumors|409325715|0-19|All Races|Male and Female|2010-2014|8.7|9.3|9.0
4.8|5.2|5.0|2057|VIII(a) Osteosarcomas|409325715|0-19|All Races|Male and Female|2010-2014|4.8|5.2|5.0
0.3|0.4|0.3|138|VIII(b) Chondrosarcomas|409325715|0-19|All Races|Male and Female|2010-2014|0.3|0.4|0.3
2.8|3.1|3.0|1213|VIII(c) Ewing tumor and related sarcomas of bone|409325715|0-19|All Races|Male and Female|2010-2014|2.8|3.1|3.0
0.4|0.5|0.4|183|VIII(d) Other specified malignant bone tumors|409325715|0-19|All Races|Male and Female|2010-2014|0.4|0.5|0.4
0.2|0.2|0.2|82|VIII(e) Unspecified malignant bone tumors|409325715|0-19|All Races|Male and Female|2010-2014|0.2|0.2|0.2
11.0|11.6|11.3|4704|X Germ cell, trophoblastic tumors & neoplasms of gonads|409325715|0-19|All Races|Male and Female|2010-2014|11.2|11.8|11.5
1.6|1.9|1.8|722|X(a) Intracranial & intraspinal germ cell tumors|409325715|0-19|All Races|Male and Female|2010-2014|1.6|1.9|1.8
1.4|1.6|1.5|606|X(b) Malignant extracranial & extragonadal germ cell tumors|409325715|0-19|All Races|Male and Female|2010-2014|1.4|1.6|1.5
7.0|7.5|7.3|3040|X(c) Malignant gonadal germ cell tumors|409325715|0-19|All Races|Male and Female|2010-2014|7.2|7.7|7.4
0.4|0.5|0.4|187|X(d) Gonadal carcinomas|409325715|0-19|All Races|Male and Female|2010-2014|0.4|0.5|0.5
0.3|0.4|0.4|149|X(e) Other and unspecified malignant gonadal tumors|409325715|0-19|All Races|Male and Female|2010-2014|0.3|0.4|0.4
19.1|19.9|19.5|8127|XI Other malignant epithelial neoplasms and malignant melanomas|409325715|0-19|All Races|Male and Female|2010-2014|19.4|20.3|19.9
0.2|0.3|0.2|95|XI(a) Adrenocortical carcinomas|409325715|0-19|All Races|Male and Female|2010-2014|0.2|0.3|0.2
9.2|9.8|9.5|3958|XI(b) Thyroid carcinomas|409325715|0-19|All Races|Male and Female|2010-2014|9.4|10.0|9.7
0.5|0.6|0.5|222|XI(c) Nasopharyngeal carcinomas|409325715|0-19|All Races|Male and Female|2010-2014|0.5|0.6|0.5
4.0|4.4|4.2|1749|XI(d) Malignant melanomas|409325715|0-19|All Races|Male and Female|2010-2014|4.1|4.5|4.3
0.1|0.1|0.1|34|XI(e) Skin carcinomas|409325715|0-19|All Races|Male and Female|2010-2014|0.1|0.1|0.1
4.8|5.2|5.0|2069|XI(f) Other and unspecified carcinomas|409325715|0-19|All Races|Male and Female|2010-2014|4.8|5.3|5.1
0.7|0.8|0.8|312|XII Other and unspecified malignant neoplasms|409325715|0-19|All Races|Male and Female|2010-2014|0.7|0.9|0.8
0.3|0.4|0.4|156|XII(a) Other specified malignant tumors|409325715|0-19|All Races|Male and Female|2010-2014|0.3|0.4|0.4
0.3|0.4|0.4|156|XII(b) Other unspecified malignant tumors|409325715|0-19|All Races|Male and Female|2010-2014|0.3|0.4|0.4
180.0|185.9|182.9|15107|All ICCC Groups Combined|82115130|0-19|All Races|Male and Female|2011|181.1|186.9|184.0
47.4|50.5|48.9|4023|I Leukemias, myeloproliferative & myelodysplastic diseases|82115130|0-19|All Races|Male and Female|2011|47.5|50.5|49.0
34.3|36.8|35.5|2915|I(a) Lymphoid leukemias|82115130|0-19|All Races|Male and Female|2011|34.2|36.8|35.5
7.7|9.0|8.3|687|I(b) Acute myeloid leukemias|82115130|0-19|All Races|Male and Female|2011|7.8|9.0|8.4
2.0|2.7|2.3|192|I(c) Chronic myeloproliferative diseases|82115130|0-19|All Races|Male and Female|2011|2.0|2.7|2.3
1.1|1.6|1.3|106|I(d) Myelodysplastic syndrome and other myeloproliferative diseases|82115130|0-19|All Races|Male and Female|2011|1.1|1.6|1.3
1.2|1.8|1.5|123|I(e) Unspecified and other specified leukemias|82115130|0-19|All Races|Male and Female|2011|1.2|1.8|1.5
26.6|28.9|27.7|2298|II Lymphomas and reticuloendothelial neoplasms|82115130|0-19|All Races|Male and Female|2011|26.9|29.2|28.0
11.1|12.6|11.8|991|II(a) Hodgkin lymphomas|82115130|0-19|All Races|Male and Female|2011|11.3|12.8|12.1
7.8|9.0|8.4|694|II(b) Non-Hodgkin lymphomas (except Burkitt lymphoma)|82115130|0-19|All Races|Male and Female|2011|7.8|9.1|8.5
2.2|2.9|2.5|204|II(c) Burkitt lymphoma|82115130|0-19|All Races|Male and Female|2011|2.2|2.8|2.5
4.2|5.2|4.7|381|II(d) Miscellaneous lymphoreticular neoplasms|82115130|0-19|All Races|Male and Female|2011|4.2|5.1|4.6
0.2|0.5|0.3|28|II(e) Unspecified lymphomas|82115130|0-19|All Races|Male and Female|2011|0.2|0.5|0.3
31.6|34.1|32.8|2691|III CNS and misc intracranial and intraspinal neoplasms|82115130|0-19|All Races|Male and Female|2011|31.5|34.0|32.8
2.5|3.3|2.9|236|III(a) Ependymomas and choroid plexus tumor|82115130|0-19|All Races|Male and Female|2011|2.5|3.3|2.9
16.2|18.0|17.0|1398|III(b) Astrocytomas|82115130|0-19|All Races|Male and Female|2011|16.1|17.9|17.0
5.6|6.6|6.1|499|III(c) Intracranial and intraspinal embryonal tumors|82115130|0-19|All Races|Male and Female|2011|5.6|6.6|6.1
5.3|6.4|5.8|478|III(d) Other gliomas|82115130|0-19|All Races|Male and Female|2011|5.3|6.4|5.8
0.4|0.7|0.5|44|III(e) Other specified intracranial & intraspinal neoplasms|82115130|0-19|All Races|Male and Female|2011|0.4|0.7|0.5
0.3|0.6|0.4|36|III(f) Unspecified intracranial and intraspinal neoplasms|82115130|0-19|All Races|Male and Female|2011|0.3|0.6|0.4
7.9|9.2|8.6|702|IV Neuroblastoma and other peripheral nervous cell tumors|82115130|0-19|All Races|Male and Female|2011|7.9|9.2|8.5
7.7|8.9|8.3|681|IV(a) Neuroblastoma and ganglioneuroblastoma|82115130|0-19|All Races|Male and Female|2011|7.7|8.9|8.3
0.2|0.4|0.3|21|IV(b) Other peripheral nervous cell tumors|82115130|0-19|All Races|Male and Female|2011|0.2|0.4|0.3
11.4|12.9|12.2|1003|IX Soft tissue and other extraosseous sarcomas|82115130|0-19|All Races|Male and Female|2011|11.5|13.0|12.2
4.3|5.2|4.7|388|IX(a) Rhabdomyosarcomas|82115130|0-19|All Races|Male and Female|2011|4.3|5.2|4.7
1.1|1.6|1.3|108|IX(b) Fibrosarcomas, peripheral nerve sheath tumors & other fibrous neoplams|82115130|0-19|All Races|Male and Female|2011|1.1|1.6|1.3
~|~|~|~|IX(c) Kaposi sarcoma|82115130|0-19|All Races|Male and Female|2011|~|~|~
4.3|5.3|4.8|395|IX(d) Other specified soft tissue sarcomas|82115130|0-19|All Races|Male and Female|2011|4.3|5.3|4.8
1.0|1.5|1.3|104|IX(e) Unspecified soft tissue sarcomas|82115130|0-19|All Races|Male and Female|2011|1.0|1.5|1.3
0.2|0.5|0.3|26|Not classified by ICCC|82115130|0-19|All Races|Male and Female|2011|0.2|0.5|0.3
2.8|3.6|3.1|259|V Retinoblastoma|82115130|0-19|All Races|Male and Female|2011|2.8|3.6|3.2
6.6|7.8|7.2|593|VI Renal tumors|82115130|0-19|All Races|Male and Female|2011|6.7|7.8|7.2
6.0|7.1|6.5|537|VI(a) Nephroblastoma and other nonepithelial renal tumors|82115130|0-19|All Races|Male and Female|2011|6.0|7.1|6.5
0.5|0.9|0.7|55|VI(b) Renal carcinomas|82115130|0-19|All Races|Male and Female|2011|0.5|0.9|0.7
~|~|~|~|VI(c) Unspecified malignant renal tumors|82115130|0-19|All Races|Male and Female|2011|~|~|~
2.2|3.0|2.6|213|VII Hepatic tumors|82115130|0-19|All Races|Male and Female|2011|2.3|3.0|2.6
1.7|2.3|2.0|166|VII(a) Hepatoblastoma|82115130|0-19|All Races|Male and Female|2011|1.7|2.4|2.0
0.4|0.7|0.5|43|VII(b) Hepatic carcinomas|82115130|0-19|All Races|Male and Female|2011|0.4|0.7|0.5
~|~|~|~|VII(c) Unspecified malignant hepatic tumors|82115130|0-19|All Races|Male and Female|2011|~|~|~
8.3|9.6|9.0|740|VIII Malignant bone tumors|82115130|0-19|All Races|Male and Female|2011|8.4|9.7|9.0
4.6|5.6|5.1|419|VIII(a) Osteosarcomas|82115130|0-19|All Races|Male and Female|2011|4.6|5.6|5.1
0.2|0.4|0.3|21|VIII(b) Chondrosarcomas|82115130|0-19|All Races|Male and Female|2011|0.2|0.4|0.3
2.8|3.6|3.2|261|VIII(c) Ewing tumor and related sarcomas of bone|82115130|0-19|All Races|Male and Female|2011|2.8|3.6|3.2
0.2|0.5|0.3|27|VIII(d) Other specified malignant bone tumors|82115130|0-19|All Races|Male and Female|2011|0.2|0.5|0.3
~|~|~|~|VIII(e) Unspecified malignant bone tumors|82115130|0-19|All Races|Male and Female|2011|~|~|~
10.1|11.5|10.8|902|X Germ cell, trophoblastic tumors & neoplasms of gonads|82115130|0-19|All Races|Male and Female|2011|10.3|11.7|11.0
1.4|2.0|1.7|138|X(a) Intracranial & intraspinal germ cell tumors|82115130|0-19|All Races|Male and Female|2011|1.4|2.0|1.7
1.1|1.6|1.4|114|X(b) Malignant extracranial & extragonadal germ cell tumors|82115130|0-19|All Races|Male and Female|2011|1.1|1.7|1.4
6.6|7.7|7.1|603|X(c) Malignant gonadal germ cell tumors|82115130|0-19|All Races|Male and Female|2011|6.8|8.0|7.3
0.2|0.5|0.3|26|X(d) Gonadal carcinomas|82115130|0-19|All Races|Male and Female|2011|0.2|0.5|0.3
0.2|0.4|0.3|21|X(e) Other and unspecified malignant gonadal tumors|82115130|0-19|All Races|Male and Female|2011|0.2|0.4|0.3
18.1|20.0|19.1|1600|XI Other malignant epithelial neoplasms and malignant melanomas|82115130|0-19|All Races|Male and Female|2011|18.5|20.5|19.5
0.1|0.4|0.2|19|XI(a) Adrenocortical carcinomas|82115130|0-19|All Races|Male and Female|2011|0.1|0.4|0.2
8.6|9.9|9.2|778|XI(b) Thyroid carcinomas|82115130|0-19|All Races|Male and Female|2011|8.8|10.2|9.5
0.5|0.8|0.6|52|XI(c) Nasopharyngeal carcinomas|82115130|0-19|All Races|Male and Female|2011|0.5|0.8|0.6
3.9|4.8|4.3|364|XI(d) Malignant melanomas|82115130|0-19|All Races|Male and Female|2011|4.0|4.9|4.4
~|~|~|~|XI(e) Skin carcinomas|82115130|0-19|All Races|Male and Female|2011|~|~|~
4.1|5.0|4.5|379|XI(f) Other and unspecified carcinomas|82115130|0-19|All Races|Male and Female|2011|4.2|5.1|4.6
0.5|0.9|0.7|57|XII Other and unspecified malignant neoplasms|82115130|0-19|All Races|Male and Female|2011|0.5|0.9|0.7
0.2|0.5|0.3|27|XII(a) Other specified malignant tumors|82115130|0-19|All Races|Male and Female|2011|0.2|0.5|0.3
0.2|0.5|0.4|30|XII(b) Other unspecified malignant tumors|82115130|0-19|All Races|Male and Female|2011|0.2|0.5|0.4
180.4|186.2|183.3|15191|All ICCC Groups Combined|82500154|0-19|All Races|Male and Female|2012|181.2|187.1|184.1
45.7|48.7|47.2|3898|I Leukemias, myeloproliferative & myelodysplastic diseases|82500154|0-19|All Races|Male and Female|2012|45.8|48.8|47.2
32.5|35.0|33.7|2783|I(a) Lymphoid leukemias|82500154|0-19|All Races|Male and Female|2012|32.5|35.0|33.7
7.2|8.5|7.8|649|I(b) Acute myeloid leukemias|82500154|0-19|All Races|Male and Female|2012|7.3|8.5|7.9
2.0|2.7|2.4|197|I(c) Chronic myeloproliferative diseases|82500154|0-19|All Races|Male and Female|2012|2.1|2.7|2.4
1.2|1.8|1.5|123|I(d) Myelodysplastic syndrome and other myeloproliferative diseases|82500154|0-19|All Races|Male and Female|2012|1.2|1.8|1.5
1.5|2.1|1.8|146|I(e) Unspecified and other specified leukemias|82500154|0-19|All Races|Male and Female|2012|1.5|2.1|1.8
28.5|30.9|29.7|2466|II Lymphomas and reticuloendothelial neoplasms|82500154|0-19|All Races|Male and Female|2012|28.7|31.1|29.9
11.7|13.2|12.4|1040|II(a) Hodgkin lymphomas|82500154|0-19|All Races|Male and Female|2012|11.9|13.4|12.6
9.1|10.5|9.8|812|II(b) Non-Hodgkin lymphomas (except Burkitt lymphoma)|82500154|0-19|All Races|Male and Female|2012|9.2|10.5|9.8
2.0|2.7|2.3|191|II(c) Burkitt lymphoma|82500154|0-19|All Races|Male and Female|2012|2.0|2.7|2.3
4.2|5.1|4.7|383|II(d) Miscellaneous lymphoreticular neoplasms|82500154|0-19|All Races|Male and Female|2012|4.2|5.1|4.6
0.3|0.7|0.5|40|II(e) Unspecified lymphomas|82500154|0-19|All Races|Male and Female|2012|0.3|0.7|0.5
30.5|33.0|31.7|2615|III CNS and misc intracranial and intraspinal neoplasms|82500154|0-19|All Races|Male and Female|2012|30.5|32.9|31.7
2.3|3.1|2.7|221|III(a) Ependymomas and choroid plexus tumor|82500154|0-19|All Races|Male and Female|2012|2.3|3.1|2.7
16.0|17.8|16.9|1394|III(b) Astrocytomas|82500154|0-19|All Races|Male and Female|2012|16.0|17.8|16.9
5.3|6.4|5.8|479|III(c) Intracranial and intraspinal embryonal tumors|82500154|0-19|All Races|Male and Female|2012|5.3|6.4|5.8
4.6|5.6|5.1|423|III(d) Other gliomas|82500154|0-19|All Races|Male and Female|2012|4.7|5.6|5.1
0.4|0.7|0.5|44|III(e) Other specified intracranial & intraspinal neoplasms|82500154|0-19|All Races|Male and Female|2012|0.4|0.7|0.5
0.5|0.9|0.7|54|III(f) Unspecified intracranial and intraspinal neoplasms|82500154|0-19|All Races|Male and Female|2012|0.5|0.9|0.7
8.0|9.3|8.6|713|IV Neuroblastoma and other peripheral nervous cell tumors|82500154|0-19|All Races|Male and Female|2012|8.0|9.3|8.6
7.8|9.1|8.4|693|IV(a) Neuroblastoma and ganglioneuroblastoma|82500154|0-19|All Races|Male and Female|2012|7.8|9.0|8.4
0.1|0.4|0.2|20|IV(b) Other peripheral nervous cell tumors|82500154|0-19|All Races|Male and Female|2012|0.1|0.4|0.2
11.0|12.5|11.7|969|IX Soft tissue and other extraosseous sarcomas|82500154|0-19|All Races|Male and Female|2012|11.0|12.5|11.7
4.1|5.0|4.6|376|IX(a) Rhabdomyosarcomas|82500154|0-19|All Races|Male and Female|2012|4.1|5.0|4.6
1.0|1.5|1.2|103|IX(b) Fibrosarcomas, peripheral nerve sheath tumors & other fibrous neoplams|82500154|0-19|All Races|Male and Female|2012|1.0|1.5|1.2
~|~|~|~|IX(c) Kaposi sarcoma|82500154|0-19|All Races|Male and Female|2012|~|~|~
4.0|4.9|4.4|368|IX(d) Other specified soft tissue sarcomas|82500154|0-19|All Races|Male and Female|2012|4.0|4.9|4.5
1.2|1.7|1.4|116|IX(e) Unspecified soft tissue sarcomas|82500154|0-19|All Races|Male and Female|2012|1.2|1.7|1.4
0.1|0.4|0.2|20|Not classified by ICCC|82500154|0-19|All Races|Male and Female|2012|0.1|0.4|0.2
2.9|3.7|3.3|270|V Retinoblastoma|82500154|0-19|All Races|Male and Female|2012|2.9|3.7|3.3
6.4|7.6|7.0|579|VI Renal tumors|82500154|0-19|All Races|Male and Female|2012|6.5|7.6|7.0
5.7|6.8|6.2|513|VI(a) Nephroblastoma and other nonepithelial renal tumors|82500154|0-19|All Races|Male and Female|2012|5.7|6.8|6.2
0.6|0.9|0.7|61|VI(b) Renal carcinomas|82500154|0-19|All Races|Male and Female|2012|0.6|0.9|0.7
~|~|~|~|VI(c) Unspecified malignant renal tumors|82500154|0-19|All Races|Male and Female|2012|~|~|~
2.4|3.2|2.8|230|VII Hepatic tumors|82500154|0-19|All Races|Male and Female|2012|2.4|3.2|2.8
1.8|2.5|2.1|176|VII(a) Hepatoblastoma|82500154|0-19|All Races|Male and Female|2012|1.8|2.5|2.1
0.5|0.8|0.6|52|VII(b) Hepatic carcinomas|82500154|0-19|All Races|Male and Female|2012|0.5|0.8|0.6
~|~|~|~|VII(c) Unspecified malignant hepatic tumors|82500154|0-19|All Races|Male and Female|2012|~|~|~
8.3|9.6|9.0|742|VIII Malignant bone tumors|82500154|0-19|All Races|Male and Female|2012|8.4|9.7|9.0
4.7|5.7|5.2|430|VIII(a) Osteosarcomas|82500154|0-19|All Races|Male and Female|2012|4.7|5.7|5.2
0.2|0.5|0.3|28|VIII(b) Chondrosarcomas|82500154|0-19|All Races|Male and Female|2012|0.2|0.5|0.3
2.4|3.2|2.8|230|VIII(c) Ewing tumor and related sarcomas of bone|82500154|0-19|All Races|Male and Female|2012|2.4|3.2|2.8
0.3|0.6|0.4|34|VIII(d) Other specified malignant bone tumors|82500154|0-19|All Races|Male and Female|2012|0.3|0.6|0.4
0.1|0.4|0.2|20|VIII(e) Unspecified malignant bone tumors|82500154|0-19|All Races|Male and Female|2012|0.1|0.4|0.2
10.8|12.3|11.5|967|X Germ cell, trophoblastic tumors & neoplasms of gonads|82500154|0-19|All Races|Male and Female|2012|11.0|12.5|11.7
1.3|1.9|1.6|130|X(a) Intracranial & intraspinal germ cell tumors|82500154|0-19|All Races|Male and Female|2012|1.3|1.9|1.6
1.4|1.9|1.6|136|X(b) Malignant extracranial & extragonadal germ cell tumors|82500154|0-19|All Races|Male and Female|2012|1.4|1.9|1.6
7.0|8.2|7.6|638|X(c) Malignant gonadal germ cell tumors|82500154|0-19|All Races|Male and Female|2012|7.1|8.4|7.7
0.3|0.6|0.4|35|X(d) Gonadal carcinomas|82500154|0-19|All Races|Male and Female|2012|0.3|0.6|0.4
0.2|0.5|0.3|28|X(e) Other and unspecified malignant gonadal tumors|82500154|0-19|All Races|Male and Female|2012|0.2|0.5|0.3
18.6|20.5|19.6|1642|XI Other malignant epithelial neoplasms and malignant melanomas|82500154|0-19|All Races|Male and Female|2012|19.0|20.9|19.9
0.2|0.4|0.3|22|XI(a) Adrenocortical carcinomas|82500154|0-19|All Races|Male and Female|2012|0.2|0.4|0.3
9.0|10.3|9.7|811|XI(b) Thyroid carcinomas|82500154|0-19|All Races|Male and Female|2012|9.2|10.5|9.8
0.3|0.6|0.5|38|XI(c) Nasopharyngeal carcinomas|82500154|0-19|All Races|Male and Female|2012|0.3|0.6|0.5
3.8|4.7|4.2|354|XI(d) Malignant melanomas|82500154|0-19|All Races|Male and Female|2012|3.9|4.8|4.3
~|~|~|~|XI(e) Skin carcinomas|82500154|0-19|All Races|Male and Female|2012|~|~|~
4.4|5.4|4.9|409|XI(f) Other and unspecified carcinomas|82500154|0-19|All Races|Male and Female|2012|4.5|5.5|5.0
0.8|1.2|1.0|80|XII Other and unspecified malignant neoplasms|82500154|0-19|All Races|Male and Female|2012|0.8|1.2|1.0
0.3|0.6|0.4|34|XII(a) Other specified malignant tumors|82500154|0-19|All Races|Male and Female|2012|0.3|0.6|0.4
0.4|0.7|0.6|46|XII(b) Other unspecified malignant tumors|82500154|0-19|All Races|Male and Female|2012|0.4|0.7|0.6
179.1|184.9|182.0|15014|All ICCC Groups Combined|82277037|0-19|All Races|Male and Female|2013|179.6|185.4|182.5
44.9|47.9|46.4|3816|I Leukemias, myeloproliferative & myelodysplastic diseases|82277037|0-19|All Races|Male and Female|2013|44.9|47.9|46.4
31.1|33.6|32.3|2656|I(a) Lymphoid leukemias|82277037|0-19|All Races|Male and Female|2013|31.1|33.5|32.3
7.6|8.8|8.2|675|I(b) Acute myeloid leukemias|82277037|0-19|All Races|Male and Female|2013|7.6|8.8|8.2
2.0|2.7|2.3|194|I(c) Chronic myeloproliferative diseases|82277037|0-19|All Races|Male and Female|2013|2.0|2.7|2.4
1.3|1.8|1.5|125|I(d) Myelodysplastic syndrome and other myeloproliferative diseases|82277037|0-19|All Races|Male and Female|2013|1.3|1.8|1.5
1.7|2.4|2.0|166|I(e) Unspecified and other specified leukemias|82277037|0-19|All Races|Male and Female|2013|1.7|2.3|2.0
26.8|29.1|27.9|2308|II Lymphomas and reticuloendothelial neoplasms|82277037|0-19|All Races|Male and Female|2013|26.9|29.2|28.1
10.7|12.2|11.4|951|II(a) Hodgkin lymphomas|82277037|0-19|All Races|Male and Female|2013|10.8|12.3|11.6
8.3|9.6|8.9|739|II(b) Non-Hodgkin lymphomas (except Burkitt lymphoma)|82277037|0-19|All Races|Male and Female|2013|8.3|9.7|9.0
2.0|2.6|2.3|188|II(c) Burkitt lymphoma|82277037|0-19|All Races|Male and Female|2013|2.0|2.6|2.3
4.4|5.4|4.9|401|II(d) Miscellaneous lymphoreticular neoplasms|82277037|0-19|All Races|Male and Female|2013|4.4|5.4|4.9
0.2|0.5|0.4|29|II(e) Unspecified lymphomas|82277037|0-19|All Races|Male and Female|2013|0.2|0.5|0.4
30.9|33.4|32.2|2641|III CNS and misc intracranial and intraspinal neoplasms|82277037|0-19|All Races|Male and Female|2013|30.9|33.3|32.1
2.3|3.0|2.6|214|III(a) Ependymomas and choroid plexus tumor|82277037|0-19|All Races|Male and Female|2013|2.3|3.0|2.6
16.4|18.2|17.2|1417|III(b) Astrocytomas|82277037|0-19|All Races|Male and Female|2013|16.3|18.1|17.2
5.1|6.2|5.6|463|III(c) Intracranial and intraspinal embryonal tumors|82277037|0-19|All Races|Male and Female|2013|5.1|6.2|5.6
5.0|6.0|5.5|449|III(d) Other gliomas|82277037|0-19|All Races|Male and Female|2013|5.0|6.0|5.5
0.5|0.9|0.7|58|III(e) Other specified intracranial & intraspinal neoplasms|82277037|0-19|All Races|Male and Female|2013|0.5|0.9|0.7
0.3|0.7|0.5|40|III(f) Unspecified intracranial and intraspinal neoplasms|82277037|0-19|All Races|Male and Female|2013|0.3|0.7|0.5
8.6|9.9|9.2|756|IV Neuroblastoma and other peripheral nervous cell tumors|82277037|0-19|All Races|Male and Female|2013|8.5|9.9|9.2
8.3|9.6|8.9|730|IV(a) Neuroblastoma and ganglioneuroblastoma|82277037|0-19|All Races|Male and Female|2013|8.2|9.5|8.9
0.2|0.5|0.3|26|IV(b) Other peripheral nervous cell tumors|82277037|0-19|All Races|Male and Female|2013|0.2|0.5|0.3
11.0|12.5|11.7|968|IX Soft tissue and other extraosseous sarcomas|82277037|0-19|All Races|Male and Female|2013|11.0|12.5|11.8
4.3|5.3|4.8|395|IX(a) Rhabdomyosarcomas|82277037|0-19|All Races|Male and Female|2013|4.3|5.3|4.8
1.0|1.5|1.2|102|IX(b) Fibrosarcomas, peripheral nerve sheath tumors & other fibrous neoplams|82277037|0-19|All Races|Male and Female|2013|1.0|1.5|1.2
~|~|~|~|IX(c) Kaposi sarcoma|82277037|0-19|All Races|Male and Female|2013|~|~|~
4.0|4.9|4.5|368|IX(d) Other specified soft tissue sarcomas|82277037|0-19|All Races|Male and Female|2013|4.0|5.0|4.5
1.0|1.5|1.2|102|IX(e) Unspecified soft tissue sarcomas|82277037|0-19|All Races|Male and Female|2013|1.0|1.5|1.2
0.2|0.4|0.3|25|Not classified by ICCC|82277037|0-19|All Races|Male and Female|2013|0.2|0.4|0.3
2.8|3.6|3.2|263|V Retinoblastoma|82277037|0-19|All Races|Male and Female|2013|2.8|3.6|3.2
6.7|7.9|7.3|602|VI Renal tumors|82277037|0-19|All Races|Male and Female|2013|6.7|7.9|7.3
5.9|7.0|6.4|527|VI(a) Nephroblastoma and other nonepithelial renal tumors|82277037|0-19|All Races|Male and Female|2013|5.9|7.0|6.4
0.7|1.1|0.9|72|VI(b) Renal carcinomas|82277037|0-19|All Races|Male and Female|2013|0.7|1.1|0.9
~|~|~|~|VI(c) Unspecified malignant renal tumors|82277037|0-19|All Races|Male and Female|2013|~|~|~
2.1|2.8|2.4|198|VII Hepatic tumors|82277037|0-19|All Races|Male and Female|2013|2.1|2.8|2.4
1.5|2.1|1.8|145|VII(a) Hepatoblastoma|82277037|0-19|All Races|Male and Female|2013|1.5|2.1|1.8
0.5|0.8|0.6|51|VII(b) Hepatic carcinomas|82277037|0-19|All Races|Male and Female|2013|0.5|0.8|0.6
~|~|~|~|VII(c) Unspecified malignant hepatic tumors|82277037|0-19|All Races|Male and Female|2013|~|~|~
8.5|9.8|9.1|752|VIII Malignant bone tumors|82277037|0-19|All Races|Male and Female|2013|8.5|9.8|9.1
4.5|5.4|4.9|406|VIII(a) Osteosarcomas|82277037|0-19|All Races|Male and Female|2013|4.5|5.4|4.9
0.2|0.5|0.4|29|VIII(b) Chondrosarcomas|82277037|0-19|All Races|Male and Female|2013|0.2|0.5|0.4
2.8|3.6|3.2|262|VIII(c) Ewing tumor and related sarcomas of bone|82277037|0-19|All Races|Male and Female|2013|2.8|3.6|3.2
0.4|0.7|0.5|41|VIII(d) Other specified malignant bone tumors|82277037|0-19|All Races|Male and Female|2013|0.4|0.7|0.5
~|~|~|~|VIII(e) Unspecified malignant bone tumors|82277037|0-19|All Races|Male and Female|2013|~|~|~
11.0|12.5|11.8|979|X Germ cell, trophoblastic tumors & neoplasms of gonads|82277037|0-19|All Races|Male and Female|2013|11.2|12.7|11.9
1.6|2.2|1.9|157|X(a) Intracranial & intraspinal germ cell tumors|82277037|0-19|All Races|Male and Female|2013|1.6|2.2|1.9
1.1|1.6|1.3|111|X(b) Malignant extracranial & extragonadal germ cell tumors|82277037|0-19|All Races|Male and Female|2013|1.1|1.6|1.3
7.0|8.2|7.6|631|X(c) Malignant gonadal germ cell tumors|82277037|0-19|All Races|Male and Female|2013|7.1|8.3|7.7
0.4|0.7|0.5|46|X(d) Gonadal carcinomas|82277037|0-19|All Races|Male and Female|2013|0.4|0.7|0.6
0.3|0.6|0.4|34|X(e) Other and unspecified malignant gonadal tumors|82277037|0-19|All Races|Male and Female|2013|0.3|0.6|0.4
18.7|20.6|19.7|1636|XI Other malignant epithelial neoplasms and malignant melanomas|82277037|0-19|All Races|Male and Female|2013|18.9|20.9|19.9
~|~|~|~|XI(a) Adrenocortical carcinomas|82277037|0-19|All Races|Male and Female|2013|~|~|~
8.7|10.1|9.4|782|XI(b) Thyroid carcinomas|82277037|0-19|All Races|Male and Female|2013|8.8|10.2|9.5
0.5|0.8|0.6|52|XI(c) Nasopharyngeal carcinomas|82277037|0-19|All Races|Male and Female|2013|0.5|0.8|0.6
3.8|4.7|4.2|352|XI(d) Malignant melanomas|82277037|0-19|All Races|Male and Female|2013|3.8|4.7|4.3
~|~|~|~|XI(e) Skin carcinomas|82277037|0-19|All Races|Male and Female|2013|~|~|~
4.7|5.7|5.2|434|XI(f) Other and unspecified carcinomas|82277037|0-19|All Races|Male and Female|2013|4.8|5.8|5.3
0.7|1.1|0.8|70|XII Other and unspecified malignant neoplasms|82277037|0-19|All Races|Male and Female|2013|0.7|1.1|0.9
0.3|0.6|0.4|36|XII(a) Other specified malignant tumors|82277037|0-19|All Races|Male and Female|2013|0.3|0.6|0.4
0.3|0.6|0.4|34|XII(b) Other unspecified malignant tumors|82277037|0-19|All Races|Male and Female|2013|0.3|0.6|0.4
181.5|187.4|184.4|15190|All ICCC Groups Combined|82156139|0-19|All Races|Male and Female|2014|182.0|187.9|184.9
44.8|47.8|46.3|3807|I Leukemias, myeloproliferative & myelodysplastic diseases|82156139|0-19|All Races|Male and Female|2014|44.9|47.8|46.3
31.2|33.6|32.4|2659|I(a) Lymphoid leukemias|82156139|0-19|All Races|Male and Female|2014|31.1|33.6|32.4
7.7|9.0|8.3|687|I(b) Acute myeloid leukemias|82156139|0-19|All Races|Male and Female|2014|7.7|9.0|8.4
1.9|2.5|2.2|182|I(c) Chronic myeloproliferative diseases|82156139|0-19|All Races|Male and Female|2014|1.9|2.6|2.2
1.2|1.8|1.5|122|I(d) Myelodysplastic syndrome and other myeloproliferative diseases|82156139|0-19|All Races|Male and Female|2014|1.2|1.8|1.5
1.6|2.2|1.9|157|I(e) Unspecified and other specified leukemias|82156139|0-19|All Races|Male and Female|2014|1.6|2.2|1.9
29.1|31.5|30.3|2502|II Lymphomas and reticuloendothelial neoplasms|82156139|0-19|All Races|Male and Female|2014|29.3|31.7|30.5
11.0|12.5|11.7|973|II(a) Hodgkin lymphomas|82156139|0-19|All Races|Male and Female|2014|11.1|12.6|11.8
9.9|11.3|10.6|873|II(b) Non-Hodgkin lymphomas (except Burkitt lymphoma)|82156139|0-19|All Races|Male and Female|2014|9.9|11.4|10.6
2.3|3.0|2.6|215|II(c) Burkitt lymphoma|82156139|0-19|All Races|Male and Female|2014|2.3|3.0|2.6
4.5|5.5|5.0|410|II(d) Miscellaneous lymphoreticular neoplasms|82156139|0-19|All Races|Male and Female|2014|4.5|5.5|5.0
0.3|0.5|0.4|31|II(e) Unspecified lymphomas|82156139|0-19|All Races|Male and Female|2014|0.3|0.5|0.4
30.4|32.8|31.6|2593|III CNS and misc intracranial and intraspinal neoplasms|82156139|0-19|All Races|Male and Female|2014|30.4|32.8|31.6
2.3|3.1|2.7|220|III(a) Ependymomas and choroid plexus tumor|82156139|0-19|All Races|Male and Female|2014|2.3|3.1|2.7
15.7|17.5|16.5|1359|III(b) Astrocytomas|82156139|0-19|All Races|Male and Female|2014|15.7|17.4|16.5
5.4|6.4|5.9|482|III(c) Intracranial and intraspinal embryonal tumors|82156139|0-19|All Races|Male and Female|2014|5.4|6.4|5.9
4.6|5.6|5.1|418|III(d) Other gliomas|82156139|0-19|All Races|Male and Female|2014|4.6|5.6|5.1
0.6|1.0|0.8|66|III(e) Other specified intracranial & intraspinal neoplasms|82156139|0-19|All Races|Male and Female|2014|0.6|1.0|0.8
0.4|0.8|0.6|48|III(f) Unspecified intracranial and intraspinal neoplasms|82156139|0-19|All Races|Male and Female|2014|0.4|0.8|0.6
8.2|9.5|8.9|728|IV Neuroblastoma and other peripheral nervous cell tumors|82156139|0-19|All Races|Male and Female|2014|8.2|9.5|8.9
7.9|9.2|8.5|701|IV(a) Neuroblastoma and ganglioneuroblastoma|82156139|0-19|All Races|Male and Female|2014|7.9|9.2|8.5
0.2|0.5|0.3|27|IV(b) Other peripheral nervous cell tumors|82156139|0-19|All Races|Male and Female|2014|0.2|0.5|0.3
11.3|12.9|12.1|995|IX Soft tissue and other extraosseous sarcomas|82156139|0-19|All Races|Male and Female|2014|11.4|12.9|12.1
3.9|4.8|4.3|353|IX(a) Rhabdomyosarcomas|82156139|0-19|All Races|Male and Female|2014|3.9|4.8|4.3
1.2|1.7|1.4|119|IX(b) Fibrosarcomas, peripheral nerve sheath tumors & other fibrous neoplams|82156139|0-19|All Races|Male and Female|2014|1.2|1.7|1.4
~|~|~|~|IX(c) Kaposi sarcoma|82156139|0-19|All Races|Male and Female|2014|~|~|~
4.4|5.4|4.9|405|IX(d) Other specified soft tissue sarcomas|82156139|0-19|All Races|Male and Female|2014|4.5|5.4|4.9
1.1|1.7|1.4|113|IX(e) Unspecified soft tissue sarcomas|82156139|0-19|All Races|Male and Female|2014|1.1|1.7|1.4
0.2|0.4|0.3|25|Not classified by ICCC|82156139|0-19|All Races|Male and Female|2014|0.2|0.4|0.3
2.8|3.6|3.2|261|V Retinoblastoma|82156139|0-19|All Races|Male and Female|2014|2.8|3.6|3.2
6.6|7.7|7.1|586|VI Renal tumors|82156139|0-19|All Races|Male and Female|2014|6.6|7.7|7.1
5.9|7.1|6.5|532|VI(a) Nephroblastoma and other nonepithelial renal tumors|82156139|0-19|All Races|Male and Female|2014|5.9|7.0|6.5
0.5|0.8|0.6|52|VI(b) Renal carcinomas|82156139|0-19|All Races|Male and Female|2014|0.5|0.8|0.6
~|~|~|~|VI(c) Unspecified malignant renal tumors|82156139|0-19|All Races|Male and Female|2014|~|~|~
2.2|2.9|2.5|205|VII Hepatic tumors|82156139|0-19|All Races|Male and Female|2014|2.2|2.9|2.5
1.6|2.2|1.9|157|VII(a) Hepatoblastoma|82156139|0-19|All Races|Male and Female|2014|1.6|2.2|1.9
0.4|0.7|0.6|46|VII(b) Hepatic carcinomas|82156139|0-19|All Races|Male and Female|2014|0.4|0.7|0.6
~|~|~|~|VII(c) Unspecified malignant hepatic tumors|82156139|0-19|All Races|Male and Female|2014|~|~|~
8.7|10.0|9.3|765|VIII Malignant bone tumors|82156139|0-19|All Races|Male and Female|2014|8.7|10.0|9.3
4.6|5.6|5.1|421|VIII(a) Osteosarcomas|82156139|0-19|All Races|Male and Female|2014|4.6|5.6|5.1
0.2|0.5|0.4|29|VIII(b) Chondrosarcomas|82156139|0-19|All Races|Male and Female|2014|0.2|0.5|0.4
2.7|3.4|3.0|249|VIII(c) Ewing tumor and related sarcomas of bone|82156139|0-19|All Races|Male and Female|2014|2.7|3.4|3.0
0.4|0.7|0.5|45|VIII(d) Other specified malignant bone tumors|82156139|0-19|All Races|Male and Female|2014|0.4|0.7|0.5
0.2|0.4|0.3|21|VIII(e) Unspecified malignant bone tumors|82156139|0-19|All Races|Male and Female|2014|0.2|0.4|0.3
10.3|11.7|11.0|911|X Germ cell, trophoblastic tumors & neoplasms of gonads|82156139|0-19|All Races|Male and Female|2014|10.4|11.8|11.1
1.4|1.9|1.6|135|X(a) Intracranial & intraspinal germ cell tumors|82156139|0-19|All Races|Male and Female|2014|1.4|1.9|1.6
1.4|2.0|1.7|137|X(b) Malignant extracranial & extragonadal germ cell tumors|82156139|0-19|All Races|Male and Female|2014|1.4|2.0|1.7
6.3|7.4|6.8|569|X(c) Malignant gonadal germ cell tumors|82156139|0-19|All Races|Male and Female|2014|6.4|7.5|6.9
0.3|0.6|0.4|37|X(d) Gonadal carcinomas|82156139|0-19|All Races|Male and Female|2014|0.3|0.6|0.5
0.3|0.6|0.4|33|X(e) Other and unspecified malignant gonadal tumors|82156139|0-19|All Races|Male and Female|2014|0.3|0.6|0.4
20.2|22.2|21.2|1760|XI Other malignant epithelial neoplasms and malignant melanomas|82156139|0-19|All Races|Male and Female|2014|20.4|22.4|21.4
0.1|0.4|0.2|20|XI(a) Adrenocortical carcinomas|82156139|0-19|All Races|Male and Female|2014|0.1|0.4|0.2
9.8|11.2|10.5|873|XI(b) Thyroid carcinomas|82156139|0-19|All Races|Male and Female|2014|9.9|11.4|10.6
0.3|0.5|0.4|31|XI(c) Nasopharyngeal carcinomas|82156139|0-19|All Races|Male and Female|2014|0.3|0.5|0.4
3.7|4.6|4.1|340|XI(d) Malignant melanomas|82156139|0-19|All Races|Male and Female|2014|3.7|4.6|4.1
~|~|~|~|XI(e) Skin carcinomas|82156139|0-19|All Races|Male and Female|2014|~|~|~
5.4|6.5|5.9|490|XI(f) Other and unspecified carcinomas|82156139|0-19|All Races|Male and Female|2014|5.4|6.5|6.0
0.5|0.8|0.6|52|XII Other and unspecified malignant neoplasms|82156139|0-19|All Races|Male and Female|2014|0.5|0.8|0.6
0.2|0.5|0.4|29|XII(a) Other specified malignant tumors|82156139|0-19|All Races|Male and Female|2014|0.2|0.5|0.4
0.2|0.4|0.3|23|XII(b) Other unspecified malignant tumors|82156139|0-19|All Races|Male and Female|2014|0.2|0.4|0.3
